cyclosporine has been researched along with Acute Disease in 773 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 314 (40.62) | 18.2507 |
| 2000's | 331 (42.82) | 29.6817 |
| 2010's | 110 (14.23) | 24.3611 |
| 2020's | 18 (2.33) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, G; Feng, Y; Gao, X; Guo, Y; He, S; Li, XR; Qi, Y; Salahdiin, K; Shang, T; Shen, R; Shi, ZX; Wang, M; Wang, Y; Yang, J; Zhao, X; Zhou, Z; Zhu, Y | 1 |
| De Las Morenas-Iglesias, J; Del Estad-Cabello, A; Franco-Ruedas, C; Gonzalez-Jauregui, B; Lechon-Caballero, B; López-Herrero, F; Moruno-Rodríguez, A; Rueda-Rueda, T; Sanchez-Vicente, JL; Talego-Sancha, A | 1 |
| Arcuri, LJ; Lerner, D; Tavares, RCBDS | 1 |
| Blosser, N; Dersch-Mills, D; Duggan, P; Ghosh, S; Jamani, K; Kwan, ACF; Leyshon, C; Puckrin, R; Savoie, L; Stewart, D; Storek, J; Zepeda, V | 1 |
| Abu El-Asrar, AM; Albloushi, AF; Alkheraiji, NF; Almater, AI; Alromaih, AZ | 1 |
| Krebs, B; Menter, AM; Valdecantos, WC; Weiss, J; Zema, CL | 1 |
| Nakase, H | 1 |
| Blanchard, I; Kodali, N; Kunamneni, S; Lebwohl, MG | 1 |
| Aala, WJF; Chen, PH; Chuang, YR; Hong, YK; Hsu, CK; Jeng, YC; Lin, YC; Yang, CC | 1 |
| Akashi, T; Ashida, K; Demiya, M; Fukami, K; Ito, H; Kubo, S; Motomura, S; Nagayama, A; Nomura, M; Ueda, U | 1 |
| Criddle, DN | 1 |
| Jiang, Z; Wan, D; Wang, M; Zhang, J; Zhao, H | 1 |
| Chung, EK; Gwak, HS; Kim, JY; Yee, J | 1 |
| Argaud, L; Cour, M; Ovize, M | 1 |
| Chu, PS; Ebinuma, H; Hoshi, H; Ikura, A; Kanai, T; Morikawa, R; Nakamoto, N; Noguchi, F; Saito, H; Taniki, N; Usui, S; Yamaguchi, A; Yamataka, K; Yoshida, A | 1 |
| Gui, Q; Jiang, Z; Zhang, L | 1 |
| Ashwell, JD; Dutta, D; Gaida, MM; Melis, N; Otsuka, S; Weigert, R | 1 |
| Dai, C; Huang, YH; Jiang, M | 1 |
| Corradini, P; Greco, R; Mussetti, A; Peccatori, J | 1 |
| Baek, S; Choi, EJ; Choi, Y; Jeon, M; Jo, JC; Joo, YD; Kang, YA; Kang, YL; Kim, DY; Kim, H; Kim, SH; Ko, SH; Lee, JH; Lee, KH; Lee, YS; Lim, SN; Park, HS; Seol, M; Yun, SC | 1 |
| Aguas, M; Aguirresarobe, M; Bermejo, F; Calvet, X; Cañas-Ventura, A; Chaparro, M; De Castro, ML; Domènech, E; Esteve, M; Fernández, L; Fernández-Bañares, F; Garcia-Planella, E; García-Sánchez, V; García-Sepulcre, MF; Gento, E; Gomollón, F; Gutiérrez, A; Iglesias-Flores, E; Jiménez, CE; Mañosa, M; Merino, O; Mir, A; Montoro, MA; Muñoz, C; Muñoz, F; Ordás, I; Panés, J; Peñalva, M; Vera, M | 1 |
| Bouhnik, Y; Maggiori, L; Mege, D; Monsinjon, M; Panis, Y; Treton, X | 1 |
| Fakin, R; Gazdhar, A; Geiser, T; Grodzki, T; Gugger, M; Kocher, G; Pieróg, J; Schmid, RA; Tamo, L | 1 |
| Chang, YC; Chao, YH; Peng, CT; Weng, TF; Wu, HP; Wu, KH | 1 |
| Du, L; Kijlstra, A; Liang, L; Qi, J; Wang, C; Wu, L; Yang, P; Ye, Z; Zhou, Q | 1 |
| Dong, Y; Liu, H; Liu, W; Miao, S; Qin, C; Ren, H; Shi, Y; Tang, B; Wang, Z | 1 |
| Akahane, D; Gotoh, M; Kobayashi, C; Ohyashiki, JH; Ohyashiki, K; Saitoh, Y; Umezu, T; Yoshizawa, S | 1 |
| Ahuja, V; Jain, S; Limdi, JK | 1 |
| Cohen, RD; Dalal, S; El Jurdi, K; Ollech, JE; Pekow, J; Rubin, DT; Sakuraba, A; Weisshof, R; Yvellez, OV | 1 |
| Blijlevens, NMA; Bremmers, MEJ; Brüggemann, RJM; de Kort, EA; de Lil, HS; Huls, G; van der Velden, WJFM; van Dorp, S; van Groningen, LFJ | 1 |
| Battipaglia, G; Bazarbachi, A; Belhocine, R; Brissot, E; Duléry, R; Ledraa, T; Malard, F; Médiavilla, C; Mohty, M; Mohty, R; Paviglianiti, A; Ruggeri, A; Sestili, S; Stocker, N; Vekhoff, A | 1 |
| Bressler, B; Moore, AC | 1 |
| Andreassen, AK; Arora, S; Aukrust, P; Berge, RK; Broch, K; Dellgren, G; Gude, E; Gullestad, L; Hov, JR; Karason, K; Mayerhofer, CCK; Svardal, A; Trøseid, M; Ueland, T | 1 |
| Blazar, BR; DeFor, TE; Holtan, SG; MacMillan, ML; Rashidi, A; Weisdorf, DJ | 1 |
| Li, D; Li, ZY; Pan, X; Qiu, T; Wu, Q; Xu, K; Yan, Z | 1 |
| Backman, JT; Fanta, S; Frobel, AK; Holmberg, C; Hoppu, K; Jalanko, H; Jönsson, S; Karlsson, MO; Keizer, RJ; Qvist, E; Seikku, P | 1 |
| D'Ascenzo, G; Feci, L; Fimiani, M; Marotta, G; Murdaca, F; Poggiali, S; Rubegni, P | 1 |
| Abu El-Asrar, AM; Al Tamimi, M; Al-Mezaine, HS; Al-Muammar, A; Hemachandran, S; Kangave, D | 1 |
| Afrooz, PN; Bourbeau, D; Lee, WPA; Pulikkottil, BJ; Solari, MG; Unadkat, JV; Washington, KM; Weber, DJ | 1 |
| Aoki, N; Fujita, K; Kikuchi, E; Okai, T; Shoji, N; Sonoda, Y; Suzuki, A; Torigai, H; Uekubo, K; Yamashita, H | 1 |
| McNeil, C | 1 |
| Chen, HS; Liu, JP; Wang, W; Wu, SN | 1 |
| Ding, XM; Jin, ZK; Jing, X; Li, Y; Luo, ZZ; Tian, PX; Tian, XH; Wang, XZ; Xue, WJ; Zheng, J | 1 |
| Hamamoto, K; Inoue, M; Kobayashi, R; Kojima, S; Muramatsu, H; Ohara, A; Ohga, S; Ohtsuka, Y; Shichino, H; Shimada, H; Takahashi, Y; Yabe, H; Yagasaki, H | 1 |
| Ichikawa, K; Mori, M; Motoi, H; Nezu, A; Oyama, Y; Takeshita, S; Watanabe, Y; Yokota, S | 1 |
| Giese, T; Hinz, U; Sandig, C; Sommerer, C; Steinebrunner, N; Stremmel, W; Zahn, A | 1 |
| Constable, H; Jones, K; Wood, F | 1 |
| Hirohata, S; Ishigatsubo, Y; Kikuchi, H; Kuwana, M; Nagafuchi, H; Sawada, T; Takeno, M | 1 |
| Farkas, K; Molnár, T; Szepes, Z | 1 |
| Ha, J; Huh, KH; Kim, YH; Kim, YL; Kim, YS; Oh, CK | 1 |
| Nakao, S | 1 |
| Abounader, D; Bolwell, B; Copelan, E; Dean, R; Duong, H; Haddad, H; Hamilton, BK; Hanna, R; Hill, BT; Kalaycio, M; Majhail, NS; Rybicki, L; Sobecks, R | 1 |
| Asashima, H; Ebe, H; Hagiwara, S; Hirota, T; Inoue, S; Kaneko, S; Kawaguchi, H; Kondo, Y; Kurashima, Y; Kurata, I; Matsumoto, I; Miki, H; Ogishima, H; Sumida, T; Suzuki, T; Takahashi, H; Tsuboi, H; Umeda, N; Yokosawa, M | 1 |
| Charron, D; Couture, F; Filion, A; Guillemette, C; Lalancette, M; Laverdière, I; Lévesque, É; Loiseau, P; Peffault de Latour, R; Robin, M; Socié, G; Tamouza, R; Tourancheau, A | 1 |
| Choudhuri, G; Kochhar, R; Ramakrishna, BS | 1 |
| Khosla, R; Kumar, NS; Makharia, GK | 1 |
| Ahuja, V; Kochhar, R; Kumar, A | 1 |
| Burger, D; Catuneanu, AM; Cesarini, M; Corte, C; Fernandopulle, N; Keshav, S; Travis, S; White, L | 1 |
| Bierings, M; Boelens, JJ; Broers, AE; Cuijpers, ML; Huisman, C; Huls, G; Janssen, JJ; Kuball, J; Lindemans, CA; Mansilla, C; Petersen, EJ; Plantinga, M; Slaper-Cortenbach, IC; Spierings, E; Te Boome, LC; Thus, KA; van der Wagen, LE; van Imhoff, GW; Westinga, K; Wulffraat, NM; Zeerleder, S | 1 |
| Murata, M | 2 |
| Djamali, A; Huang, G; Redfield, RR; Reese, SR; Wilson, NA; Zhong, W | 1 |
| Azmandian, J; Khatami, SM; Nazemian, F; Razeghi, E; Sadri, F; Sagheb, MM; Sayyah, M; Shahidi, S; Shamshiri, AR; Taheri, S | 1 |
| Alarcón-Payer, C; García-Martín, P; Jurado, M; López-Fernández, E; Moratalla, L; Ríos, R; Romero, A; Sainz, J | 1 |
| Afanasyev, B; Al Seraihy, A; Aljurf, M; Ancliff, P; Bierings, M; Calvillo, M; de Wreede, L; Donadieu, J; Dufour, C; Fioredda, F; Fischer, A; Ganser, A; Gaspar, B; Iacobelli, S; Kalwak, K; Ljungman, P; Marsh, J; Matthes-Martin, S; Morreale, G; Or, R; Ozturk, G; Peffault de Latour, R; Peters, C; Sánchez de Toledo Codina, J; Smith, O; van 't Veer-Tazelaar, N; van Biezen, A; Veys, P; Wynn, R; Yesilipek, A | 1 |
| Barbruni, G; Caratto, E; Caratto, M; Fornaro, F; Fornaro, R; Giovinazzo, D; Salerno, A; Sticchi, C | 1 |
| Arora, M; Bejanyan, N; Blazar, BR; Brunstein, CG; DeFor, T; Holtan, S; Lazaryan, A; MacMillan, ML; Wagner, JE; Weisdorf, DJ | 1 |
| Arai, Y; Atsuta, Y; Eto, T; Fukuda, T; Hirokawa, M; Iwato, K; Kaida, K; Kanda, J; Kanda, Y; Kondo, T; Morishima, Y; Murata, M; Nagamura-Inoue, T; Nakamae, H; Nakasone, H; Ohashi, K; Uchida, N | 1 |
| Bhagani, S; Davies, G; Gathogo, E; Harber, M; Hilton, R; Jones, R; Levy, J; Post, FA | 1 |
| Ashizawa, M; Doki, N; Kakihana, K; Kako, S; Kanamori, H; Kanda, Y; Kato, J; Kikuchi, M; Kimura, SI; Kobayashi, T; Mori, T; Nakaseko, C; Okamoto, S; Tanaka, M; Tanihara, A; Watanabe, R; Yokota, A | 1 |
| Akyuz, F; Besisik, F; Dogan, IO; Gulluoglu, M; Kara, E; Sahutoglu, T | 1 |
| Ding, K; Geng, L; Liu, H; Sun, G; Sun, Z; Tang, B; Wang, L; Wang, X; Zheng, C | 1 |
| De Cruz, P; Seah, D | 1 |
| Davies, SM; Filipovich, AH; Grimley, MS; Khandelwal, P; Lane, A; Marsh, RA; Mellor-Heineke, S; Rehman, N; Smiley, K; Villanueva, J | 1 |
| Adachi, S; Ago, H; Atsuta, Y; Eto, T; Fukuda, T; Iwato, K; Kanamori, H; Kobayashi, N; Miyamura, K; Mori, T; Morishima, Y; Morita, S; Murata, M; Nagamura-Inoue, T; Ohashi, K; Oshima, K; Sakai, R; Sakamaki, H; Taguri, M; Taniguchi, S | 1 |
| Belleannée, G; Capdepont, M; Chabrun, E; Fron, C; Laharie, D; Pierry, C; Poullenot, F; Subtil, C; Zerbib, F | 1 |
| Gregory, DG | 1 |
| Annese, V; Bagnoli, S; Caini, S; Deiana, S; Giannotta, M; Manetti, N; Scaringi, S | 1 |
| Deza, G; Giménez-Arnau, AM | 1 |
| D'Haens, G; Hindryckx, P; Jairath, V | 1 |
| Andreoli, A; Boissel, N; de Latour, RP; Dhédin, N; Granier, C; Larghero, J; Lengliné, E; Masson, E; Robin, M; Schlageter, MH; Socié, G; Vignon, M | 1 |
| Agüero, F; Ambrosioni, J; Brunet, M; Caballero, M; de Lazzari, E; Gallart, T; Gatell, JM; Guardo, AC; López-Diéguez, M; Manzardo, C; Marcos, MÁ; Miró, JM; Mosquera, MM; Muñoz-Fernández, MÁ; Nicolás, D; Plana, M; Sued, O; Tuset, M | 1 |
| Danylesko, I; Nagler, A; Shem-Tov, N; Shimoni, A; Shouval, R; Yerushalmi, R | 1 |
| Altınörs, DD; Asena, L; Burcu, A; Çolak, M; Ercan, E; Şıngar Özdemir, E | 1 |
| Barker, JN; Capon, F; Choon, SE; Lau, BW; Lim, DZ | 1 |
| Chen, X; Du, X; Gao, L; Kong, P; Li, H; Liu, H; Liu, J; Liu, Y; Peng, X; Su, Y; Sun, A; Zhang, C; Zhang, X; Zhang, Y; Zhong, J | 1 |
| Kanda, Y | 1 |
| Empey, P; Hatton, J; Kryscio, R; Rosbolt, B; Young, B | 1 |
| Al-Abdwani, RM; Balkhair, A; Khamis, FA; Sacharia, M; Wali, YA | 1 |
| Constantinou, M; Lamoureux, E; Poon, A; Taylor, HR | 1 |
| Nashan, B | 1 |
| Chiang, GS; Liew, A; Vathsala, A | 1 |
| Ferrer Arranz, L; Huguet Malavés, JM; Medina Chuliá, E; Ruiz Sánchez, L | 1 |
| Pandit, RT | 1 |
| Jeong, HJ; Kim, YS; Kwon, J; Lee, D; Park, J | 1 |
| de Hoon, J; Meersseman, W; Spriet, I; von Winckelmann, S; Willems, L; Wilmer, A | 1 |
| Kuypers, DR; Naesens, M; Sarwal, M | 1 |
| Aisa, Y; Ikeda, Y; Kato, J; Mori, T; Okamoto, S; Shimizu, T; Suzuki, N; Suzuki, S; Tsukada, Y | 1 |
| Anasetti, C; Appelbaum, FR; Carnevale-Schianca, F; Carpenter, PA; Deeg, HJ; Furlong, T; Kiem, HP; Leisenring, W; Martin, PJ; McDonald, GB; Nash, RA; Schoch, G; Storb, R | 1 |
| Arrigain, S; Aurora, P; Ballmann, M; Boyer, D; Conrad, C; Danziger-Isakov, LA; Eichler, I; Elidemir, O; Faro, A; Goldfarb, S; Mallory, GB; Michaels, MG; Mogayzel, PJ; Parakininkas, D; Solomon, M; Sweet, S; Visner, G; Worley, S | 1 |
| Bahceci, E; Devetten, M; Herzig, R; Holland, K; Isola, L; Jansen, J; Kebriaei, P; McGuirk, J; Monroy, R; Rowley, S; Schuster, M; Uberti, J | 1 |
| Li, J; Xia, J; Xu, L; Zhang, K | 1 |
| Cho, GJ; Choi, YJ; Chung, JS; Kwon, BR; Seol, YM; Shin, HJ; Song, MK | 1 |
| Hu, RH; Lai, IR; Lee, CY; Lee, PH; Tsai, MK; Wu, FL | 1 |
| Koltun, WA | 1 |
| Cheifetz, AS; Doherty, GA | 1 |
| Kautzner, J; Kubánek, M; Málek, I; Skalická, B; Vymětalová, J | 1 |
| Kamoi, K; Kawaguchi, T; Mochizuki, M; Sugita, S; Tanaka, H; Yamada, Y | 1 |
| Fujimoto, K; Fukushima, K; Ito, Y; Kokuhu, T; Okamoto, M; Sugioka, N; Takada, K; Tanaka, Y; Yoshimura, N | 1 |
| Balshaw, R; Freue, GC; Hollander, Z; Ignaszewski, A; Imai, C; Keown, PA; Lin, D; McManus, BM; McMaster, R; Meredith, A; Mui, A; Ng, RT; Qasimi, P; Triche, T; Wilson-McManus, JE | 1 |
| Beaune, P; Bouvier, N; Choukroun, G; Legendre, C; Martinez, F; Pallet, N; Thervet, E | 1 |
| Hawkins, N; Punekar, YS | 1 |
| den Hartigh, J; Egeler, RM; Lankester, AC; Press, RR; Vossen, JM; Willemze, AJ | 1 |
| Holme, O; Thiis-Evensen, E; Vatn, MH | 1 |
| Cury, DB; Moss, AC | 1 |
| Ayari, S; Blin, N; Brissot, E; Chevallier, P; Delaunay, J; Dubruille, V; Gastinne, T; Guillaume, T; Harousseau, JL; Le Gouill, S; Mahe, B; Malard, F; Mohty, M; Moreau, P; Saulquin, B; Szydlo, RM | 1 |
| Banner, NR; Barton, PJ; Breen, JB; Burke, M; Leaver, N; Lyster, H; Pantelidis, P; Smith, J; Taegtmeyer, AB; Yacoub, MH | 1 |
| Fujii, T; Homma, S; Kurosaki, A; Miyamoto, A; Sakamoto, S; Yoshimura, K | 1 |
| Arnol, M; Bren, AF; Kandus, A; Kmetec, A; Oblak, M; Omahen, K; Vidan-Jeras, B | 1 |
| Gaber, AO; Kahan, BD; Katz, SM; Kerman, RH; Knight, RJ; Lawless, A; Podder, H; Van Buren, CT | 1 |
| Braida, S; Defabianis, P; Guagnano, R | 1 |
| Lam, PT; Tam, PM; Young, AL | 1 |
| DeBoer, DJ; Favrot, C; Jackson, HA; Mueller, RS; Nuttall, T; Olivry, T; Prélaud, P | 1 |
| Andronis, L; Bryan, S; Connock, M; Fry-Smith, A; Hyde, C; Wang, D | 1 |
| Agarwal, SK; Bharti, AC; Bhowmik, DM; Guleria, S; Gupta, N; Kumar, R; Mehra, NK; Panigrahi, A; Sharma, PK; Shukla, S | 1 |
| Ivanes, F; Ovize, M; Piot, C; Rioufol, G | 1 |
| Keränen, MA; Krebs, R; Lemström, KB; Nykänen, AI; Syrjälä, SO; Tammi, M; Tuuminen, R | 1 |
| Akpek, EK; Stern, M; Utine, CA | 1 |
| Rutgeerts, P; Van Assche, G; Vermeire, S | 1 |
| Fu, Z; Shen, X; Tang, Y; Wang, Q; Zheng, Q; Zou, S | 1 |
| Huang, QM; Liu, JF; Wu, YB | 1 |
| Farkas, K; Molnár, T; Nagy, F; Nyári, T; Szepes, Z; Wittmann, T | 1 |
| Hanafusa, T; Hata, K; Kotani, T; Makino, S; Nagai, K; Shoda, T; Takeuchi, T; Wakura, D; Yoshida, S | 1 |
| Burger, DC; Travis, S | 1 |
| Avellini, C; Fabro, M; Fiorino, G; Sorrentino, D; Szabo, H; Tabuso, M; Terrosu, G | 1 |
| Ishigatsubo, Y; Kanamori, H; Maruta, A; Matsumoto, K; Numata, A; Tachibana, T; Takasaki, H; Tanaka, M | 1 |
| Morozumi, K; Takeda, A | 1 |
| Komiya, T; Muso, E | 1 |
| Bruijnen, CP; Cornelisse, PB; Cornelissen, JJ; Emmelot, M; Huisman, C; Huls, G; Janssen, JJ; Kersten, MJ; Kneppers, E; Lokhorst, HM; Meijer, E; Minnema, MC; Mutis, T; Sonneveld, P; van der Holt, B; Zweegman, S | 1 |
| Peng, ZH; Quan, ZW; Weng, MZ; Xu, JM; Xu, YG; Zhang, JY; Zhang, Y | 1 |
| Sachar, DB | 1 |
| Guan, W; Israni, A; Jacobson, PA; Lamba, V; Leduc, R; Lin, YC; Matas, AJ; Oetting, WS; Schladt, D | 1 |
| Aida, N; Hayashi, T; Iai, M; Osaka, H; Sameshima, K; Tsuji, M; Wada, T; Watanabe, Y; Yamashita, S | 1 |
| Alvarez Castro, AM; Castroagudín, JF; Molina Pérez, E; Seijo Ríos, S; Varo Pérez, E | 1 |
| Hu, C; Manwani, D; Pan, DH; Taylor, S | 1 |
| Awadain, W; el-Agroudy, A; El-Deeb, S; Fouda, A; Gheith, O; Ghoneim, MA; Hassan, A; Hassan, N | 1 |
| Allez, M; Bommelaer, G; Bouhnik, Y; Bourreille, A; Branche, J; Carbonnel, F; Coffin, B; Colombel, JF; Cosnes, J; de Vos, M; Delchier, JC; Dewit, O; Dupas, JL; Esteve, M; Färkkilä, M; Filippi, J; Franchimont, D; Gisbert, JP; Laharie, D; Lémann, M; Lopez-Sanroman, A; Marteau, P; Mary, JY; Moreau, J; Nachury, M; Nahon, S; Ricart, E; Roblin, X; Savoye, G; Van Assche, G; Zerbib, F | 1 |
| Aoun, B; Azema, C; Bandin, F; Brocheriou, I; Callard, P; Decramer, S; Ulinski, T; Vitkevic, R; Wannous, H | 1 |
| Burke, JP; Chang, KH; Coffey, JC | 1 |
| Ansari, M; Banner, NR; Ceschi, A; Krähenbühl, S; Kupferschmidt, H; Rauber-Lüthy, C; Taegtmeyer, AB | 1 |
| Aloulou, M; Ben Mkaddem, S; Bens, M; Charles, N; Chassin, C; Elbim, C; Girardin, SE; Goujon, JM; Hertig, A; Monteiro, RC; Pellefigues, C; Philpott, DJ; Rondeau, E; Tourneur, E; Vandewalle, A; Werts, C | 1 |
| Andreu, H; Bruguera, M; Cirera, I; García-Valdecasas, JC; Grande, L; Navasa, M; Rimola, A; Rodés, J | 1 |
| Chen, L; Ding, X; Hou, J; Li, H; Lou, J; Min, B; Song, X; Tong, S; Wang, J; Zhang, W | 1 |
| Chen, Y; Gao, Z; Guo, N; Huang, X; Lu, D; Ren, H; Xu, L; Zhang, Y | 1 |
| Higashi, Y; Pallis, M; Russell, N; Turzanski, J | 1 |
| Arias, M; Cotorruelo, JG; de Francisco, AL; Escallada, R; Fernández-Fresnedo, G; Herráez, I; Piñera, C; Rodrigo, E; Ruiz, JC; Zubimendi, JA | 1 |
| Berman, JA; Caro, J; Patel, K | 1 |
| Hirohata, S | 1 |
| Hyland, JM; McCormack, G; McCormick, PA; O'Donoghue, DP | 1 |
| Ault, BH; Duhart, BT; Hays, DW; Honaker, MR; Jones, DP; Osama Gaber, A; Powell, SL; Wyatt, RJ | 1 |
| Bernaudin, F; Blatt, J; Brichard, B; Brochstein, JA; Ertem, M; Garnier, F; Giorgiani, G; Gluckman, E; Grafakos, S; Haut, PR; Ionescu, I; Kurtzberg, J; Li, X; Locatelli, F; Lubin, BH; Lutz, P; Miniero, R; Nagler, A; Nugent, DJ; Raja, T; Reed, W; Roberts, I; Rocha, V; Rubin, CM; Tannoia, N; Vermylen, C; Walters, MC; Will, AM; Woodard, P; Yaniv, I | 1 |
| Kandus, A | 1 |
| Boratyńska, M; Klinger, M; Kuriata-Kordek, M; Patrzalek, D; Szyber, P; Tupka, D; Urbaniak, J; Woźniak, M | 1 |
| Chiba, T; Fukai, K; Imazeki, F; Kanda, T; Nishimura, M; Saisho, H; Saito, Y; Yokosuka, O | 1 |
| Ayalon, A; Ben-Haim, M; Kuriansky, J; Lustig, S; Malinger-Saavedra, P; Rosin, D; Shabtai, EL; Shabtai, M; Shapira, Z; Zemer, D | 1 |
| Luan, FL | 1 |
| Aletaha, D; Smolen, JS | 1 |
| Bolton, DT; Cassidy, JV; Haynes, SR; Smith, JH | 1 |
| Coosemans, W; Evenepoel, P; Kuypers, D; Lemahieu, W; Maes, BD; Pirenne, J; Vanrenterghem, YF | 1 |
| Alvarez Arroyo, MV; Barat, A; Belda, E; Caramelo, C; Castilla, MA; Deudero, JJ; Egido, J; González-Pacheco, FR; Jiménez, S; Lorz, C; Ortiz, A; Soto, C; Suzuki, Y; Yagüe, S | 1 |
| Bloom, RD; Mange, KC | 1 |
| Abramowicz, D; Del Castillo, D; Fung, S; Lao, M; Manas, D; Vanrenterghem, Y; Wijngaard, P | 1 |
| Gruber, A; Knaust, E; Peterson, C; Porwit-MacDonald, A; Xu, D | 1 |
| Chiba, T; Fukai, K; Imazeki, F; Kojima, H; Nishimura, M; Saisho, H; Saito, Y; Yokosuka, O | 1 |
| Mohr, FW; Olbrich, HG; Richter, HR; Richter, MH | 1 |
| Bachleda, P; Korn, A; Lao, M; Matl, I; Matthisson, M; Michalský, R; Navrátil, P; Prestele, H; Treska, V | 1 |
| Beschorner, WE; Dixon, RS; Fox, IJ; Franco, KL; Goertzen, TC; Hill, AC; Johnson, ND; Kuszynski, CA; Langnas, AN; Lechtenberg, KF; Matamoros, A; Radio, SJ; Rubocki, RJ; Shearon, CC; Sudan, DL; Thompson, SC; Yang, T | 1 |
| Carpenter, PA; Sanders, JE | 1 |
| Böswald, M; Bulla, M; Burghard, R; Dippell, J; Greiner, C; Helmchen, U; Jungraithmayr, T; Kirste, G; Klare, B; Klaus, G; Leichter, HE; Michalk, DV; Mihatsch, MJ; Misselwitz, J; Plank, C; Querfeld, U; Staskewitz, A; Tönshoff, B; Weber, LT; Wiesel, M; Zimmerhackl, LB | 1 |
| Hu, RH; Lee, CJ; Lee, PH; Tsai, MK | 1 |
| Abramowicz, D; Berthoux, F; Bourbigot, B; Cassuto, E; Charpentier, B; Civati, G; Glotz, D; Hurault De Ligny, B; Kessler, M; Lang, P; Le Pogamp, P; Lebranchu, Y; Legendre, C; Leski, M; Merville, P; Mignon, F; Moulin, B; Mourad, G; Olmer, M; Pouteil-Noble, C; Pruna, A; Purgus, R; Rifle, G; Rostaing, L; Squifflet, JP; Touchard, G; Toupance, O; Touraine, JL; Vialtel, P; Wauters, JP; Wolf, P | 1 |
| Claas, FH; de Kuiper, P; Smak Gregoor, P; van Besouw, NM; van der Mast, BJ; van Gelder, T; Weimar, W; Witvliet, MD | 1 |
| Constantinescu, I; Hortopan, M; Iliescu, O; Ionescu, C; Ismail, G; Mandache, E; Voiculescu, M | 1 |
| Bailey, RJ; Lam, EC | 1 |
| Birsan, T; Deviatko, E; Klepetko, W; Reichart, B; Reichenspurner, H; Treede, H; Zuckermann, A | 1 |
| Bouhnik, Y | 1 |
| Chueh, SC; Hu, RH; Lee, PH; Tsai, MK | 1 |
| Bader, P; Bamberg, M; Einsele, H; Faul, C; Hebart, H; Kanz, L; Liebisch, P; Meisner, C; Plasswilm, L; Schäfer, HJ | 1 |
| Baboolal, K | 1 |
| Barrett, AJ; Carter, C; Childs, R; Dunbar, CE; Leitman, SF; Nakamura, R; Read, EJ; Solomon, SR; Young, NS | 1 |
| Christiaans, MH; Kooman, JP; Nieman, FH; van den Ham, EC; van Hooff, JP | 1 |
| Laurinavicius, A; Papinigiene, L; Rainiene, T | 1 |
| Braun, WE | 1 |
| Bruijn, JA; Claas, FH; de Fijter, JW; Doxiadis, II; Paul, LC; Sijpkens, YW; van Kemenade, FJ; Zwinderman, AH | 1 |
| Ikuta, K; Kamitani, W; Kobayashi, T; Lee, BJ; Tomonaga, K; Watanabe, M; Yamashita, M | 1 |
| Cea-Calvo, L; de la Calzada, CS; de la Cámara, AG; Delgado, JF; Escribano, P; Gómez-Sánchez, MA; Pascual, JG; Rufilanchas, JJ; Sánchez, V; Sotelo, T | 1 |
| Bain, V; Barkun, J; Erb, S; Ghent, C; Grant, D; Greig, P; Kneteman, N; Lilly, L; Marleau, D; Marotta, P; McAlister, V; Peltekian, K; Roy, A; Scudamore, C; Tchervenkov, J; Wall, W; Yoshida, E | 1 |
| Gu, SY; Gu, X; Tan, JM; Tang, XD; Yang, SQ; Zhou, PJ | 1 |
| Dutartre, P; Garcia, B; Hosiawa, KA; Kelvin, DJ; Shum, JB; Wang, H; Zhong, R | 1 |
| Burke, P; Karp, J; Smith, BD | 1 |
| Ahsan, N; Alfrey, EJ; Corwin, C; Danovitch, G; Fitzsimmons, WE; Gonwa, T; Halloran, P; Hardy, M; Johnson, C; Leonhardt, M; Light, J; Metzger, R; Mulloy, L; Rocher, L; Scandling, J; Shield, C; Sorensen, J; Stegall, M; VanVeldhuisen, P; Wachs, M | 1 |
| Abou-Jaoude, MM; Almawi, WY; Ghantous, I | 1 |
| Atra, A; Goyal, S; Horton, C; Kulkarni, S; Mehta, J; Meller, S; Ortin, M; Pinkerton, CR; Powles, R; Rudin, C; Sankpal, S; Saso, R; Singhal, S; Sirohi, B; Treleaven, J | 1 |
| Holdaas, H; Jardine, A | 1 |
| Albitar, M; Cortes, J; Estey, E; Faderl, S; Garcia-Manero, G; Giles, FJ; Kantarjian, H; Thomas, D; Tsimberidou, A; Verstovsek, S | 1 |
| de Leeuw, FE; Kiemeneij, IM; Ramos, LM; van Gijn, J | 1 |
| Inase, N; Isogai, S; Miyake, S; Miyazaki, Y; Ohtani, Y; Sakashita, H; Sawada, M; Yoshizawa, Y | 1 |
| Emmanuel, AV; Kamm, MA; McCormack, G; Rayner, CK | 1 |
| Bicknell, GR; Brook, NR; Nicholson, ML; Waller, JR; White, SA | 1 |
| Dymecki, D; Gruca, Z; Głowacki, J; Lachinski, A; Stefaniak, T | 1 |
| Bemelman, FJ; Florquin, S; Meijer, RT; Schellekens, PT; Surachno, S; Ten Berge, IJ; Yong, SL | 1 |
| Alves, MA; Bittar, AE; Bruno, RM; Garcia, CD; Garcia, VD; Goldani, JC; Keitel, E; Neto, JP; Pozza, R; Santos, AF; Schaefer, PG; See, D | 1 |
| Fatome, A; Lebreton, G | 1 |
| Cortes, JE; Estey, E; Faderl, S; Ferrajoli, A; Garcia-Manero, G; Giles, FJ; Kantarjian, HM; Keating, MJ; O'Brien, S; Thomas, DA; Tsimberidou, AM; Verstovsek, S | 1 |
| Andoh, TF; Bennett, WM; Burdmann, EA; Yu, L | 1 |
| Garcia, B; Hosiawa, KA; Ichim, TE; Kelvin, DJ; Lian, D; Min, W; Wang, H; Yang, J; Zhang, X; Zhong, R; Zhou, D | 1 |
| Arts, J; Asnong, K; D'Haens, G; D'Hoore, A; Hiele, M; Noman, M; Penninckx, F; Rutgeerts, P; Van Assche, G; Vermeire, S | 1 |
| Aulagner, G; Bertrand, Y; Bleyzac, N; Galambrun, C; Jelliffe, RW; Maire, PH; Martin, P; Souillet, G | 2 |
| Bräsen, JH; Budde, K; Dragun, D; Fritsche, L; Luft, FC; Neumayer, HH; Schönemann, C; Wallukat, G | 1 |
| Foroncewicz, B; Gornicka, B; Krawczyk, M; Mucha, K; Niewczas, M; Nyckowski, P; Oldakowska-Jedynak, U; Paczek, L; Patkowski, W; Senatorski, G; Wyzgal, J; Zegarska, J; Ziarkiewicz-Wroblewska, B; Zieniewicz, K; Ziolkowski, J | 1 |
| Hittmair, A; Jeske, HC; Klima, G; Margreiter, R; Oberladstätter, J; Obrist, P; Ollinger, R; Roberts, K; Schneeberger, S; Schubert, H; Steurer, W | 1 |
| Behling, C; Chiou, HC; Hart, ME; Hong, IC; Khanna, A; Li, M; Lopez, VF; Moss, RB; Mullen, PM; Precht, AF | 1 |
| Im, YH; Jung, CW; Kang, WK; Kim, K; Ko, YH; Lee, H; Lee, HR; Lee, KE; Lee, MH; Lee, SH; Park, J; Park, JO; Park, K; Park, SH | 1 |
| Butt, NM; Clark, RE; McGinnity, N | 1 |
| Kokado, Y; Ohzono, K; Sakai, T; Sugano, N; Takahara, S; Yoshikawa, H | 1 |
| Alsina, J; Andres, E; Bover, J; Castelao, AM; Gilvernet, S; Gonzalez, C; Griño, JM; Sabate, I; Seron, D | 1 |
| Chybicka, A; Gorczyñska, E; Kalwak, K; Rybka, B; Ryczan, R; Sajewicz, L; Toporski, J; Turkiewicz, D | 1 |
| Ekberg, H; Gül-Baykurt, N; Källen, R; Persson, NH | 1 |
| Leiper, K; Thuraisingam, A | 1 |
| Aoki, K; Asano, Y; Chiba, S; Hangaishi, A; Hirai, H; Imai, Y; Izutsu, K; Kanda, Y; Kandabashi, K; Kurokawa, M; Matsubara, M; Motokura, T; Nakagawa, M; Ogawa, N; Ogawa, S; Sakata-Yanagimoto, M; Tsujino, S | 1 |
| Bauer, JA; Crouser, ED; Gadd, ME; Huff, JE; Joshi, MS; Julian, MW; Pfeiffer, DR; Wewers, MD | 1 |
| Cattaneo, D; Dimitrov, BD; Donati, D; Ganeva, M; Gaspari, F; Gotti, E; Perico, N; Remuzzi, G; Ruggenenti, P; Salvadori, M; Sandrini, S; Segoloni, G; Valente, U | 1 |
| Appelbaum, FR; Banker, DE; Bernstein, ID; Cronk, MR; Raden, BW; Walter, RB | 1 |
| Fuke, S; Kohno, M; Kondo, I; Mizushige, K; Ohmori, K; Oshita, A; Shinomiya, K; Suzuki, T; Takeuchi, H; Yoshida, J | 1 |
| Brault, Y; Burke, JT; Campistol, JM; Daloze, P; Gioud-Paquet, M; Kreis, H; Mathew, T; Neylan, JF; Oberbauer, R; Scarola, JA; Schena, FP | 1 |
| Kawauchi, K; Ogasawara, T; Ohkawa, S; Takei, K; Yasuyama, M | 1 |
| Fellström, B | 1 |
| Busauschina, A; Schnuelle, P; van der Woude, FJ | 1 |
| Burdelski, MM | 1 |
| Parekh, K; Patterson, GA; Trulock, E | 1 |
| Beani, JC | 1 |
| Aubert, JD; Auterith, A; Böttcher, H; Chaparro, C; Corris, P; Estenne, M; Gerbase, MW; Glanville, A; Klepetko, W; Knoop, C; Levvey, B; Niedermayer, J; Reichenspurner, H; Sarahrudi, K; Venuta, F; Verleden, G | 1 |
| Barrs, V; Beatty, J | 1 |
| Bechstein, WO; Berney, T; Boucek, P; Fernandez-Cruz, L; Kahl, A; Land, W; Landgraf, R; Malaise, J; Margreiter, R; Nakache, R; Saudek, F; Secchi, A; Squifflet, JP; Tydén, G; Van Ophem, D; Vanrenterghem, Y | 1 |
| Au, WY; Chan, GC; Ha, SY; Hon, C; Ma, SK; Wong, KF | 1 |
| C Doherty, C; Connolly, JK; Courtney, AE; Herron, B; Jefferson, JA; McCarron, MO | 1 |
| Atsuta, Y; Emi, N; Hamajima, N; Hirabayashi, N; Hiraoka, A; Iwato, K; Kanda, Y; Kato, S; Naoe, T; Okamoto, S; Sakamaki, H; Takahashi, S; Tanimoto, M; Tanosaki, R; Yanada, M | 1 |
| Bonvoisin, SC; Cenni, JC; Descos, L; Flourié, B; Moussata, D; Nancey, S | 1 |
| Kishida, S; Ohta, K; Sakamaki, H; Yoritaka, A | 1 |
| Daenen, S; Ferrant, A; Huijgens, PC; Kramer, MH; Löwenberg, B; Schouten, HC; Sonneveld, P; Steijaert, MM; van den Berg, E; van der Holt, B; van Marwijk Kooy, R; Verdonck, LF; Verhoef, GE; Wijermans, PW | 1 |
| Choi, SJ; Kim, S; Kim, WK; Lee, JH; Lee, JS; Lee, KH; Lee, YS; Seol, M | 1 |
| Cantarovich, M; Cecere, R; Giannetti, N; Joyal, D | 1 |
| Inoue, K; Yoshiba, M | 1 |
| McDonald, RA; Nemeth, TL; Smith, JM | 1 |
| Arnold, R; Dörken, B; Heine, F; Le Coutre, P; Massenkeil, G; Nagy, M; Rosen, O | 1 |
| Yoshiba, M | 1 |
| Jong-Hon, K; Maekubo, H; Mishiro, S; Ohnishi, S; Takahashi, K | 1 |
| Bischoff, SC; Fleig, W; Reissmann, A | 1 |
| Budde, K; Fritsche, L; Kuypers, DR; Neumayer, HH; Rodicio, JL; Vanrenterghem, Y | 1 |
| Heer, M; Kashyap, R; Minz, M; Singh, B; Thomas, R | 1 |
| Dobrea, C; Gioadă, L; Gologan, R; Ostroveanu, D | 1 |
| Honsova, E; Kocik, M; Kriz, J; Kudla, M; Mergental, H; Pantoflicek, T; Ryska, M; Saudek, F; Tcherentsova, K | 1 |
| Baluom, M; Borie, D; Chavez, G; Christians, U; Cozzi, E; Duthaler, R; Harrison, R; Hausen, B; Higgins, J; Hook, L; Jacobsen, W; Katopodis, A; Lam, TT; Lau, M; Morris, RE; Schuurman, HJ | 1 |
| Campbell, S; Jewell, D; Travis, S | 1 |
| Andrews, CD; Hammad, AQ; Lodge, JP; Parrott, NR; Watson, CJ | 1 |
| Balbontin, F; Fraser, A; Kiberd, B; Kiberd, M; Lawen, J | 1 |
| Benedetti, E; Dong, G; Jarzembowski, T; Panaro, F; Raofi, V; Sankary, H; Testa, G | 1 |
| Berdowska, A; Gajewska, K; Jochem, J; Zakliczyński, M; Zembala, M; Zwirska-Korczala, K | 1 |
| Balshaw, R; Carreño, CA; Keown, PA; Machnicki, G; Otero, A; Toselli, L | 1 |
| Tan, J; Wu, W; Yang, S | 1 |
| Legendre, Ch; Mourad, G; Rostaing, L | 1 |
| Al-Flaiw, A; Al-Ghamdi, G; Ghalib, M; Hala, K; Hejaili, F; Jumani, A; Khader, AA; Qureshi, J; Raza, H; Tahir, S | 1 |
| Chen, G; Garcia, B; Gies, D; Jiang, J; Kubelik, D; Liu, W; Rother, RP; Wang, H; Zhong, R | 1 |
| Edemir, B; Gabriëls, G; Hirsch, JR; Paasche, S; Schlatter, E; Schröter, R; Velic, A | 1 |
| Gazdhar, A; Grodzki, T; Gugger, M; Hyde, S; Mathiesen, I; Pierog, J; Schmid, RA; Stammberger, U | 1 |
| Brunet, S; Caballero, MD; Carreras, E; de León, A; del Cañizo, MC; Díez-Campelo, M; López-Fidalgo, J; Martino, R; Pérez-Simón, JA; San Miguel, JF; Sierra, J; Urbano, A; Valcárcel, D | 1 |
| Blancho, G; Charpentier, B; Durrbach, A; Grinyo, J; Hagerty, D; Halloran, PF; Lang, P; Larsen, C; Levy, E; Nashan, B; Natarajan, K; Solez, K; Vincenti, F; Wekerle, T; Zhou, W | 1 |
| Amano, K; Kameda, H; Nagasawa, H; Ogawa, H; Sekiguchi, N; Takei, H; Takeuchi, T; Tokuhira, M | 1 |
| Csapó, Z; Forgács, B; Kahan, B; Podder, H | 1 |
| Han, SB; Kang, JS; Kim, HM; Kim, YK; Lee, CW; Lee, K; Lee, KH; Park, SK; Yoon, WK; Yoon, YD | 1 |
| Kim, HJ; Lee, JW; Lee, SJ; Sung, SH | 1 |
| Al-Mousawi, M; Halim, MA; Johny, KV; Mansour, M; Nair, MP; Nampoory, MR; Said, T; Samhan, M | 1 |
| Niemczyk, M; Paczek, L; Perkowska, A; Porowski, D; Wyzgał, J | 1 |
| Akram, A; Cameron, MJ; DeVries, ME; Garcia, B; Hosiawa, KA; Jiang, J; Kelvin, DJ; Liu, W; Sun, H; Wang, H; Zhong, R; Zhou, D | 1 |
| Ahmed, P; Altaf, C; Anwar, M; Hashmi, K; Hussain, I; Iqbal, H; Kamal, K; Khan, B; Khan, MA; Malik, HS; Naeem, M; Raza, S | 1 |
| Hashmi, K | 1 |
| Bonadies, G; Fedele, S; Lo Muzio, L; Lo Russo, L; Mignogna, MD; Nappa, S | 1 |
| Burke, JT; Eris, J; Friend, P; Grinyó, JM; Hartmann, A; Lawen, J; Legendre, C; Lelong, M; Mota, A; Neylan, JF; Oberbauer, R; Russ, G; Schena, FP; Segoloni, G | 1 |
| Allan, JS; Hasse, RS; Hoerbelt, R; Houser, SL; Iribarne, A; Johnston, DR; Ledgerwood, LG; Madsen, JC; Sachs, DH; Sayegh, MH; Shoji, T | 1 |
| Homma, S; Kawabata, M; Kishi, K; Motoi, N; Sakamoto, S; Tsuboi, E; Yoshimura, K | 1 |
| Kandus, A; Kotnik, V; Kovac, D | 1 |
| Prenner, G; Schwarz, M; Schweiger, M; Tripolt, M; Tscheliessnigg, KH; Wasler, A | 1 |
| Burckart, GJ; Corcoran, TE; Dauber, JH; Fung, JJ; Grgurich, WF; Griffith, BP; Iacono, AT; Johnson, BA; McCurry, KR; Seiler, DA; Smaldone, GC; Yousem, SA; Youssef, JG; Zeevi, A | 1 |
| Ekberg, H; Hedner, U; Osterholm, C; Simanaitis, M; Veress, B | 1 |
| Bélanger, R; Busque, L; Chamakhi, I; Dhédin, N; Ducruet, T; Fish, D; Perreault, C; Roy, DC; Roy, J; Sauvageau, G | 1 |
| Apostolidis, I; Arvanitopoulou, E; Asprogeraka, T; Bakiri, M; Giannakoulas, N; Kotsianidis, I; Marinakis, T; Matsouka, P; Pagoni, M; Papaioannou, M; Skandali, A; Spanoudakis, E; Tsatalas, K; Viniou, N; Yataganas, X; Zikos, P | 1 |
| Empey, PE; Hatton, J; McNamara, PJ; Rosbolt, MB; Young, B | 1 |
| Arp, J; Garcia, B; Huang, X; Jiang, J; Kanai, N; Liu, W; Min, W; O'Connell, PJ; Ramcharran, S; Wang, H; Zhong, R | 1 |
| Cetkovská, P; Pizinger, K | 1 |
| Fritz, S; Gebhard, MM; Hackert, T; Hartwig, W; Klar, E; Pfeil, D; Werner, J | 1 |
| Chaoui, D; Faussat, AM; Klein, C; Legrand, O; Majdak, P; Marie, JP; Pasco, S; Perrot, JY; Tang, R | 1 |
| Broliden, PA; Dahl, IM; Hast, R; Hellstrom-Lindberg, E; Johansson, B; Juvonen, E; Kjeldsen, L; Oberg, G; Porwit-MacDonald, A; Sjoo, M; Tangen, JM; Uggla, B | 1 |
| Almenar, L; Arizón Del Prado, JM; Arpesella, G; Crespo-Leiro, MG; Duveau, D; Frigerio, M; Gandjbakhch, J; Grimm, M; Laufer, G; Maccherini, M; Ordonez-Fernandez, A; Pulpón, LA; Rinaldi, M; Rodriguez Lambert, JL; Villemot, JP; Yonan, NA | 1 |
| Chapman, JR; Nankivell, BJ | 1 |
| Pascual, J | 1 |
| Chak, WL; Chan, HW; Chan, YH; Chau, KF; Cheung, CY; Choi, KS; Li, CS; Liu, YL; Wong, HS; Wong, KM | 1 |
| Gluud, LL; Haddad, E; Kjaer, MS; Malthaner, RA; McAlister, VC; Renouf, E | 1 |
| Blanche, S; Casanova, JL; Cavazzana-Calvo, M; Fischer, A; Le Deist, F; Neven, B; Ouachée-Chardin, M; Picard, C; Renella, R | 1 |
| Aboyoun, CL; Glanville, AR; Malouf, MA; Morton, JM; Plit, M | 1 |
| Ikeda, K; Shimizu, Y; Sugahara, S; Yamamoto, S | 1 |
| Barkholt, L; Hassan, Z; Mattsson, J; Omazic, B; Remberger, M; Ringdén, O; Sairafi, D; Uzunel, M | 1 |
| Gommers, D; Haitsma, JJ; Lachmann, B | 1 |
| Boura, P; Kamali, S; Sarantopoulos, A; Skendros, P; Topouzis, F; Tselios, K | 1 |
| Hayashi, N; Hino, M; Kanashima, H; Koh, H; Koh, KR; Mochizuki, K; Nakamae, H; Nakamae, M; Nakane, T; Sakamoto, E; Takeoka, Y; Yamane, T | 1 |
| Kinjo, S; Nagasaki, A; Nakachi, S; Takasu, N; Yamanoha, A | 1 |
| Bosmans, JL; Budde, K; Fischer, W; Glander, P; Neumayer, HH; Pisarski, P; Schütz, M; Sennesael, J; Zeier, M | 1 |
| Holler, E | 1 |
| Derumeaux, G; Dumont, JM; Gharib, A; Gomez, L; Ovize, M; Scalfaro, P; Thibault, H; Vuagniaux, G | 1 |
| Meng, K; Song, Z; Zhou, X | 1 |
| Andrés, I; Camarena, C; de la Vega, A; Diaz, MC; Díez, R; Frauca, E; Gámez, M; Hierro, L; Jara, P; López Santamaría, M; Muñoz Bartolo, G; Murcia, J; Sanchez Peinado, C | 1 |
| Kami, M; Kato, D; Kishi, Y; Kusumi, E; Masuoka, K; Matsumura, T; Miyakoshi, S; Murashige, N; Narimatsu, H; Takagi, S; Taniguchi, S; Tanimoto, T; Uchida, N; Wake, A; Yamaguchi, T; Yuji, K | 1 |
| Limat, S; Raymond, S; Woronoff-Lemsi, MC | 1 |
| Abe, T; Aizawa, Y; Furukawa, T; Izumi, N; Kurasaki, T; Masuko, M; Okazuka, K; Sato, N; Takahashi, M; Toba, K; Tsukada, N; Yano, T | 1 |
| Arai, S; Asai, T; Chiba, S; Hangaishi, A; Hosoya, N; Izutsu, K; Kanda, Y; Kurokawa, M; Motokura, T; Nakasone, H; Nishimoto, N; Oshima, K; Sato, H; Watanabe, T | 1 |
| Holmberg, C; Jalanko, H; Krogerus, L; Qvist, E; Their, M | 1 |
| Hall, ED; Mbye, LH; Singh, IN; Springer, JE; Sullivan, PG | 1 |
| Choi, G; Hong, W; Kim, YC; Shin, J; Song, H | 1 |
| Chen, H; Chen, Y; Chen, YH; Han, W; Huang, XJ; Liu, DH; Liu, KY; Lu, DP; Shi, HX; Wang, JZ; Wang, Y; Xu, LP; Zhang, XU; Zhang, YC | 1 |
| Lichtiger, S | 1 |
| Alimoghaddam, K; Ashouri, A; Ghaffari, H; Ghavamzadeh, A; Hadjibabaie, M; Iravani, M; Mahdavi, N; Mousavi, SA; Namdar, R; Nedaeifard, L; Shamshiri, A | 1 |
| Herbort, CP; Klaeger, AJ | 1 |
| Durrbach, A; Kessler, M; Ouali, N; Pouteil-Noble, C; Rostaing, L; Thervet, E; Tricot, L; Viron, B; Wolf, P | 1 |
| Jansson, L; Karlsson, A; Karlsson, L; Melgar, S; Michaëlsson, E; Rehnström, E; Utkovic, H | 1 |
| Hasegawa, A; Kamidono, S; Kawamura, T; Ogawa, O; Sakuma, T | 1 |
| Aguilar, D; Andújar, M; Aneiros, J; Bustos, M; García del Moral, R; Gómez-Morales, M; Medina-Cano, MT; Montes, A; O'Valle, F; Ramírez, C | 1 |
| Bordigoni, P; Brion, A; Burdach, S; Cahn, JY; Kolb, HJ; Lioure, B; Michel, G; Milpied, N; Tiberghien, P; Widjenes, J | 1 |
| Ito, T; Kimura, T; Kinjo, M; Nakano, I; Nawata, H; Sumii, T; Yamaguchi, H | 1 |
| Busuttil, RW; Klintmalm, GB; McDiarmid, SV | 1 |
| Brinkmann, C; Buhr, T; Jost, U; Melter, M; Pichlmayr, R; Ringe, B; Rodeck, B; Winkler, M | 1 |
| Calmus, Y | 1 |
| Gaweco, AS; Geisse, T; Hofmann, WJ; Otto, G; Otto, HF | 1 |
| Doi, R; Echigo, Y; Higashide, S; Imamura, M; Inoue, K; Kaji, H; Kogire, M; Sumi, S | 1 |
| Bechstein, WO; Blumhardt, G; Lobeck, H; Mueller, AR; Neuhaus, P; Platz, KP; Zytowski, M | 1 |
| Bechstein, WO; Blumhardt, G; Christe, W; Hopf, U; Lobeck, H; Mueller, AR; Neuhaus, P; Platz, KP; Steinmüller, T | 2 |
| Cornu, C; Geubel, A; Goffin, E; Horsmans, Y; Pirson, Y; van Ypersele De Strihou, C | 1 |
| Andersen, J; Ashigbi, M; Cassileth, P; Paietta, E; Racevskis, J; Wiernik, PH | 1 |
| Appelbaum, FR; Chen, IM; Godwin, JE; Head, DR; Kopecky, KJ; Leith, CP; Weick, JK; Willman, CL | 1 |
| Griffith, BP; Hardesty, RL; Iacono, AT; Kawai, A; Keenan, RJ; Konishi, H; Nunley, DR; Paradis, IL; Weyant, RJ | 1 |
| Delaere, PR; Feenstra, L; Hermans, R; Liu, ZY; Sciot, R | 1 |
| Cooper, DK; Fagiuoli, S; Jazzar, A; Sisson, S; Zuhdi, N | 2 |
| Bradstock, KF; Gottlieb, D; Srivastava, A | 1 |
| Dohy, H; Kakishita, E; Kanamaru, A; Kasai, M; Katoh, S; Kodera, Y; Moriyama, Y; Saitoh, H; Shibata, A; Takemoto, Y | 1 |
| Azuma, E; Hiratake, S; Hirayama, M; Komada, Y; Nagai, M; Nakano, T; Sakurai, M | 1 |
| Carreras, E; Rovira, M; Rozman, C; Sierra, J; Urbano-Ispizua, A | 1 |
| Sollinger, HW | 1 |
| Bercedo, J; Chamorro, A; García, MA; Jiménez, C; Loinaz, C; Manzanera, M; Marcello, M; Moreno, C; Moreno, E; Palomo, JC | 1 |
| Arnold, R; Bunjes, D; Duncker, C; Heimpel, H; Heit, W; Hertenstein, B; Novotny, J; Stefanic, M; Wiesneth, M | 1 |
| Banner, B; Langrehr, JM; Lee, KK; Lee, TK; Müller, A; Schraut, WH; Stangl, MJ | 1 |
| Backman, L; Gibbs, JF; Goldstein, RM; Gonwa, TA; Holman, MJ; Husberg, BS; Klintmalm, GB; Levy, M; McMillan, R; Morris, C | 1 |
| Ascher, NL; Goldstein, R; Gonwa, T; Klintmalm, GB; Krom, RA; Lake, J; Roberts, JW; Shaw, BW; Stratta, R; Wiesner, RH | 2 |
| Morris, RE; Yuh, DD | 1 |
| Jost, U; Pichlmayr, R; Ringe, B; Rodeck, B; Winkler, M | 1 |
| Fujita, R; Inoue, K; Sekiyama, K; Yoshiba, M | 1 |
| Enomoto, N; Hirata, R; Ishiwata, N; Koyama, N; Marumo, F; Noguchi, O; Sakamoto, H; Sato, C; Tanaka, Y | 1 |
| Bitterman, PB; Bula, W; Hertz, MI; Latchaw, RE; Maxwell, RE; Nussbaum, ES | 1 |
| Hofmann, GO; Land, W; Schneeberger, H | 1 |
| Benkov, KJ; Janowitz, HD; LeLeiko, NS; Rosh, JR; Schwersenz, AH | 1 |
| Adams, PC; Ghent, CN; Grant, DR; McAlister, VC; Roy, A; Wall, WJ | 1 |
| Bellazzi, R; Quaglini, S | 1 |
| Alloway, RR; Flax, S; Gaber, AO; Gaber, LW; Moore, LW | 1 |
| Cherqui, D; Dhumeaux, D; Duvoux, C; Fagniez, PL; Julien, M; Lauzet, JY; Metreau, JM; Salvat, A | 1 |
| Ar'Rajab, A; Dawidson, I; Lu, C; Melone, D | 1 |
| Carl, S; Daniel, V; Staehler, G; Wiesel, M | 1 |
| Ahonen, J; Eklund, B; Höckerstedt, K; Isoniemi, H; Kyllönen, L; Salmela, K; von Willebrand, E | 1 |
| Fukuchi, H; Kadoyama, M; Kihira, K; Kimura, Y; Kitaura, T; Miyake, K; Yoshida, M | 1 |
| al-Sabah, A; Baines, P; Burnett, A; Hoy, T; Limaye, M; Padua, RA; Whittaker, J | 1 |
| Alberti, A; Bellati, G; Belli, LS; De Carlis, L; Fesce, E; Ideo, G; Romani, F; Rondinara, GF; Sansalone, CV; Zavaglia, C | 1 |
| Jennison, SH; McBride, LR; Miller, LW; Wesp, AG | 1 |
| Aihara, Y; Kimura, S; Nagasaka, Y; Nezu, A; Osaka, H; Saitoh, K; Shimizu, C; Yoshida, Y | 1 |
| Antin, JH; Bierer, BE; Fruman, DA; Leong, T; McGarigle, C; Neuberg, D; Pai, SY; Rosano, TG | 1 |
| Morris, PJ; Roake, JA; Toogood, GJ | 1 |
| Beelen, DW; Liedtke, W; Quabeck, K; Schaefer, UW; Straeten, V | 1 |
| Chitwood, KK; Heim-Duthoy, KL; Kasiske, BL; Massy, ZA; Tortorice, KL | 1 |
| Budihna, NV; Kajtna-Koselj, M; Malovrh, M; Milcinski, M | 1 |
| Higa, T; Kasai, M; Kiyama, Y; Masauzi, N; Matsuura, A; Morii, K; Naohara, T; Ohizumi, H; Tanaka, J; Watanabe, M | 1 |
| Jones, AR; Poon, MC; Ruether, BA; Russell, JA; Woodman, RC | 1 |
| Nakamura, H; Okada, M; Oobo, H; Tobe, S; Yamamoto, H; Yamashita, C | 1 |
| Cochat, P; Ecochard, R; Kalboussi-Touzi, C; Martin, X; Poix, D | 1 |
| Brenchley, PE; Coupes, BM; Newstead, CG; Short, CD | 1 |
| Luke, RG | 1 |
| Ferguson, R | 1 |
| Endo, T; Kumano, K; Mashimo, S; Masui, N; Soh, S | 1 |
| Choi, IJ; Jeong, HJ; Kim, YS; Oh, CK; Park, K | 1 |
| Bohdanecká, M; Petrásek, R; Reitschlägerová, V; Schück, O; Sedivý, J | 1 |
| Bartucci, MR | 1 |
| Berra, N; Chapuis, F; Hadj-Aissa, A; Lacavalerie, B; Lefrançois, N; Martin, X; Pouteil-Noble, C; Touraine, JL | 1 |
| Faussat-Suberville, AM; Marie, JP; Zhou, D; Zittoun, R | 1 |
| Baier, M; Dalton, W; Dorr, R; Futscher, B; Greer, J; Hutter, J; List, AF; Salmon, S; Spier, C; Wolff, S | 1 |
| Arminio, A; Mendez, A; Milanes, CL; Naffah, M; Pinto, A; Rodriguez, C; Stempel, C; Weisinger, J | 1 |
| Flores, J; García, R; Gutiérrez, H; Herrera, J; Rodríguez-Iturbe, B; Salgado, O | 1 |
| Herson, J; Hricik, DE; O'Toole, MA; Schulak, JA | 1 |
| Auchincloss, H; Bazari, H; Cosimi, AB; Delmonico, FL; Fang, LT; Farrell, ML; Tolkoff-Rubin, N; Williams, WW | 1 |
| Andolina, M; Arcese, W; Dini, G; Locatelli, F; Messina, C; Miniero, R; Porta, F; Rovelli, A; Uderzo, C; Zecca, M | 1 |
| Ermel, LD; Lyson, T; McMullan, DM; Morgan, BJ; Victor, RG | 1 |
| Chong, AS; Clardy, C; Foster, P; McChesney, L; Sankary, H; Williams, JW; Xiao, F | 1 |
| Okada, M; Yamamoto, H; Yamashita, C | 1 |
| Bacigalupo, A; Clavio, M; Fagioli, F; Frassoni, F; Gualandi, F; Lamparelli, T; Occhini, D; Sogno, G; Van Lint, MT; Vitale, V | 1 |
| Arnold, R; Hay, B; Kern, P; Kern, WV; Marre, R | 1 |
| Bloom, EJ; Schwinghammer, TL | 1 |
| Fox, M; Greaves, M; Johnson, BF; Preston, FE; Raftery, AT; Thomas, G; Wiley, KN | 1 |
| Bellomo, R; Boyce, N; Farmer, M; Wong, C | 1 |
| Furudera, S; Hamada, T; Hino, T; Kage, M; Koga, Y; Kumashiro, R; Sakisaka, S; Sata, M; Taguchi, J; Tanikawa, K | 1 |
| Akashi, K; Eto, T; Gondo, H; Harada, M; Hayashi, S; Nagafuji, K; Takamatsu, Y; Taniguchi, S; Teshima, T; Yamasaki, K | 1 |
| Alexander, JW; First, MR; Pesce, AJ; Schroeder, TJ; Sridhar, N | 1 |
| Aikawa, A; Bakran, A; Davies, HM; Johnson, PM; McDicken, IW; McLaughlin, PJ; Sells, RA; Southern, SA | 1 |
| Bungey, J; Cross, NC; Feng, L; Ferrant, A; Goldman, JM; Hughes, TP; Marks, DI; Martiat, P; O'Shea, P | 1 |
| Cooper, HS; Ibrahim, SA; Murthy, SN; Sedergran, DJ; Shah, RS; Shim, H | 1 |
| Bader, A; Christians, U; Linck, A; Link, H; Schottmann, R; Sewing, KF; Spiekermann, K; Wonigeit, K | 1 |
| Busch, C; Schärer, K; Schweer, H; Seyberth, HW; Tönshoff, B | 1 |
| Actis, GC; Barletti, C; Ottobrelli, A; Pera, A; Pinna-Pintor, M; Ponti, V; Verme, G | 1 |
| Kastrukoff, LF; Lau, AS; Leung, GY; Thomas, EE | 1 |
| Amylon, MD; Chao, NJ; Dagis, AC; Long, GD; Nademanee, AP; Negrin, RS; Niland, JC; O'Donnell, MR; Parker, PM; Schmidt, GM | 1 |
| Ascher, NL; Busuttil, RW; Deierhoi, M; Gonwa, TA; Kauffman, R; Klintmalm, GB; McDiarmid, S; Poplawski, S; Roberts, J; Sollinger, H | 1 |
| Bleisch, J; Candinas, D; Largiadèr, F; Retsch, M; Röthlin, M; Schlumpf, R; Weder, W; Zollinger, A | 1 |
| Batchelor, JR; Braun, MY; McCormack, A; Webb, G | 1 |
| Hirano, T; Kono, K; Kozaki, K; Kozaki, M; Matsuno, N; Oka, K; Sakurai, E; Tamaki, T; Tanaka, M; Uchiyama, M | 1 |
| Bourke, JE; Campbell, WG; Delaney, V; Fekete, PS; Ling, BN; O'Brien, DP; Taylor, AT; Whelchel, JD | 1 |
| Cormont, F; de Hemptinne, B; de Ville de Goyet, J; Jamart, J; Latinne, D; Rahier, J; Reding, R; Sokal, E; Vincenzotto, C; Vraux, H | 1 |
| Belanger, C; Bordigoni, P; Esperou-Bourdeau, H; Herve, P; Jouet, JP; Kuentz, M; Milpied, N; Reiffers, J; Souillet, G; Troussard, X | 1 |
| Hunter, A; Rogers, S; Russell, N | 1 |
| Ishibashi, M; Kameoka, H; Kokado, Y; Moutabarrik, A; Okuyama, A; Sonoda, T; Takahara, S; Takano, Y; Zaid, D | 1 |
| Cacciarelli, TV; Daskalakis, P; Georgi, B; Goldberg, K; Hong, JH; Miles, AM; Sommer, BG; Sumrani, N | 1 |
| Corey, HE; Greenstein, SM; Greifer, I; Spitzer, A; Tellis, V | 1 |
| Bäckman, L; Bentdal, O; Brattström, C; Claesson, K; Felldin, M; Nordal, K; Persson, NH | 1 |
| Eisterer, W; Hilbe, W; Hofmann, J; Ludescher, C; Thaler, J | 1 |
| Bouchard, D; Carrier, M; Cartier, R; Despatis, MA; Leung, TK | 1 |
| Brugger, SA; Dieckmann, KU; Fischer, G; Geissler, K; Greinix, HT; Haas, O; Hinterberger, W; Hocker, P; Jager, U; Kalhs, P; Keil, F; Lechner, K; Linkesch, W; Mannhalter, C; Reiter, E; Schneider, B; Schwarzinger, I | 1 |
| Actis, GC; Balzola, F; Boggio-Bertinet, D; Bonino, F; Debernardi-Venon, W; Lagget, M; Marzano, A; Ottobrelli, A; Ponzetto, A; Rocca, G | 1 |
| Kuse, E; Nashan, B; Pichlmayr, R; Ringe, B; Schlitt, HJ; Schwinzer, R; Tusch, G; Wonigeit, K | 1 |
| Furukawa, Y; Hirozane, T; Matsui, S; Matsumori, A; Ono, K; Sasayama, S; Sato, Y | 1 |
| List, AF | 1 |
| Aker, M; Kapelushnik, J; Nagler, A; Or, R; Shapira, J | 1 |
| Bechstein, WO; Bismuth, H; Calne, R; Ericzon, BG; McMaster, P; Neuhaus, P; Otto, G; Pichlmayr, R; Williams, R | 1 |
| Conway, P; Madras, PN; Monaco, AP; Shaffer, D; Simpson, MA; Washburn, WK | 1 |
| Amuchastegui, S; Bontempelli, M; Perico, N; Remuzzi, G | 1 |
| Jordan, SC; Kass, RM; Koerner, SK; Nathan, SD; Ross, DJ | 1 |
| Arseniev, L; Bähre, O; Diedrich, H; Kadar, JG; Link, H; Poliwoda, H | 1 |
| Endo, T; Irie, A; Koshiba, K; Kumano, K; Mashimo, S | 1 |
| Wang, XH; Xie, T | 1 |
| Han, DJ; Lee, HM; Yoon, HS | 1 |
| Chiewsilp, P; Jirasiritham, S; Sumethkul, V | 1 |
| Joo, I; Kim, HC; Kwon, JK; Park, SB; Suk, J | 1 |
| Blinder, L; Chong, AS; Foster, P; Sankary, H; Shen, J; Wei, L; Williams, J; Xiao, F | 1 |
| Arndt, JW; Hermans, J; Kooijmans-Coutinho, MF; Rischen-Vos, J; van der Woude, FJ | 1 |
| Akard, LP; Burns, S; Chang, Q; English, D; Garrett, P; Hanks, S; Jansen, J; Thompson, JM | 1 |
| Brodsky, I; Bulova, S; Crilley, P; Marks, DI; Styler, MJ; Topolsky, D | 1 |
| Beckmann, N; Bruttel, K; Joergensen, J; Rudin, M; Schuurman, HJ | 1 |
| Kim, JY; Suh, KS | 1 |
| Andant, C; Edery, J; Fouchard, I; Pouchot, J; Soulé, JC | 1 |
| First, MR; Hariharan, S; Schroeder, TJ; Shah, M | 1 |
| Lemmens, P; Lobeck, H; Mueller, AR; Neuhaus, P; Platz, KP; Zytowski, M | 1 |
| Carson, RW; Douzdjian, V; Fisch, JC; Gugliuzza, KK; Rice, JC | 1 |
| Aswad, S; Burdick, J; Burrows, L; Danovitch, GM; Deierhoi, MH; Delmonico, FL; Freeman, RB; Gordon, JH; Laskow, D; Mendez, R; Munn, SR; Neylan, J; Pirsch, JD; Rohrer, RJ; Schwartz, B; Shaffer, D; Simpson, MA; Sollinger, H; Thistlethwaite, JR; Vincenti, F; Whelchel, J; Wiesner, RH; Wilkinson, AH; Woodle, ES | 1 |
| Alegre, A; Benet, I; Besalduch, J; Brunet, S; Carreras, E; de la Rubia, J; Díaz, MA; Domingo-Albós, A; García-Conde, J; Hernández, F; Moraleda, JM; Ojeda, E; Petit, J; Rozman, C; Sanz, G; Solano, C; Urbano-Ispizua, A; Vivancos, P | 1 |
| Angelucci, E; Baronciani, D; Erer, B; Galimberti, M; Gaziev, D; Giardini, C; Lucarelli, G; Maiello, A; Polchi, P | 1 |
| Curtis, JJ; Deierhoi, MH; Diethelm, AG; Gaston, RS; Julian, BA; Sanders, CE | 1 |
| Chiba, S; Horigome, I; Hotta, O; Kitamura, H; Miyazawa, S; Sudou, K; Taguma, Y; Tokoi, T | 1 |
| Iguchi, Y; Ota, K; Takahashi, K; Tanabe, K; Teraoka, S; Tokumoto, N; Toma, H; Yagisawa, T | 1 |
| Derouin, F; Garin, YJ; Sumyuen, MH | 1 |
| Campistol, JM; Fernández-Solà, J; Garcés, N; Grau, JM; Miró, O; Soy, D | 1 |
| Flechner, SM; Goldfarb, DA; Goormastic, M; Mastroianni, B; Modlin, CS; Novick, AC; Papajcik, D; Serrano, DP | 1 |
| Kurrle, R; Ruuth, E; Schorlemmer, HU; Schwab, W | 1 |
| Berg, T; Fukomoto, T; Haller, GW; Hopf, U; Lemmens, HP; Lobeck, H; Mueller, AR; Naumann, U; Neuhaus, P; Platz, KP | 1 |
| Koskinen, PK; Lemström, KB | 1 |
| Ahn, SJ; Bang, BK; Chang, YS; Jin, DC; Kim, SY; Kim, YS; Koh, YB; Yoon, SA; Yoon, YS | 1 |
| Chen, H; Choi, CH; Hedley, DW; Ling, V; Minden, MD; Xie, SX | 1 |
| Agrawal, S; Bhandari, M; Gupta, A; Kher, V; Kumar, A; Kumar, P; Rai, PK; Sharma, RK | 1 |
| Burckart, GJ; Dauber, JH; Griffith, BP; Iacono, A; Kawai, A; Keenan, RJ; Ohori, NP; Smaldone, GC; Yousem, SA; Zeevi, A | 1 |
| Gerber, M; Gmeinhart, B; Greinix, H; Kalhs, P; Knobler, R; Volc-Platzer, B | 1 |
| Casà, A; Cottone, M; Oliva, L; Orlando, A; Rosselli, M | 1 |
| Pavlović, S; Sindjić, M; Stojković, D; Velimirović, D | 1 |
| Deierhoi, MH; Filo, RS; Miller, J; Pirsch, JD; Vincenti, F | 1 |
| Apperley, JF; Gratwohl, A; Niederwieser, D; Ruutu, T | 1 |
| Barnas, U; Clodi, M; Hörl, WH; Kotzmann, H; Luger, A; Mayer, G; Mühlbacher, F; Mustafa, G; Riedl, M; Schmidt, A; Waldhäusl, W | 1 |
| Burckart, GJ; Dauber, JH; Diot, P; Griffith, BP; Iacono, AT; Keenan, RJ; Smaldone, GC; Zeevi, A | 1 |
| Chida, K; Hayakawa, H; Imokawa, S; Iwata, M; Ohashi, H; Sato, A; Shirai, M; Todate, A; Toyoshima, M; Yagi, H | 1 |
| Eggen, H; Erb, SR; Ford, JA; Keown, PA; Mori, LM; Partovi, N; Scudamore, CH; Shackleton, CR; Wynn, V; Yoshida, EM | 1 |
| Alexander, JW; First, MR; Hariharan, S; Ogle, CK; Peddi, VR; Schroeder, TJ; Valente, JF | 1 |
| Alsina, J; Castelao, AM; Cruzado, JM; Fulladosa, X; Gil-Vernet, S; Grinyo, JM; Hooftman, L; Moreso, F; Serón, D; Torras, J | 1 |
| Adams, DH; Carey, M; Fisher, NC; Heafield, MT; Ruban, E; West, RJ | 1 |
| Ahonen, JP; Isoniemi, HM; Lehtonen, SR; Salmela, KT; Taskinen, EI; von Willebrand, EO; vWillebrand, EO | 1 |
| Boggi, U; Carmellini, M; Filipponi, F; Frosini, F; Mosca, F | 1 |
| Akatsuka, J; Hamajima, N; Imashuku, S; Kigasawa, H; Kiriyama, Y; Kojima, S; Ohara, A; Ohta, S; Okamura, J; Sasaki, H; Sugita, K; Tsuchida, M; Tsukimoto, I | 1 |
| Kulkarni, S; Mehta, J; Powles, R; Singhal, S; Treleaven, J | 1 |
| Burckart, G; Cai, J; Dauber, J; Grgurich, W; Griffith, B; Iacono, A; Keenan, R; Ohori, NP; Pham, S; Smaldone, G; Spichty, K; Williams, P; Yousem, S; Zeevi, A | 1 |
| Apsner, R; Greinix, H; Janata, K; Kalhs, P; Keil, F; Schulenburg, A; Steinhoff, N | 1 |
| Baliga, PK; Bhaskar, S; Douzdjian, V; Rajagopalan, PR | 1 |
| Cantarovich, M; Latter, DA; Loertscher, R | 1 |
| Barr, D; Carithers, RL; Emond, MJ; Kowdley, KV; Marsh, CL; McVicar, JP; Perkins, JD | 1 |
| Harano, H; Kanamori, H; Matsuzaki, M; Mohri, H; Ogawa, K; Okubo, T; Sasaki, S; Tamura, T; Ueda, S; Yamazaki, E | 1 |
| Fisher, LR; Henley, KS; Lucey, MR | 1 |
| Arbustini, E; Campana, C; Gavazzi, A; Goggi, C; Grossi, P; Ippoliti, G; Martinelli, L; Pellegrini, C; Regazzi, M; Rinaldi, M; Vigano, M | 1 |
| Ghandour, FZ; Hricik, DE; Knauss, TC; Mulligan, DC; Schulak, JA | 1 |
| Besner, JG; Cantarovich, M; Fitchett, DH; Latter, DA | 1 |
| Aquino, A; Carr, J; Currier, CB; Ghasemian, SR; Light, JA; Rees, J; Sasaki, T; Ward, W | 1 |
| Ashman, LK; Sincock, PM | 1 |
| Cooper, DK; Hancock, WW; Kobayashi, T; Kosanke, S; Neethling, FA; Niekrasz, M; Rose, AG; Taniguchi, S; White, DJ; Wright, LJ; Ye, Y | 1 |
| Hricik, DE; Knauss, TC; Phinney, MS; Schulak, JA; Weigel, KA | 1 |
| Bouchard, D; Buluran, J; Cartier, R; Despatis, MA | 1 |
| Borg, AG; Burgess, R; Fisher, A; Grey, M; Wood, P; Yin, JA | 1 |
| Carl, S; Wiesel, M | 1 |
| Săceleanu, AM; Stan, C | 1 |
| Bilir, B; Everson, G; Kam, I; Karrer, F; Shrestha, R; Stegall, MD; Steinberg, T; Wachs, ME | 1 |
| Di Paolo, S; Gesualdo, L; Ranieri, E; Schena, FP; Stallone, G | 1 |
| Armati, R; Hunt, MJ; Lee, SH; Salisbury, EL; Wills, EJ | 1 |
| Gooley, T; Hackman, RC; Ko, CW; Lee, SP; McDonald, GB; Myerson, D; Sale, GE; Schoch, HG; Shulman, HM | 1 |
| Giuliani, MJ; Lacomis, D; Oddis, CV; Rana, SS | 1 |
| Morse, LS; Reed, JB; Schwab, IR | 1 |
| Amenábar, JJ; Aurrecoechea, B; García-Erauzkin, G; García-López, FJ; Gómez-Ullate, P; Lampreabe, I | 1 |
| First, MR | 2 |
| Ankova, EV; Shoĭkhet, IN; Treĭvish, VS | 1 |
| Baumann, R; Duclos, B; Reimund, JM | 1 |
| D'Haens, G; Rutgeerts, P; Suenaert, P; Westhovens, R | 1 |
| Bacigalupo, A; Berisso, G; Bregante, S; De Stefano, F; Frassoni, F; Gualandi, F; Lamparelli, T; Mordini, N; Occhini, D; Soracco, M; Van Lint, MT; Vitale, V; Zikos, P | 1 |
| Crespo Valadés, E; González Fernández, MR; Jimeno Torres, B; Robles Pérez, NR | 1 |
| Buhr, HJ; Foitzik, T; Forgacs, B; Gebhardt, MM; Hotz, H; Klar, E; Ryschich, E | 1 |
| Hyde, GM; Jewell, DP; Thillainayagam, AV | 1 |
| Bonomini, L; DeFranco, P; Friedman, G; Jacobs, M; Kaplan, B; Lyman, N; Mulgaonkar, SP; Viscuso, R | 1 |
| González, N; Padró, L; Rovira, R; Sueiras, M | 1 |
| Kurrle, R; Schorlemmer, HU | 1 |
| Kusaka, M; Nadeau, KC; Nagano, H; Shaw, GD; Takada, M; Tilney, NL | 1 |
| Fukao, K; Jinzenji, Y; Otsuka, M; Sakurayama, N; Suzuki, S; Takada, Y; Taniguchi, H; Yuzawa, K | 1 |
| Vanrenterghem, Y | 1 |
| Bruce, DS; Cronin, DC; Davis, B; Grewal, H; Loss, GE; Millis, JM; Newell, KA; Siegel, C; Thistlethwaite, JR; Todo, T; Turner, CD; Woodle, ES | 1 |
| Charpentier, B; Thervet, E | 1 |
| Adham, M; Aljuaid, N; Baulieux, J; Berthoux, N; Bizollon, T; Chevallier, M; Delaroche, E; Ducerf, C; Taibi, A | 1 |
| Figueira, ER; Leitão, RM; Massarollo, PC; Mies, S; Raia, S | 1 |
| Angelico, M; Buonomo, O; Casciani, CU; Negrini, S; Palmieri, G; Tisone, G; Vennarecci, G | 1 |
| Krause, P; Lobeck, H; Mueller, AR; Neuhaus, P; Neuhaus, R; Platz, KP | 1 |
| Busuttil, RW; Goss, J; Maggard, M; Ramdev, S; Swenson, K | 1 |
| Stratta, RJ | 1 |
| Abeywickrama, K; Amlot, P; Moore, R; Nashan, B; Schmidt, AG; Soulillou, JP | 1 |
| Suzuki, K; Tanaka, T; Tsugawa, R | 1 |
| Bährle, S; Dengler, TJ; Kübler, W; Stiehl, A; Szabó, G; Theilmann, L; Zimmermann, R | 1 |
| Kurrle, R; Ruuth, E; Schorlemmer, HU | 1 |
| Basara, N; Bischoff, M; Blau, WI; Fauser, AA; Günzelmann, S; Kirsten, D; Römer, E; Rudolphi, M; Sanchez, H | 1 |
| Hillebrand, G; Illner, WD; Land, W; Rothenpieler, U; Schneeberger, H; Stangl, M; Theodorakis, I; Zanker, B | 1 |
| Bechstein, WO; Glanemann, M; Guckelberger, O; Keck, H; Klupp, J; Knoop, M; Langrehr, JM; Lobeck, H; Lohmann, R; Machens, C; Neuhaus, PJ; Neumann, U; Schlag, H; Settmacher, U | 1 |
| Abramowicz, D; Broeders, N; Sternon, J; Wissing, M | 1 |
| Barnes, PD; duPlessis, AJ; Gleeson, JG; Riviello, JJ | 1 |
| Blinder, L; Chong, AS; Ma, LL; Sankary, H; Shen, J; Williams, JW; Yin, D | 1 |
| Asztalos, L; Balázs, G; Berczi, C; Kincses, Z; Löcsey, L | 1 |
| Aziz, H; Bianco, G; Braslavsky, G; Cueto, G; Duek, F; Imventarza, O; Lendoire, J; Saúl, J; Trigo, P | 1 |
| Bernazzali, S; Biagioli, B; Bizzarri, F; Caciorgna, M; Davoli, G; Diciolla, F; Giomarelli, PP; Giunti, G; Lisi, GF; Maccherini, M; Marchetti, L; Pula, G; Sani, G; Simeone, F; Toscano, M | 1 |
| Fernández-Crespo, P; Lloveras, J; Manresa, JM; Marcas, LI; Masramón, J; Mir, M; Puig, JM | 1 |
| Hayakawa, M; Kamiya, Y; Kasai, M; Kato, C; Kato, H; Kitaori, K; Morishima, Y; Sao, H; Shimokawa, T; Yamaguchi, T; Yanada, M | 1 |
| Bessell, EM; Byrne, JL; Haynes, AP; Hyde, H; Miflin, G; Russell, NH; Stainer, C | 1 |
| Azuma, H; Ichimaru, N; Kokado, Y; Li, BS; Matsumiya, K; Miki, T; Nonomura, N; Okuyama, A; Suzuki, S; Takahara, S; Wang, JD | 1 |
| Bennett, WM | 1 |
| Abraham, I; Daenen, W; De Geest, S; Evers, G; Moons, P; Van Cleemput, J; Vandeputte, M; Vanhaecke, J | 1 |
| Fujita, R; Higuchi, D; Inoue, K; Sekiyama, K; Yoshiba, M | 1 |
| Boulland, ML; Calmus, Y; Chereau, C; Conti, F; Dousset, B; Leroy-Viard, K; Soubrane, O; Weill, B | 1 |
| Acker, MA; DeNofrio, D; Loh, E; Reynolds, C; Rook, AH; Rosengard, BR | 1 |
| Bradley, JA; Briggs, JD; Junor, BJ; MacPhee, IA; MacPherson, SG; McMillan, MA; Rodger, RS; Watson, MA | 1 |
| Banerjee, D; Fyles, G; Lipton, JH; Lowsky, R; Messner, HA; Ng, CM; Spaner, D; Wade, JA | 1 |
| Bour, C; Colosetti, P; Guerci, AP; Guerci, O; Kataki, A; Marchal, S; Merlin, JL | 1 |
| Ando, Y; Beck, Y; Kikuchi, K; Meigata, K; Nishimura, Y; Nomura, Y; Tomikawa, S | 1 |
| Cheah, PL; Chua, CT; Goh, BL; Morad, Z; Tan, SY | 1 |
| Lam, DS; Leung, AT; Tham, CC; Wong, AK | 1 |
| Andreani, P; Caccamo, L; Fassati, LR; Gatti, S; Latham, L; Maggi, U; Melada, E; Paone, G; Reggiani, P; Rossi, G; Vannelli, A | 1 |
| Basara, N; Bischoff, M; Blau, WI; Fauser, AA; Günzelmann, S; Kiehl, MG; Kirsten, D; Römer, E; Rudolphi, M; Sanchez, H | 1 |
| Kokot, F; Nowicki, M; Ritz, E; Wiecek, A | 1 |
| Chueh, SC; Clark, J; Kahan, BD; Qu, X; Stepkowski, SM; Troncoso, P; Wang, ME | 1 |
| Detry, O; Honoré, P; Jacquet, N; Meurisse, M | 1 |
| Colombi, F; Fassi, A; Perico, N; Remuzzi, A; Remuzzi, G; Sangalli, F | 1 |
| Bennett, JM; Lee, S; Paietta, E; Rowe, JM; Sikic, BI; Tallman, MS; Wiernik, PH | 1 |
| Berger, C; Braumann, D; de Witt, M; Erttmann, R; Fiedler, W; Grimm, J; Horstmann, M; Hossfeld, KD; Illiger, HJ; Kabisch, H; Kröger, N; Krüger, W; Kuse, R; Schönrock, P; Stockshläder, M; Weh, HJ; Zander, AR; Zeller, W | 1 |
| Barr, ML; Longoria, J; Marboe, CC; Roberts, RF; Starnes, VA; Stouch, BC | 1 |
| Berry, GJ; Boeke, K; Christians, U; Hausen, B; Morris, RE; Segarra, IT | 1 |
| Archimbaud, E; Belhabri, A; Fière, D; Guyotat, D; Michallet, M; Molina, L; Nicolini, F; Perrin, MC; Sotto, JJ; Tigaud, JD | 1 |
| Belitsky, P; Mahalati, K; Sketris, I; West, K | 1 |
| Berquist, W; Cao, S; Castillo, RO; Concepcion, W; Cox, KL; Esquivel, CO; Frerker, M; Hammes, GB; Hayashi, M; Monge, H; Ojogho, OK; So, SK | 1 |
| Seikaly, MG | 1 |
| Canver, CC; Hoffman, AM; Jahania, MS; Love, RB; Mentzer, RM; Michalski, M; Onsager, DR; Welter, D | 1 |
| Calmus, Y; Conti, F; Gaulard, P; Houssin, D; Louvel, A; Rouer, E; Zafrani, ES | 1 |
| Hanauer, SB; Stein, RB | 1 |
| Malagelada, JR; Molero, X; Salas, A; Tian, X; Vaquero, E | 1 |
| Harness, J; McCombe, PA; Pender, MP | 1 |
| Belitsky, P; Mahalati, K; Panek, R; Sketris, I; West, K | 1 |
| Briegel, J; Deutsch, O; Fürst, H; Kur, F; Meiser, BM; Müller, C; Reichart, B; Reichenspurner, H; Schwaiblmair, M; Treede, H; Vogelmeier, C; Welz, A | 1 |
| de Fijter, JW; Hale, MD; Hené, RJ; Hilbrands, LB; Navarro, MT; Nicholls, AJ; Squifflet, JP; van Gelder, T; Vanrenterghem, Y; Verpooten, GA; Weimar, W | 1 |
| Agranat, O; Freimark, D; Gruberg, L; Har-Zahav, Y | 1 |
| Kim, SI; Kim, YS; Moon, JI; Park, K | 1 |
| Kahan, BD | 2 |
| Vincenti, F | 1 |
| Andrés, A; Carreño, A; Dominguez-Gil, B; Hernández, E; Herrero, JC; Morales, E; Morales, JM; Ortuño, T; Praga, M | 1 |
| Fernández-Crespo, P; Iñigo, V; Lloveras, J; Manresa, JM; Masramón, J; Mir, M; Puig, JM | 1 |
| Alonso, O; Gómez, R; González-Pinto, I; Loinaz, C; Moreno-González, E; Paseiro, G; Pérez-Saborido, B; Rodríguez, F; Rodríguez-Cañete, A | 1 |
| Charney, DA; Lo, AW; Nadasdy, T; Racusen, LC | 1 |
| Dzau, VJ; Ennen, M; Hoyt, EG; Mann, MJ; Poston, RS; Robbins, RC | 1 |
| Gooley, T; Hansen, JA; Lin, MT; Martin, EG; Martin, PJ; Pei, J; Petersdorf, EW; Smith, AG; Tseng, LH | 1 |
| Gómez-Almaguer, D; Herrera-Garza, J; Ibarra-Peart, R; Jaime-Pérez, J; Montemayor, J | 1 |
| Chang, SY; Lee, SS; Ma, CP; Sun, GH; Wu, CJ; Yu, DS | 1 |
| Amylon, MD; Blume, KG; Chao, NJ; Dagis, AC; Forman, SJ; Long, GD; Nademanee, AP; Negrin, RS; Niland, JC; O'Donnell, MR; Parker, PM; Ross, M; Schmidt, GM; Smith, EP; Snyder, DS; Stein, AS; Wong, RM | 1 |
| Johnson, RW; Lear, PA; Moore, RH; Pollard, SG; Ready, AR | 1 |
| Aküyrek, LM; Backman, U; Fellström, B; Jonsson, C; Larsson, E; Tufveson, G; Wahlberg, J | 1 |
| Edelweiss, MI; Gonçalves, LF; Manfro, RC; Veronese, FV | 1 |
| Becker, GJ; Jamil, B; Nicholls, K; Walker, RG | 1 |
| Csizmadia, V; Gao, W; Gerard, CJ; Hancock, WW; King, JA; Lu, B; Smiley, ST; Topham, PS | 1 |
| Barkun, JS; Cantarovich, M; de Varennes, B; Elstein, E | 1 |
| Kasai, M; Kato, C; Kitaori, K; Morishima, Y; Sao, H; Shimokawa, T; Ueda, R; Yamanishi, H | 1 |
| Bacigalupo, A; Barra, S; Berisso, G; Bregante, S; Corvò, R; Frassoni, F; Gualandi, F; Lamparelli, T; Mordini, N; Raiola, AM; Van Lint, MT; Vitale, V | 1 |
| Boasquevisque, CH; Boglione, M; McCarthy, TJ; Mora, BN; Patterson, GA; Uy, G; Welch, MJ | 1 |
| Ohbo, H; Okada, M; Tobe, S; Tsuji, F; Yamamoto, H; Yamashita, C | 1 |
| Goh, YT; How, GF; Hwang, WY; Tan, CH; Tan, HC | 1 |
| Hibi, S; Imashuku, S; Misawa, A; Sawada, T; Takeuchi, Y; Todo, S | 1 |
| Bennett, WM; de Mattos, AM; Olyaei, AJ | 1 |
| Bonetti, F; Dini, G; Giorgiani, G; Giraldi, E; Locatelli, F; Messina, C; Pession, A; Porta, F; Prete, A; Ripaldi, M; Rondelli, R; Uderzo, C; Zecca, M | 1 |
| Bicknell, GR; Doughman, T; Furness, P; Jain, S; Nicholson, ML; White, SA; Williams, ST | 1 |
| Ahsan, N; Holman, MJ; Ulsh, PJ; Yang, HC | 1 |
| Calabrese, KS; Gonçalves da Costa, SC; Mortara, RA; Paradela, AS; Silva, S; Tedesco, RC; Zaverucha do Valle, T | 1 |
| Cantarovich, M; de Varennes, B; Elstein, E; Ergina, P; Magnan, C; Quantz, M | 1 |
| Brewer, ED; Goldstein, SL; Portman, RJ; Sorof, JM; Steiger, HM | 1 |
| Basara, N; Bischoff, M; Blau, WI; Fauser, AA; Günzelmann, S; Kiehl, MG; Kirsten, D; Schmetzer, B | 1 |
| Bannister, KM; Barratt, LJ; Clarkson, AR; Elias, TJ; Faull, RJ; Mathew, TH; Russ, GR | 1 |
| Chiba, K; Kobayakawa, T | 1 |
| Haghshenas, M; Khojasteh, HN; Ramzi, M; Zakerinia, M | 1 |
| Abramowicz, D; Berthoux, FC; Brattström, C; Campistol, JM; Cisterne, JM; Grinyo, JM; Kreis, H; Land, W; Lebranchu, Y; Morales, JM; Mourad, G; Squifflet, JP; Vialtel, P; Wramner, L | 1 |
| Escousse, A; Gouyon, JB; Guignard, JP; Justrabo, E; Prévot, A; Semama, DS | 1 |
| Chakfe, N; Charloux, A; Geny, B; Hardy, H; Lampert, E; Lonsdorfer, J; Mettauer, B; Piquard, F | 1 |
| Eguchi, K; Kawabe, Y; Kawakami, A; Migita, K; Origuchi, T; Tanaka, F; Tominaga, M | 1 |
| Murata, S; Nakame, T; Ohmi, M; Tabayashi, K; Tofukuji, M; Yanai, K | 1 |
| Boyle, TM; Hensler, H; Hosenpud, JD; Khanna, AK; Sanford, G | 1 |
| Davisson, RL; Hill, JA; Karimi, M; Kerber, RE; Kutschke, W; Wang, Z; Weiss, RM; Zimmerman, K | 1 |
| Amylon, MD; Bluzme, KG; Chao, NJ; Forman, SJ; Fung, H; Hu, WW; Jain, M; Johnston, LJ; Kashyap, A; Kohler, S; Krishnan, A; Long, GD; Molina, A; Nademanee, AP; Negrin, RS; Niland, JC; O'Donnell, MR; Parker, P; Rodriguez, R; Snyder, DS; Spielberger, R; Stein, A; Stockerl-Goldstein, KE; Tierney, DK; Wong, RM | 1 |
| Andrés, A; Campistol, JM; Herrero, JC; Morales, JM | 1 |
| Baltzan, M; George, D; Shoker, A; Yang, H | 1 |
| Fabel, H; Harringer, W; Haverich, A; Hoeper, MM; Hoffmeyer, F; Niedermeyer, J; Spiekerkötter, E | 1 |
| Coles, JG; Straatman, LP | 1 |
| Blomberg, B; Järnerot, G | 1 |
| Bishay, E; Cook, DJ; Dennis, V; El Fettouh, HA; Flechner, S; Goldfarb, D; Modlin, C; Novick, AC | 1 |
| Gouyon, JB; Guignard, JP; Justrabo, E; Prévot, A; Semama, DS; Tendron, A | 1 |
| Anasetti, C; Antin, JH; Avalos, BR; Bartels, P; Buell, D; Davies, S; Fay, JW; Fitzsimmons, W; Karanes, C; Nash, RA; Petersen, FB; Przepiorka, D; Ratanatharathorn, V; Storb, R; Yeager, AM | 1 |
| Elonen, E; Juvonen, E; Parkkali, T; Ruutu, T; Volin, L | 1 |
| Acharya, MK; Auchincloss, H; Carpenter, CB; Kirkman, RL; McKay, DB; Milford, EL; Sayegh, MH; Tran, HTB | 1 |
| Blancho, G; Cantarovich, D; Dantal, J; Giral-Classe, M; Hourmant, M; Lerat, L; Moreau, A; Soulillou, JP | 1 |
| Jordan, SC; Marchevsky, A; Matloff, JM; Okada, Y; Toyoda, M; Yap, HK; Zuo, XJ | 1 |
| Bell, WJ; Blaney, TJ; Francis, JM; Lindner, MD; McDermott, PE; Saydoff, JA; Sherman, SS | 1 |
| Benedetto, BJ; Braden, GL; Germain, MJ; Lipkowitz, GS; Madden, RL; Mulhern, JG; O'Shaughnessy, J; O'Shea, MH | 1 |
| Batteux, F; Breton, S; Calmus, Y; Conti, F; Furlan, V; Houssin, D; Weill, B | 1 |
| Bathgate, AJ; Hayes, PC; Lee, P; Simpson, KJ | 1 |
| Flowers, ME; Margolis, DA; McDonald, GB; Prumbaum, M; Reddy, R; Seropian, SE; Shulman, HM; Strasser, SI | 1 |
| Capasso, G; Ciani, F; De Santo, NG; Pica, A; Rizzo, A; Russo, F; Unwin, R | 1 |
| Anasetti, C; Appelbaum, FR; Deeg, HJ; Doney, K; Furlong, T; Martin, P; Nash, RA; Storb, R; Sullivan, K; Witherspoon, R | 1 |
| Curwood, V; Furness, PN; Jain, S; Nicholson, ML; White, SA | 1 |
| Faidutti, B; Khatchatourian, G; Kondo-Oestreicher, M; Schnetzler, B; Vala, D | 1 |
| Chalermsanyakorn, P; Jirasiritham, S; Jirasiritham, SI; Sumethkul, V | 1 |
| Ebisui, C; Fukunishi, T; Hanafusa, T; Ichikawa, Y; Kyo, M; Nagano, S; Nojima, M; Tsubakihara, Y; Yazawa, K | 1 |
| Han, DJ; Jang, HJ; Kim, SC | 1 |
| Chueh, SC; Hong, JC; Huang, CY; Lai, MK | 1 |
| Fan, ST; Lai, CL; Lam, BK; Lau, GK; Liu, CL; Lo, CM; Ng, IO; Wong, J; Yong, BH | 1 |
| Baron, F; Beguin, Y; Fillet, G; Gothot, A; Hermanne, JP; Pierard, GE; Salmon, JP | 1 |
| Hashimoto, H; Makino, H; Ogawa, D; Ueno, A; Wada, J; Yamamura, M; Yamasaki, Y | 1 |
| Dübel, HP; Hummel, M; Kruse, I; Lutsch, G; Meyer, R; Pregla, R; Schernes, U; Schimke, I; Stahl, J | 1 |
| Azzawi, M; Deiraniya, AK; Hasleton, PS; Hutchinson, IV; Sinnott, PJ; Turner, DM; Yonan, N | 1 |
| Van Gossum, A | 1 |
| MacDonald, AS | 1 |
| de Witte, T; Linssen, P; Masereeuw, R; Muus, P; Raymakers, R; Smeets, M; Vierwinden, G | 1 |
| Dubey, D; Gupta, A; Kumar, A; Mandhani, A; Sharma, AP; Sharma, RK; Srivastava, A | 1 |
| Devlin, J; Gane, E; Portmann, B; Ramage, J; Williams, R; Wong, P | 1 |
| Tejani, A | 1 |
| Ashman, L; Cole, S; Ferrao, P; Sincock, P | 1 |
| Durrant, S; Irving, I; Mollee, P; Morton, AJ | 1 |
| Schlesinger, N; Schumacher , HR | 1 |
| Asztalos, L; Balzs, G; Berczi, C; Fedor, R; Kincses, Z; Locsey, L; Szabo, L | 1 |
| Baan, CC; Balk, AH; de Groot-Kruseman, HA; Loonen, EH; Maat, AP; Mol, WM; Niesters, HG; Weimar, W | 1 |
| Birsan, T; Klepetko, W; Meiser, B; Reichenspurner, H; Reichert, B; Treede, H; Wisser, W; Zuckermann, A | 1 |
| Bismuth, H; Freeman, R; Kalayoglu, M; Klintmalm, G; Langnas, A; Levy, G; Mamelok, R; McDiarmid, S; McMaster, P; Neuhaus, P; Punch, J; Rabkin, J; Wang, W; Wiesner, R | 1 |
| Basara, N; Bischoff, M; Blau, W; Fauser, AA; Günzelmann, S; Kiehl, MG; Kirsten, D; Römer, E; Schmetzer, B | 1 |
| Balk, AH; Hesse, CJ; van Gelder, T; van Riemsdijk-van Overbeeke, IC; Vantrimpont, P; Weimar, W | 1 |
| Keur, I; Meijer, RT; Schellekens, PT; Surachno, S; ten Berge, IJ | 1 |
| Amada, N; Miura, S; Ohashi, Y; Okazaki, H; Sato, T | 1 |
| Borka, P; Járay, J; Máthé, Z; Perner, F; Remport, A; Toronyi, E | 1 |
| Chariat, M; Chariat, MN; Deng, M; Dietl, KH; Erren, M; Wolters, HH | 1 |
| Faggian, G; Forni, A; Lamascese, N; Lamasciese, N; Luciani, GB; Mazzucco, A | 1 |
| Burnett, AK; Liu Yin, JA; Rees, JK; Wheatley, K | 1 |
| Boger, RS; Cambon, N; Kahan, BD; Kaplan, B; Lorber, MI; Winkler, M | 1 |
| Akaza, H; Fukao, K; Koyama, A; Otsuka, M; Takada, Y; Taniguchi, H; Todoroki, K; Yuzawa, K | 1 |
| Geiger, H; Hauser, IA; Koziolek, MJ; Riess, R; Thévenod, F | 1 |
| Kahan, BD; Kramer, WG | 1 |
| Hawkey, CJ; Logan, RP; Mahida, YR; Richardson, PD; Stack, WA | 1 |
| Pakkala, I; Pakkala, S; Räisänen-Sokolowski, A; Taskinen, E | 1 |
| Appelbaum, FR; Bennett, JM; Berger, MS; Bernstein, ID; Flowers, D; Gooley, TA; Hong, T; Leopold, LH; Linenberger, ML; Sievers, EL | 1 |
| Aftimos, G; Meguerian-Bedoyan, Z | 1 |
| Ganji, MR; Golbabaie, M; Hakemi, M; Kayedi, M; Mehraban, D; Naderi, GH; Najafi, I | 1 |
| Abdelnoor, AM; Ayvazian, PJ; Bigwood, P; Birbari, AE; Daouk, MM; Habbal, AA; Harland, R; Khauli, RB; Lovewell, T; Medawar, WA; Rahman Bizri, A; Sanjad, S; Stoff, JS; Uwaydah, M; Yang Fan, P | 1 |
| Hussein, I; Kahan, BD; Katz, S; Podbielski, J; Podder, H; Van Buren, C | 1 |
| Arnold, D; Brunner, T; Frutschi, C; Green, DR; Lin, T; Mueller, C; Vallan, C; Wasem, C | 1 |
| Baryshnikov, AIu; Kharazishvili, DI; Kokhno, AV; Lukashina, MI; Parovichnikova, EN; Savchenko, VG; Sokolovskaia, AA | 1 |
| Bumgardner, GL; Lin, A; Ramos, E; Vincenti, F | 1 |
| Bumgardner, GL; Hardie, I; Johnson, RW; Lin, A; Nashan, B; Pescovitz, MD; Ramos, E; Vincenti, F | 1 |
| Caravaggio, C; Cole, E; Halloran, P; Kiberd, B; Landsberg, D; Russell, D; Vasquez, AR; Zaltzman, J | 1 |
| Gloor, JM; Larson, TS; Stegall, MD; Velosa, JA | 1 |
| Böhringer, D; Cartsburg, O; De Clercq, E; Godehardt, E; Hillenkamp, J; Reinhard, T; Roggendorf, M; Ross, RS; Sundmacher, R | 2 |
| Hyde, GM; Jewell, DP; Kettlewell, MG; Mortensen, NJ | 1 |
| Chiba, T; Fujii, S; Nakase, H; Nishi, T; Nishihara, T; Ohana, M; Okazaki, K; Uchida, K; Uose, S | 1 |
| Briggs, JD; Hamilton, DN; Jaques, BC; Jardine, AG; Jindal, RM; Joseph, JT; Junor, BJ; Kingsmore, DB; Mun Woo, Y | 1 |
| Abul-Ezz, SR; Ahmad, I; Barone, GW; Barri, YM; Bonsib, SM; Ketel, BL; Walker, PD | 1 |
| Akdis, CA; Akdis, M; Blaser, K; Bröcker, EB; Disch, R; Schmid-Grendelmeier, P; Trautmann, A | 1 |
| Chiba, T; Inomata, M; Orii, S; Saito, S; Sannohe, I; Shitomi, T; Suzuki, K | 1 |
| Barrett, AJ; Carter, C; Childs, R; de Witte, M; Kang, EM; Leitman, SF; Little, R; Malech, H; Morgan, RA; Phang, S; Tisdale, JF | 1 |
| Benamenyo, JP; Droz, D; Niaudet, P | 1 |
| Hymes, LC; Warshaw, BL | 1 |
| Arcese, W; Cerretti, R; De Felice, L; Donato, V; Fenu, S; Guglielmi, C; Iori, A; Laurenti, L; Mengarelli, A; Micozzi, A; Romano, A; Torromeo, C | 1 |
| Acevedo, A; Escudero, A; Fernández-Rañada, JM; Gil-Fernández, JJ; Martínez, E; Martínez-Chamorro, C | 1 |
| Denney, J; Espino, G; Fitzsimmons, W; Furlong, T; Nash, RA | 1 |
| de Fijter, JW; Paul, LC; Schnuelle, P; Tegzess, A; van der Heide, JH; van der Woude, FJ; Verburgh, CA | 1 |
| Braunstein, C; Godehardt, E; Megahed, M; Reinhard, T; Reis, A; Sundmacher, R | 1 |
| Levi, M; Moons, AH; Peters, RJ | 1 |
| Appelbaum, FR | 1 |
| Modigliani, R | 1 |
| Strong, SA | 1 |
| Barbui, T; Bassan, R; Borleri, G; Buelli, M; Chiodini, B; Lerede, T; Rambaldi, A; Rossi, A; Viero, P | 1 |
| Carretta, A; Dobrovits, M; Klepetko, W; Miwai Marta, G; Neuhauser, P; Papp, A; Ploner, M; Sarahrudi, K; Senbaklavaci, O; Wisser, W | 1 |
| Huang, H; Huang, J; Jin, J; Lin, M; Luo, Y; Meng, H; Qian, W | 1 |
| Browne, BJ; Emovon, OE; Holt, CO | 1 |
| Jacobsohn, DA; Vogelsang, GB | 1 |
| Balzar, E; Bjorn Brekke, I; Ehrich, JH; Filler, G; Friman, S; Ghio, L; Grenda, R; Gusmano, R; Hughes, D; Janda, J; Klare, B; McGraw, M; Milford, DV; Perner, F; Stolpe, J; Trompeter, R; Tyden, G; Watson, AR; Webb, NJ; Zacchello, G | 1 |
| Dalmau, R; Delgado, JF; Escribano, P; Gómez-Sánchez, MA; Lázaro, M; Pombo, M; Rufilanchas, JJ; Sáenz de la Calzada, C; Sánchez, V; Velázquez, MT | 1 |
| Hiramatsu, A; Imamura, A; Kanakura, M; Kato, Y; Mihara, H; Miwa, H; Nitta, M; Sato, A; Tajima, E; Wakabayashi, M | 1 |
| Becton, DL; Bomgaars, L; Chang, MN; Dahl, GV; Lacayo, NJ; Lauer, SJ; Lum, BL; Ravindranath, Y; Sikic, BI; Weinstein, H | 1 |
| Cole, E; Levy, G; Nashan, B; Thervet, E | 1 |
| Chargui, J; Isobe, M; Kishimoto, T; Suzuki, J; Wada, S; Watanabe, Y; Yoshimura, R | 1 |
| Benjamin, CD; Chandraker, A; Coito, AJ; Dong, VM; Salama, AD; Sayegh, MH; Waaga, AM; Yuan, X | 1 |
| Beattie, JV; Petruska, PJ | 1 |
| Boratyńska, M; Szepietowski, T; Szewczyk, Z; Szydłowski, Z | 1 |
| Boström, L; Forsgren, M; Ringdén, O | 1 |
| Hansen, HE; Olsen, TS; Zachariae, H | 1 |
| Darmstadt, GL; Donnenberg, AD; Farmer, ER; Horn, TD; Vogelsang, GB | 1 |
| Fogo, A; Hellings, SE; Inagami, T; Kon, V | 1 |
| Hiller, E; Holler, E; Kolb, HJ; Seeber, C | 1 |
| Acharya, VN; Almeida, AF; Dikshit, MP; Trivedi, HS | 1 |
| de Abrew, K; de Mel, CP; Fernando, H; Jayasekera, G; Jayasinghe, S; Kuruppruarchchi, L; Nanayakkara, S; Rajakanthan, K; Sheriffdeen, AH; Weerasinghe, A | 1 |
| Asano, H; Haba, T; Numano, M; Orihara, A; Sato, K; Takagi, H; Tominaga, Y; Uchida, K; Yokoyama, I | 1 |
| Armitage, JM; Dauber, JH; Duncan, S; Griffith, BP; Hardesty, RL; Kormos, RL; Marrone, GC; Paradis, I; Williams, P; Yousem, SA | 1 |
| Blaise, D; Bordigoni, P; Esperou-Bourdeau, H; Gluckman, E; Kuentz, M; Michel, G; Milpied, N; Rubie, H; Thuret, I; Vernant, JP | 1 |
| Bessell, EM; Hunter, AE; Russell, NH | 1 |
| Bredberg, A; Ekberg, H; Lundell, A; Olsson, M; Persson, NH | 1 |
| Fox, M; Henry, L; Johnson, BF; Raftery, AT | 1 |
| Asano, T; Isono, K; Kenmochi, T; Ochiai, T; Shimada, H | 1 |
| Correia, O; Delgado, L; Nunes, JP; Polónia, J; Resende, C | 1 |
| Gerdin, B; Tufveson, G; Wanders, A | 1 |
| Reiffers-Mettelock, J | 1 |
| Caracciolo, F; Carulli, G; Grassi, B; Mattii, L; Pardi, C; Petrini, M; Sabbatini, A | 1 |
| Donovan, J; Langnas, A; Markin, R; Shaw, BW; Sorrell, M; Stratta, R | 1 |
| Kakishita, E; Kanamaru, A; Masaoka, T; Moriyama, Y; Shibata, H; Takemoto, Y | 1 |
| Abu-Elmagd, K; Alessiani, M; Demetris, AJ; Fung, JJ; Jain, A; McCauley, J; Starzl, TE; Takaya, S; Todo, S; Van Thiel, DH | 1 |
| Buoncompagni, A; Ciccone, O; Cordone, G; De Langlade, E; Fasce, L; Minetti, C; Scribanis, R | 1 |
| Dietze, O; Habringer, C; Klima, G; Königsrainer, A; Krausler, R; Margreiter, R | 1 |
| Ashby, M; Atkinson, K; Biggs, J; Concannon, A; Dodds, A; Downs, K; Wilson, F; Young, S | 1 |
| Lien, YH; Robinson, WA; Schröter, GP; Weil, R | 1 |
| Chiang, GS; Vathsala, A; Woo, KT | 1 |
| Dalton, HR; Jewell, DP | 1 |
75 review(s) available for cyclosporine and Acute Disease
| Article | Year |
|---|---|
Acute Severe Ulcerative Colitis: Optimal Strategies for Drug Therapy.
Topics: Acute Disease; Adrenal Cortex Hormones; Colectomy; Colitis, Ulcerative; Cyclosporine; Humans; Infliximab; Treatment Outcome | 2023 |
Current management of generalized pustular psoriasis.
Topics: Acute Disease; CARD Signaling Adaptor Proteins; Chronic Disease; Cyclosporine; Female; Guanylate Cyclase; Humans; Interleukins; Membrane Proteins; Methotrexate; Psoriasis; Retinoids; Skin Diseases, Vesiculobullous | 2023 |
Insights into the modulatory role of cyclosporine A and its research advances in acute inflammation.
Topics: Acute Disease; Animals; Cyclosporine; Humans; Immunomodulation; Immunosuppressive Agents; Inflammation; Organ Transplantation; Reperfusion Injury; Sepsis; T-Lymphocytes; Wounds and Injuries | 2021 |
Post-transplant cyclophosphamide, a promising anti-graft versus host disease prophylaxis: where do we stand?
Topics: Acute Disease; Allografts; Antilymphocyte Serum; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Sirolimus | 2017 |
Optimal management of acute severe ulcerative colitis.
Topics: Acute Disease; Adrenal Cortex Hormones; Colectomy; Colitis, Ulcerative; Cyclosporine; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Risk Assessment | 2019 |
Corticosteroids for viral myocarditis.
Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Azathioprine; Child; Chronic Disease; Cyclosporine; Humans; Myocarditis; Prednisone; Randomized Controlled Trials as Topic; Virus Diseases | 2013 |
Ability of different rescue therapies to save the bowel in acute, severe, steroid-refractory ulcerative colitis.
Topics: Acute Disease; Adrenal Cortex Hormones; Antibodies, Monoclonal; Colitis, Ulcerative; Cyclosporine; Drug Resistance; Drug Substitution; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Salvage Therapy; Severity of Illness Index; Tacrolimus; Treatment Failure | 2014 |
[Recent progress in the management of aplastic anemia].
Topics: Acute Disease; Anemia, Aplastic; Antilymphocyte Serum; Benzoates; Chronic Disease; Cyclosporine; Disease Progression; Hematopoiesis; Humans; Hydrazines; Immunosuppressive Agents; Pyrazoles | 2014 |
Predictors of the response to treatment in acute lupus hemophagocytic syndrome.
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Antibodies, Antinuclear; C-Reactive Protein; Cyclosporine; Female; Ferritins; Hemoglobins; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Lymphohistiocytosis, Hemophagocytic; Male; Middle Aged; Predictive Value of Tests; Prednisolone; Retrospective Studies; Young Adult | 2015 |
Natural history of first episode of acute severe colitis.
Topics: Acute Disease; Adrenal Cortex Hormones; Antibodies, Monoclonal; Colectomy; Colitis, Ulcerative; Cyclosporine; Diagnosis, Differential; Disease Progression; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Risk Factors | 2014 |
Cyclosporine in steroid refractory acute severe colitis.
Topics: Acute Disease; Adrenal Cortex Hormones; Antibodies, Monoclonal; Colectomy; Colitis, Ulcerative; Cyclosporine; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Infusions, Intravenous | 2014 |
Prophylactic and therapeutic treatment of graft-versus-host disease in Japan.
Topics: Acute Disease; Bone Marrow Transplantation; Calcineurin Inhibitors; Chronic Disease; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Japan; Mycophenolic Acid; Tacrolimus; Transplantation, Homologous | 2015 |
Surgical and medical treatment in patients with acute severe ulcerative colitis.
Topics: Acute Disease; Adrenal Cortex Hormones; Colectomy; Colitis, Ulcerative; Cyclosporine; Emergency Medical Services; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Severity of Illness Index; Treatment Outcome | 2015 |
Review article: the practical management of acute severe ulcerative colitis.
Topics: Acute Disease; Antibodies, Monoclonal; Colitis, Ulcerative; Cyclosporine; Humans; Immunosuppressive Agents; Infliximab; Male; Middle Aged; Randomized Controlled Trials as Topic; Salvage Therapy; Steroids; Treatment Outcome | 2016 |
Itch in Urticaria Management.
Topics: Acute Disease; Adrenal Cortex Hormones; Anti-Allergic Agents; Antibodies, Anti-Idiotypic; Chronic Disease; Cyclosporine; Histamine Antagonists; Humans; Immunosuppressive Agents; Leukotriene Antagonists; Omalizumab; Pruritus; Urticaria | 2016 |
Acute severe ulcerative colitis: from pathophysiology to clinical management.
Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Algorithms; Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Calcineurin Inhibitors; Clinical Trials as Topic; Colitis, Ulcerative; Colonoscopy; Cyclosporine; Disease Models, Animal; Electrolytes; Humans; Infliximab; Parenteral Nutrition; Salvage Therapy; Thromboembolism; Treatment Outcome; Tumor Necrosis Factor-alpha | 2016 |
[Graft-versus-host disease: friend or foe?].
Topics: Acute Disease; Cell Separation; Cyclosporine; Disease-Free Survival; Graft vs Host Disease; Graft vs Leukemia Effect; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Methotrexate; T-Lymphocytes; Tacrolimus; Transplantation, Homologous | 2008 |
Is acute rejection the key predictor for long-term outcomes after renal transplantation when comparing calcineurin inhibitors?
Topics: Acute Disease; Adrenal Cortex Hormones; Calcineurin Inhibitors; Cyclosporine; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Pancreas Transplantation; Randomized Controlled Trials as Topic; Tacrolimus; Time Factors; Treatment Outcome | 2009 |
Mini-series: II. clinical aspects. clinically relevant CYP450-mediated drug interactions in the ICU.
Topics: Acute Disease; Analgesics, Opioid; Anti-Bacterial Agents; Anticonvulsants; Benzodiazepines; Catecholamines; Chronic Disease; Critical Care; Cyclosporine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Interactions; Drug Monitoring; Humans; Immunosuppressive Agents; Intensive Care Units; Midazolam; Tacrolimus | 2009 |
Calcineurin inhibitor nephrotoxicity.
Topics: Acute Disease; Calcineurin Inhibitors; Chronic Disease; Cyclosporine; Diagnosis, Differential; Humans; Immunosuppressive Agents; Kidney; Kidney Diseases; Risk Assessment; Risk Factors; Tacrolimus | 2009 |
Management of acute severe ulcerative colitis.
Topics: Acute Disease; Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antibodies, Monoclonal; Clinical Protocols; Colitis, Ulcerative; Colonic Pouches; Cyclosporine; Digestive System Surgical Procedures; Drug Resistance; Gastrointestinal Agents; Humans; Infliximab; Patient Selection; Proctocolectomy, Restorative; Recurrence; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2009 |
Infliximab for the treatment of acute exacerbations of ulcerative colitis.
Topics: Acute Disease; Antibodies, Monoclonal; Colectomy; Colitis, Ulcerative; Cost-Benefit Analysis; Cyclosporine; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Models, Economic; Quality of Life; Risk; Survival Analysis; Treatment Outcome | 2010 |
Postconditioning in acute myocardial infarction patients.
Topics: Acute Disease; Animals; Cyclosporine; Enzyme Inhibitors; Humans; Ischemic Postconditioning; Ischemic Preconditioning, Myocardial; Myocardial Infarction; Myocardial Reperfusion Injury | 2011 |
Clinical review: topical ophthalmic use of cyclosporin A.
Topics: Acute Disease; Blepharitis; Conjunctival Diseases; Conjunctivitis, Allergic; Corneal Transplantation; Cyclosporine; Dry Eye Syndromes; Emulsions; Eye Diseases; Graft Rejection; Graft vs Host Disease; Humans; Immunosuppressive Agents; Ophthalmic Solutions; Rosacea | 2010 |
Management of acute severe ulcerative colitis.
Topics: Acute Disease; Antibodies, Monoclonal; Colectomy; Colitis, Ulcerative; Cyclosporine; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Treatment Outcome | 2011 |
Colon salvage therapy for acute severe colitis: cyclosporine or infliximab?
Topics: Acute Disease; Anti-Inflammatory Agents; Antibodies, Monoclonal; Colitis, Ulcerative; Cyclosporine; Humans; Immunosuppressive Agents; Infliximab; Salvage Therapy | 2011 |
Acute severe colitis: infliximab and/or cyclosporine?
Topics: Acute Disease; Anti-Inflammatory Agents; Antibodies, Monoclonal; Colitis, Ulcerative; Cyclosporine; Humans; Immunosuppressive Agents; Infliximab; Randomized Controlled Trials as Topic | 2011 |
[Calcineurin inhibitor nephrotoxicity in renal allografts].
Topics: Acute Disease; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Calcineurin Inhibitors; Chronic Disease; Cyclosporine; Humans; Kidney Diseases; Kidney Glomerulus; Kidney Transplantation; Kidney Tubules; Renin-Angiotensin System; Tacrolimus; Transplantation, Homologous | 2011 |
[Ischemic tubulointerstitial injury].
Topics: Acute Disease; Antiphospholipid Syndrome; Arteriosclerosis; Calcineurin Inhibitors; Chronic Disease; Contrast Media; Cyclosporine; Humans; Infarction; Ischemia; Kidney Cortex Necrosis; Kidney Diseases; Renal Artery | 2011 |
Infliximab versus cyclosporine as rescue therapy in acute severe steroid-refractory ulcerative colitis: a systematic review and meta-analysis.
Topics: Acute Disease; Antibodies, Monoclonal; Colectomy; Colitis, Ulcerative; Cyclosporine; Humans; Infliximab; Postoperative Complications; Publication Bias; Steroids | 2013 |
P-glycoprotein in acute myeloid leukaemia: therapeutic implications of its association with both a multidrug-resistant and an apoptosis-resistant phenotype.
Topics: Acute Disease; Adult; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cell Division; Ceramides; Child; Cyclosporine; Cyclosporins; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Leukemia, Myeloid; Lovastatin; Multicenter Studies as Topic; Neoplasm Proteins; Oxides; Phenotype; Protein Kinase C; Randomized Controlled Trials as Topic; Signal Transduction; Tumor Cells, Cultured | 2002 |
[Central nervous system involvement in Behçet's disease].
Topics: Acute Disease; Behcet Syndrome; Biomarkers; Chronic Disease; Cyclosporine; HLA-B Antigens; HLA-B51 Antigen; Humans; Interleukin-6; Magnetic Resonance Imaging; Methotrexate | 2001 |
Steroid-refractory graft-vs.-host disease: past, present and future.
Topics: Acute Disease; Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Child; Chronic Disease; Cyclosporine; Daclizumab; Glucocorticoids; Graft vs Host Disease; Humans; Immunoglobulin G; Immunosuppressive Agents; Infliximab; Mycophenolic Acid; Photopheresis; Prednisone; Prodrugs; Sirolimus; Tacrolimus | 2003 |
[Medical management of inflammatory bowel disease: consensus and controversies].
Topics: Acute Disease; Antibodies, Monoclonal; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Parenteral Nutrition; Preoperative Care | 2003 |
Long-term renal transplantation. Recent successes and new problems.
Topics: Acute Disease; Chronic Disease; Cyclosporine; Forecasting; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Time Factors | 2003 |
Acute renal allograft rejections, a role for statins?
Topics: Acute Disease; Animals; Anticholesteremic Agents; Cholesterol, LDL; Clinical Trials as Topic; Cyclosporine; Drug Evaluation, Preclinical; Drug Interactions; Graft Rejection; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Immunosuppressive Agents; Kidney Transplantation; Lymphocyte Activation; Naphthalenes; Postoperative Complications; Protein Prenylation; Protein Processing, Post-Translational | 2003 |
[Management of severe acute colitis].
Topics: Acute Disease; Adrenal Cortex Hormones; Algorithms; Case Management; Colectomy; Colitis; Colonoscopy; Cyclosporine; Humans; Ileostomy; Immunosuppressive Agents; Inflammatory Bowel Diseases | 2003 |
Cyclosporine nephrotoxicity.
Topics: Acute Disease; Chronic Disease; Cyclosporine; Drug-Related Side Effects and Adverse Reactions; Humans; Immunosuppressive Agents; Kidney Diseases | 2003 |
Medical management of ulcerative colitis.
Topics: Acute Disease; Administration, Oral; Aminosalicylic Acids; Anti-Bacterial Agents; Antibodies, Monoclonal; Colitis, Ulcerative; Colonic Neoplasms; Cyclosporine; Epidermal Growth Factor; Gastrointestinal Agents; Heparin; Humans; Infliximab; Probiotics; Purines; Risk Factors; Steroids | 2003 |
Cyclosporine nephrotoxicity.
Topics: Acute Disease; Chronic Disease; Cyclosporine; Drug Monitoring; Humans; Immunosuppressive Agents; Kidney; Mycophenolic Acid; Transplantation Immunology | 2004 |
Cyclosporine nephrotoxicity.
Topics: Acute Disease; Chronic Disease; Cyclosporine; Humans; Hypertension; Immunosuppression Therapy; Immunosuppressive Agents; Kidney; Renin-Angiotensin System; Vasoconstriction; Vasodilation | 2004 |
Use of cyclosporine in lung transplantation.
Topics: Acute Disease; Calcineurin Inhibitors; Chemistry, Pharmaceutical; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Humans; Hypertension; Immunosuppressive Agents; Infections; Lung Transplantation; Neoplasms; Postoperative Complications | 2004 |
[Prescription of phototherapy in psoriasis].
Topics: Acute Disease; Combined Modality Therapy; Cyclosporine; Furocoumarins; Humans; Immunosuppressive Agents; Photosensitizing Agents; Phototherapy; Psoriasis; Risk Factors; Severity of Illness Index; Skin Neoplasms | 2004 |
[Treatment of fulminant hepatitis C or subacute hepatitis C].
Topics: Acute Disease; Antiviral Agents; Cyclosporine; Hepatitis C; Humans; Immunosuppressive Agents; Interferon-beta; Liver Failure; Sorption Detoxification | 2004 |
[Recent advances in the treatment of fulminant hepatitis B].
Topics: Acute Disease; Antiviral Agents; Carrier State; Cyclosporine; Drug Therapy, Combination; Guanine; Hemodiafiltration; Hepatitis B; Humans; Immunosuppressive Agents; Lamivudine; Liver Failure, Acute; Liver Transplantation; Methylprednisolone; Plasma Exchange; Prognosis; Pulse Therapy, Drug | 2004 |
[Clinical features of acute hepatitis E in Sapporo].
Topics: Acute Disease; Age Factors; Animals; Combined Modality Therapy; Cyclosporine; Genotype; Hemodiafiltration; Hepatitis E; Hepatitis E virus; Humans; Japan; Male; Methylprednisolone; Middle Aged; Plasma Exchange; Pulse Therapy, Drug; RNA, Viral; Sex Factors; Zoonoses | 2004 |
Nephrotoxicity of ciclosporin A: short-term gain, long-term pain?
Topics: Acute Disease; Chronic Disease; Clinical Trials as Topic; Cyclosporine; Disease Progression; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Graft Rejection; Graft vs Host Disease; Humans; Immunosuppressive Agents; Kidney Diseases; Postoperative Complications; Sirolimus; Tacrolimus | 2006 |
Everolimus in clinical practice--renal transplantation.
Topics: Acute Disease; Calcineurin; Calcineurin Inhibitors; Cell Proliferation; Clinical Trials as Topic; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Everolimus; Graft Rejection; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Postoperative Complications; Practice Guidelines as Topic; Signal Transduction; Sirolimus | 2006 |
Cyclosporin versus tacrolimus as primary immunosuppressant after liver transplantation: a meta-analysis.
Topics: Acute Disease; Cyclosporine; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Liver Transplantation; Risk Factors; Tacrolimus | 2006 |
Risk assessment in haematopoietic stem cell transplantation: GvHD prevention and treatment.
Topics: Acute Disease; Adrenal Cortex Hormones; Calcineurin Inhibitors; Chronic Disease; Cyclosporine; Graft vs Host Disease; Graft vs Leukemia Effect; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Methotrexate; Methylprednisolone; Mycophenolic Acid; Risk Assessment; T-Lymphocytes; Tacrolimus | 2007 |
Treatment of choice for acute severe steroid-refractory ulcerative colitis is cyclosporine.
Topics: Acute Disease; Clinical Trials as Topic; Colitis, Ulcerative; Cyclosporine; Drug Resistance; Glucocorticoids; Humans; Immunosuppressive Agents | 2009 |
Acute leucoencephalopathy during cyclosporin A therapy in a patient with nephrotic syndrome.
Topics: Acute Disease; Adolescent; Brain; Cyclosporine; Drug Therapy, Combination; Female; Humans; Leukoencephalopathy, Progressive Multifocal; Magnetic Resonance Imaging; Nephrotic Syndrome; Prednisolone | 1994 |
Steroid-free immunosuppression in cyclosporine-treated renal transplant recipients: a meta-analysis.
Topics: Acute Disease; Adrenal Cortex Hormones; Cyclosporine; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Kidney Transplantation; Odds Ratio; Prospective Studies; Randomized Controlled Trials as Topic; Survival Rate | 1993 |
Pharmacologic prophylaxis of acute graft-versus-host disease after allogeneic marrow transplantation.
Topics: Acute Disease; Bone Marrow Transplantation; Clinical Trials as Topic; Cyclosporine; Drug Therapy, Combination; Graft vs Host Disease; Humans; Immunosuppressive Agents; Methotrexate; Randomized Controlled Trials as Topic; Risk Factors | 1993 |
The role of multidrug resistance and its pharmacological modulation in acute myeloid leukemia.
Topics: Acute Disease; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Clinical Trials as Topic; Cyclosporine; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Leukemia, Myeloid; Multicenter Studies as Topic; Treatment Failure | 1996 |
[Treatment of acute a steroid-resistant ulcerative colitis with continuous venous infusion of cyclosporine].
Topics: Acute Disease; Adolescent; Adult; Colitis, Ulcerative; Cyclosporine; Drug Resistance; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Infusions, Intravenous; Male; Methylprednisolone; Middle Aged | 1996 |
[Behçet's disease with a fatal evolution].
Topics: Acute Disease; Adult; Behcet Syndrome; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Fatal Outcome; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Optic Neuritis; Prednisone | 1997 |
Clinical application of immunosuppressive agents in renal transplantation.
Topics: Acute Disease; Cadaver; Cyclosporine; Forecasting; Graft Rejection; Graft Survival; HLA Antigens; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Tacrolimus; Tissue Donors; Treatment Outcome | 1998 |
The nephrotoxicity of new and old immunosuppressive drugs.
Topics: Acute Disease; Animals; Chronic Disease; Cyclosporine; Humans; Immunosuppressive Agents; Kidney; Kidney Diseases; Kidney Transplantation; Prognosis; Sirolimus; Tacrolimus | 1998 |
Acute failure of the transplanted kidney--pathophysiology, diagnosis and prevention.
Topics: Acute Disease; Animals; Communicable Diseases; Cyclosporine; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Kidney Tubular Necrosis, Acute; Postoperative Complications; Treatment Failure | 1996 |
Mycophenolate mofetil--is it worth the cost? The in-favor opinion.
Topics: Acute Disease; Azathioprine; Child; Chronic Disease; Cost of Illness; Cyclosporine; Drug Costs; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Technology Assessment, Biomedical; Treatment Outcome | 1999 |
Medical therapy for inflammatory bowel disease.
Topics: Acute Disease; Adrenal Cortex Hormones; Anti-Bacterial Agents; Anti-Inflammatory Agents; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Methotrexate; Recurrence; Salicylates; Severity of Illness Index; Steroids | 1999 |
The potential role of rapamycin in pediatric transplantation as observed from adult studies.
Topics: Acute Disease; Adult; Age Factors; Antibodies, Monoclonal; Basiliximab; Child; Cohort Studies; Cyclosporine; Drug Monitoring; Fingolimod Hydrochloride; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Propylene Glycols; Protein-Tyrosine Kinases; Recombinant Fusion Proteins; Sirolimus; Sphingosine; Time Factors; Tyrphostins | 1999 |
Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for the future.
Topics: Acute Disease; Chronic Disease; Costs and Cost Analysis; Cyclosporine; Diagnosis, Differential; Forecasting; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Transplantation; Monitoring, Physiologic; Risk Factors; Tacrolimus; Time Factors | 2000 |
[Immunosuppressive agent FTY720].
Topics: Acute Disease; Animals; Autoimmune Diseases; Cyclosporine; Drug Design; Drug Therapy, Combination; Fingolimod Hydrochloride; Graft Rejection; Humans; Immunosuppressive Agents; Propylene Glycols; Sphingosine; Transplantation, Homologous | 2000 |
Immunosuppression in older renal transplant patients.
Topics: Acute Disease; Adrenal Cortex Hormones; Aged; Antilymphocyte Serum; Azathioprine; Clinical Protocols; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Middle Aged; Mycophenolic Acid; Quality of Life; Survival Analysis; Tacrolimus; Treatment Outcome | 2000 |
Clinical evaluation and management of acute severe colitis.
Topics: Acute Disease; Adrenal Cortex Hormones; Anti-Bacterial Agents; Colitis, Ulcerative; Cyclosporine; Diagnosis, Differential; Humans; Ileostomy; Immunosuppressive Agents; Life Style; Prognosis; Severity of Illness Index; Tacrolimus | 2000 |
Gout: can management be improved?
Topics: Acute Disease; Causality; Cyclosporine; Gout; Gout Suppressants; Humans; Immunosuppressive Agents; Uric Acid | 2001 |
The impact of late acute rejection after cadaveric kidney transplantation.
Topics: Acute Disease; Adult; Cadaver; Cyclosporine; Graft Rejection; Graft Survival; Histocompatibility Testing; HLA Antigens; Humans; Immunosuppressive Agents; Kidney Transplantation; Middle Aged; Risk Factors; Survival Analysis; Time Factors | 2001 |
Acute necrotizing gastritis by Escherichia coli in a severely neutropenic patient.
Topics: Acute Disease; Amikacin; Anemia, Aplastic; Antilymphocyte Serum; Combined Modality Therapy; Cyclosporine; Drug Therapy, Combination; Escherichia coli Infections; Gastric Mucosa; Gastritis; Granulocyte Colony-Stimulating Factor; Immunosuppressive Agents; Meropenem; Methylprednisolone; Necrosis; Neutropenia; Omeprazole; Parenteral Nutrition, Total; T-Lymphocytes; Thienamycins | 2002 |
Tissue factor and coronary artery disease.
Topics: Acute Disease; Angioplasty, Balloon, Coronary; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Anticoagulants; Arginine; Aspirin; Coronary Artery Disease; Coronary Thrombosis; Cyclosporine; Endothelium, Vascular; Factor VIIa; Heparin, Low-Molecular-Weight; Hirudin Therapy; Humans; Hypolipidemic Agents; Leukocytes, Mononuclear; Muscle, Smooth, Vascular; Recombinant Proteins; Thrombin; Thromboplastin | 2002 |
Medical management of fulminant colitis.
Topics: Acute Disease; Colitis, Ulcerative; Colonoscopy; Cyclosporine; Decision Trees; Humans; Severity of Illness Index | 2002 |
Novel pharmacotherapeutic approaches to prevention and treatment of GVHD.
Topics: Acute Disease; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Carbamates; Chronic Disease; Combined Modality Therapy; Cyclosporine; Daclizumab; Fibroblast Growth Factor 7; Fibroblast Growth Factors; Graft vs Host Disease; Humans; Immunoglobulin G; Immunosuppressive Agents; Infliximab; Interleukin-11; Mycophenolic Acid; Receptors, Interleukin-2; Sirolimus; T-Lymphocytes; Tacrolimus | 2002 |
Clinical validation studies of Neoral C(2) monitoring: a review.
Topics: Absorption; Acute Disease; Clinical Trials as Topic; Creatinine; Cyclosporine; Drug Monitoring; Graft Rejection; Health Care Costs; Humans; Immunosuppressive Agents; Kidney Transplantation; Liver Transplantation; Risk Factors; Tacrolimus | 2002 |
The management of acute severe ulcerative colitis.
Topics: Acute Disease; Colectomy; Colitis, Ulcerative; Cyclosporine; Fluid Therapy; Humans; Hydrocortisone; Methylprednisolone | 1991 |
177 trial(s) available for cyclosporine and Acute Disease
| Article | Year |
|---|---|
Reduced-Intensity Conditioning with Busulfan, Fludarabine, and Antithymocyte Globulin for Hematopoietic Cell Transplantation from Unrelated or Haploidentical Family Donors in Patients with Acute Myeloid Leukemia in Remission.
Topics: Acute Disease; Adolescent; Adult; Aged; Antilymphocyte Serum; Busulfan; Chronic Disease; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Multiple Myeloma; Myeloablative Agonists; Prospective Studies; Recurrence; Remission Induction; Siblings; Survival Analysis; Transplantation Conditioning; Transplantation, Haploidentical; Unrelated Donors; Vidarabine | 2017 |
Increased intracellular adenosine triphosphate level as an index to predict acute rejection in kidney transplant recipients.
Topics: Acute Disease; Adenosine Triphosphate; Adult; CD4-Positive T-Lymphocytes; Cell Count; Cyclosporine; Disease Progression; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Intracellular Space; Kidney Transplantation; Male; Middle Aged; Predictive Value of Tests; Prognosis; Prospective Studies; Tacrolimus; Transplantation | 2014 |
Pharmacodynamic monitoring of nuclear factor of activated T cell-regulated gene expression in liver allograft recipients on immunosuppressive therapy with calcineurin inhibitors in the course of time and correlation with acute rejection episodes--a prospe
Topics: Acute Disease; Adult; Aged; Calcineurin Inhibitors; Cyclosporine; Drug Monitoring; Female; Gene Expression; Graft Rejection; Humans; Immunosuppressive Agents; Liver Transplantation; Longitudinal Studies; Male; Middle Aged; NFATC Transcription Factors; Prospective Studies; T-Lymphocytes; Tacrolimus; Transplantation, Homologous | 2014 |
Safety and efficacy of the early introduction of everolimus with reduced-exposure cyclosporine a in de novo kidney recipients.
Topics: Acute Disease; Adult; Antibodies, Monoclonal; Basiliximab; Calcineurin Inhibitors; Cyclosporine; Drug Therapy, Combination; Everolimus; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Prospective Studies; Recombinant Fusion Proteins; Republic of Korea; Sirolimus; Steroids; Time Factors; Treatment Outcome | 2015 |
Biomarker profiling of steroid-resistant acute GVHD in patients after infusion of mesenchymal stromal cells.
Topics: Acute Disease; Adolescent; Adult; Aged; Antigens, Neoplasm; Biomarkers; Child; Child, Preschool; Cyclosporine; Cytokines; Drug Resistance; Female; Graft vs Host Disease; Humans; Immunophenotyping; Immunosuppressive Agents; Infant; Lymphocytes; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Middle Aged; Prednisone; Prognosis; Steroids; Treatment Outcome; Young Adult | 2015 |
One-Year Multicenter Double-Blind Randomized Clinical Trial on the Efficacy and Safety of Generic Cyclosporine (Iminoral) in De Novo Kidney Transplant Recipients.
Topics: Acute Disease; Adolescent; Adrenal Cortex Hormones; Adult; Aged; Calcineurin Inhibitors; Cyclosporine; Double-Blind Method; Drug Therapy, Combination; Drugs, Generic; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Iran; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Risk Factors; Time Factors; Treatment Outcome; Young Adult | 2015 |
Stem cell transplantation in severe congenital neutropenia: an analysis from the European Society for Blood and Marrow Transplantation.
Topics: Acute Disease; Adolescent; Adult; Allografts; Child; Child, Preschool; Cyclosporine; Europe; Female; Graft Rejection; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Incidence; Male; Methotrexate; Middle East; Neutropenia; Retrospective Studies; Societies, Medical; Unrelated Donors | 2015 |
Risk factors and prognosis of hepatic acute GvHD after allogeneic hematopoietic cell transplantation.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Allografts; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Liver Diseases; Male; Middle Aged; Registries; Risk Factors; Survival Rate | 2016 |
A randomized controlled trial of cyclosporine and tacrolimus with strict control of blood concentrations after unrelated bone marrow transplantation.
Topics: Acute Disease; Adult; Allografts; Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Hematologic Neoplasms; Humans; Male; Middle Aged; Survival Rate; Tacrolimus; Unrelated Donors | 2016 |
Cyclosporine A in addition to standard ART during primary HIV-1 infection: pilot randomized clinical trial.
Topics: Acute Disease; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cyclosporine; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lopinavir; Male; Middle Aged; Pilot Projects; Ritonavir; Young Adult | 2017 |
Low incidence of acute graft-versus-host disease with short-term tacrolimus in haploidentical hematopoietic stem cell transplantation.
Topics: Acute Disease; Adolescent; Adult; Child; Cyclosporine; Cytomegalovirus Infections; Disease-Free Survival; Female; Graft vs Host Disease; Haplotypes; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Lymphocyte Subsets; Male; Middle Aged; Premedication; Recurrence; Survival Rate; Tacrolimus; Young Adult | 2017 |
Dosing and safety of cyclosporine in patients with severe brain injury.
Topics: Acute Disease; Adult; Brain Injuries; Cyclosporine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Glasgow Coma Scale; Humans; Immunosuppressive Agents; Injections, Intravenous; Male; Middle Aged; Neuroprotective Agents; Placebos; Prospective Studies; Treatment Outcome | 2008 |
Topical Cyclosporin A in the treatment of acute graft rejection: a randomized controlled trial.
Topics: Acute Disease; Administration, Topical; Adult; Aged; Aged, 80 and over; Corneal Transplantation; Cyclosporine; Double-Blind Method; Drug Therapy, Combination; Epithelium, Corneal; Female; Graft Rejection; Humans; Immunosuppressive Agents; Intraocular Pressure; Kaplan-Meier Estimate; Male; Middle Aged; Prednisolone; Treatment Failure | 2008 |
Adult human mesenchymal stem cells added to corticosteroid therapy for the treatment of acute graft-versus-host disease.
Topics: Acute Disease; Adolescent; Adrenal Cortex Hormones; Adult; Aged; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Middle Aged; Mycophenolic Acid; Tacrolimus | 2009 |
Basiliximab versus daclizumab combined with triple immunosuppression in deceased donor renal transplantation: a prospective, randomized study.
Topics: Acute Disease; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Basiliximab; Cyclosporine; Daclizumab; Drug Therapy, Combination; Female; Graft Rejection; Graft Survival; Humans; Immunoglobulin G; Immunosuppressive Agents; Kaplan-Meier Estimate; Kidney Transplantation; Male; Methylprednisolone; Middle Aged; Mycophenolic Acid; Prospective Studies; Receptors, Interleukin-2; Recombinant Fusion Proteins; Time Factors; Treatment Outcome | 2010 |
Lenalidomide maintenance after nonmyeloablative allogeneic stem cell transplantation in multiple myeloma is not feasible: results of the HOVON 76 Trial.
Topics: Acute Disease; Adult; Aged; Antineoplastic Agents; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Drug Eruptions; Feasibility Studies; Female; Graft vs Host Disease; Hematologic Diseases; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Immunologic Factors; Immunosuppressive Agents; Lenalidomide; Lymphocyte Count; Male; Melphalan; Middle Aged; Multiple Myeloma; Mycophenolic Acid; Prospective Studies; Remission Induction; Thalidomide; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; Whole-Body Irradiation | 2011 |
Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial.
Topics: Acute Disease; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Colitis, Ulcerative; Cyclosporine; Drug Resistance; Female; Humans; Immunosuppressive Agents; Infliximab; Infusions, Intravenous; Male; Middle Aged; Steroids; Treatment Failure | 2012 |
Short-term outcomes of Thymoglobulin induction in pediatric renal transplant recipients.
Topics: Acute Disease; Adolescent; Animals; Antilymphocyte Serum; Child; Child, Preschool; Cyclosporine; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Postoperative Complications; Rabbits; Tacrolimus; Treatment Outcome | 2002 |
Cyclosporine withdrawal from a mycophenolate mofetil-containing immunosuppressive regimen in stable kidney transplant recipients: a randomized, controlled study.
Topics: Acute Disease; Adolescent; Adult; Aged; Blood Pressure; Cholesterol; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid | 2002 |
Safety and efficacy of an alternative basiliximab (Simulect) regimen after renal transplantation: administration of a single 40-mg dose on the first postoperative day in patients receiving triple therapy with azathioprine.
Topics: Acute Disease; Adult; Antibodies, Monoclonal; Azathioprine; Basiliximab; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Recombinant Fusion Proteins | 2003 |
Pediatric renal transplantation with mycophenolate mofetil-based immunosuppression without induction: results after three years.
Topics: Acute Disease; Adolescent; Azathioprine; Blood Pressure; Child; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Hypertension; Immunosuppressive Agents; Kidney; Kidney Transplantation; Male; Mycophenolic Acid; Prospective Studies; Treatment Outcome | 2003 |
A three-arm study comparing immediate tacrolimus therapy with antithymocyte globulin induction therapy followed by tacrolimus or cyclosporine A in adult renal transplant recipients.
Topics: Acute Disease; Adult; Antilymphocyte Serum; Cyclosporine; Female; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Male; Middle Aged; Patient Compliance; Prospective Studies; Survival Analysis; Tacrolimus | 2003 |
Cyclosporine A versus tacrolimus in combination with mycophenolate mofetil and steroids as primary immunosuppression after lung transplantation: one-year results of a 2-center prospective randomized trial.
Topics: Acute Disease; Adult; Aged; Cyclosporine; Drug Therapy, Combination; Female; Glucocorticoids; Graft Rejection; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Lung Transplantation; Male; Methylprednisolone; Middle Aged; Mycophenolic Acid; Prospective Studies; Recurrence; Survival Rate; Tacrolimus; Time Factors | 2003 |
Effect of sirolimus in combination with low-dose cyclosporine and steroids on acute renal allograft rejection.
Topics: Acute Disease; Adult; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Glucocorticoids; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Methylprednisolone; Middle Aged; Prospective Studies; Sirolimus; Treatment Outcome | 2003 |
A phase III prospective, randomized study to evaluate concentration-controlled sirolimus (rapamune) with cyclosporine dose minimization or elimination at six months in de novo renal allograft recipients.
Topics: Acute Disease; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Incidence; Kidney; Kidney Transplantation; Osmolar Concentration; Sirolimus; Survival Analysis; Transplantation, Homologous | 2003 |
Cyclosporine is required to prevent severe acute GVHD following T-cell-depleted peripheral blood stem cell transplantation.
Topics: Acute Disease; Adolescent; Adult; Child; Cyclosporine; Dose-Response Relationship, Drug; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Lymphocyte Depletion; Lymphocyte Transfusion; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Time Factors; Transplantation, Homologous | 2003 |
Early steroid withdrawal after liver transplantation: the Canadian tacrolimus versus microemulsion cyclosporin A trial: 1-year follow-up.
Topics: Acute Disease; Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Canada; Child; Chronic Disease; Cyclosporine; Emulsions; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Prospective Studies; Tacrolimus | 2003 |
Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three years.
Topics: Acute Disease; Azathioprine; Cadaver; Creatinine; Cyclosporine; Drug Therapy, Combination; Florida; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Hyperglycemia; Kidney Transplantation; Mycophenolic Acid; Postoperative Complications; Probability; Racial Groups; Survival Analysis; Tacrolimus; Time Factors; Tissue Donors | 2003 |
Tacrolimus (FK506) versus cyclosporin A microemulsion (Neoral) maintenance immunosuppression: effects on graft survival and function, infection, and metabolic profile following kidney transplantation (KT).
Topics: Acute Disease; Adolescent; Adult; Aged; Creatinine; Cyclosporine; Cytomegalovirus Infections; Emulsions; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Lipids; Male; Middle Aged; Tacrolimus | 2003 |
Gemtuzumab ozogamicin, fludarabine, cytarabine and cyclosporine combination regimen in patients with CD33+ primary resistant or relapsed acute myeloid leukemia.
Topics: Acute Disease; Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Cytarabine; Drug Resistance, Neoplasm; Female; Gemtuzumab; Humans; Leukemia, Myeloid; Male; Middle Aged; Platelet Count; Recurrence; Remission Induction; Sialic Acid Binding Ig-like Lectin 3; Survival Rate; Vidarabine | 2003 |
Fibrosis-associated gene expression in renal transplant glomeruli after acute renal allograft rejection.
Topics: Acute Disease; Adolescent; Adult; Cyclosporine; Female; Fibrosis; Gene Expression; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Glomerulus; Kidney Transplantation; Male; Middle Aged; RNA, Messenger; Tacrolimus; Transforming Growth Factors; Transplantation, Homologous | 2003 |
Treatment of acute kidney allograft rejection with a non-mitogenic CD3 antibody.
Topics: Acute Disease; Adolescent; Adult; Antibodies, Monoclonal; CD3 Complex; Cyclosporine; Cytokines; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunoglobulin A; Immunosuppressive Agents; Kidney Transplantation; Lymphocyte Subsets; Male; Middle Aged; Prednisolone; Statistics, Nonparametric; Survival Rate; Transplantation, Homologous | 2003 |
Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis.
Topics: Acute Disease; Adult; Colitis, Ulcerative; Cyclosporine; Double-Blind Method; Endoscopy, Digestive System; Female; Humans; Immunosuppressive Agents; Injections, Intravenous; Male; Middle Aged; Severity of Illness Index; Treatment Outcome | 2003 |
Relationship between CsA trough blood concentration and severity of acute graft-versus-host disease after paediatric stem cell transplantation from matched-sibling or unrelated donors.
Topics: Acute Disease; Adolescent; Bayes Theorem; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Infant; Male; Severity of Illness Index; Siblings; Tissue Donors; Transplantation, Homologous | 2003 |
Clinical and pharmacological risk factors for acute graft-versus-host disease after paediatric bone marrow transplantation from matched-sibling or unrelated donors.
Topics: Acute Disease; Adolescent; Area Under Curve; Bayes Theorem; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Drug Monitoring; Female; Graft vs Host Disease; Histocompatibility; Humans; Incidence; Infant; Male; Methotrexate; Risk Factors; Tissue Donors | 2003 |
Autologous peripheral blood stem cell transplantation with induction of autologous graft-versus-host disease in acute myeloid leukemia.
Topics: Acute Disease; Adolescent; Adult; Cyclosporine; Female; Graft Survival; Graft vs Host Disease; Graft vs Leukemia Effect; Humans; Interferon-gamma; Killer Cells, Natural; Leukemia, Myeloid; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Pilot Projects; Survival Analysis; Transplantation, Autologous | 2003 |
Tacrolimus may be associated with lower osteonecrosis rates after renal transplantation.
Topics: Acute Disease; Adult; Anti-Inflammatory Agents; Cyclosporine; Drug Therapy, Combination; Female; Femur Head Necrosis; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Knee; Magnetic Resonance Imaging; Male; Osteonecrosis; Prednisolone; Risk Factors; Tacrolimus; Time Factors; Treatment Outcome | 2003 |
Cyclosporin A (CsA) and azathioprine (AZA) combination in renal allografts with CsA nephrotoxicity.
Topics: Acute Disease; Adult; Azathioprine; Cadaver; Chronic Disease; Creatinine; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Histocompatibility Testing; Humans; Immunosuppressive Agents; Kidney; Kidney Transplantation; Male; Reoperation; Time Factors; Tissue Donors | 1992 |
Prompt initiation of immunotherapy in children with an increasing number of autologous cells after allogeneic HCT can induce complete donor-type chimerism: a report of 14 children.
Topics: Acute Disease; Adolescent; Child; Child, Preschool; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transplantation Chimera; Transplantation, Autologous; Treatment Outcome | 2004 |
In renal transplantation blood cyclosporine levels soon after surgery act as a major determinant of rejection: insights from the MY.S.S. trial.
Topics: Acute Disease; Adolescent; Adult; Aged; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Predictive Value of Tests; Prospective Studies | 2004 |
Long-term benefits with sirolimus-based therapy after early cyclosporine withdrawal.
Topics: Acute Disease; Cyclosporine; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Sirolimus; Survival Rate; Time Factors | 2004 |
Efficacy and safety of tacrolimus compared with cyclosporine microemulsion in primary simultaneous pancreas-kidney transplantation: 1-year results of a large multicenter trial.
Topics: Acute Disease; Adult; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Emulsions; Europe; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Israel; Kidney Transplantation; Male; Middle Aged; Pancreas Transplantation; Safety; Tacrolimus | 2004 |
Addition of cyclosporin A to the combination of mitoxantrone and etoposide to overcome resistance to chemotherapy in refractory or relapsing acute myeloid leukaemia: a randomised phase II trial from HOVON, the Dutch-Belgian Haemato-Oncology Working Group
Topics: Acute Disease; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Leukemia, Myeloid; Male; Middle Aged; Mitoxantrone; Prognosis; Recurrence; Regression Analysis; Survival Analysis; Treatment Outcome | 2004 |
Cyclosporine alone vs cyclosporine plus methotrexate for post-transplant immunosuppression after HLA-identical sibling bone marrow transplantation: a randomized prospective study.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; HLA Antigens; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Prospective Studies; Recurrence; Siblings; Survival Rate; Tissue Donors | 2004 |
Calcium channel blockade and preservation of renal graft function in cyclosporine-treated recipients: a prospective randomized placebo-controlled 2-year study.
Topics: Acute Disease; Adolescent; Adult; Blood Pressure; Calcium Channel Blockers; Child; Cyclosporine; Dihydropyridines; Female; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Kidney; Kidney Transplantation; Male; Middle Aged; Osmolar Concentration; Patient Compliance; Patient Readmission; Placebos; Prospective Studies; Time Factors; Treatment Failure | 2004 |
Multicenter, randomized study of the effectiveness of basiliximab in avoiding addition of steroids to cyclosporine a monotherapy in renal transplant recipients.
Topics: Acute Disease; Adrenal Cortex Hormones; Antibodies, Monoclonal; Basiliximab; Cyclosporine; Double-Blind Method; Drug Therapy, Combination; Female; Graft Rejection; Histocompatibility Testing; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Placebos; Recombinant Fusion Proteins; Survival Analysis | 2005 |
Long-term results of a prospective randomized trial comparing tacrolimus versus cyclosporine in African-American recipients of primary cadaver renal transplant.
Topics: Acute Disease; Adult; Black or African American; Cholesterol; Creatinine; Cyclosporine; Diabetes Mellitus; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Longitudinal Studies; Male; Middle Aged; Postoperative Complications; Tacrolimus | 2005 |
Basiliximab (Simulect) reduces acute rejection among sensitized kidney allograft recipients.
Topics: Acute Disease; Adult; Antibodies, Monoclonal; Basiliximab; Cadaver; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Humans; Immunization; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Recombinant Fusion Proteins; Tissue Donors; Transplantation, Homologous | 2005 |
Assessment of two strategies of neoral administration, early versus delayed, on renal function and efficacy in de novo renal transplant patients receiving myfortic, steroids, and anti-IL2R antibodies: 12-month results of a randomized, multicentre, open, p
Topics: Acute Disease; Adrenal Cortex Hormones; Cadaver; Chronic Disease; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Function Tests; Kidney Transplantation; Living Donors; Postoperative Complications; Survival Analysis; Tissue Donors; Treatment Failure | 2005 |
Costimulation blockade with belatacept in renal transplantation.
Topics: Acute Disease; Adult; Antigens, CD; Antigens, Differentiation; CTLA-4 Antigen; Cyclosporine; Female; Glomerular Filtration Rate; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Lipids; Lymphocyte Activation; Male; Middle Aged; T-Lymphocytes; Transplantation, Homologous | 2005 |
Combination therapy with corticosteroids, cyclosporin A, and intravenous pulse cyclophosphamide for acute/subacute interstitial pneumonia in patients with dermatomyositis.
Topics: Acute Disease; Adult; Aged; Cyclophosphamide; Cyclosporine; Dermatomyositis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Lung Diseases, Interstitial; Male; Middle Aged; Pilot Projects; Prednisolone; Probability; Pulse Therapy, Drug; Respiratory Function Tests; Severity of Illness Index; Statistics, Nonparametric; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2005 |
Superior outcomes in renal transplantation after early cyclosporine withdrawal and sirolimus maintenance therapy, regardless of baseline renal function.
Topics: Acute Disease; Adolescent; Adult; Aged; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Kidney; Kidney Transplantation; Male; Middle Aged; Sirolimus; Steroids; Treatment Outcome | 2005 |
Basiliximab and mycophenolate mofetil in combination with low-dose cyclosporine and methylprednisolone effectively prevent acute rejection in kidney transplant recipients.
Topics: Acute Disease; Adolescent; Adult; Aged; Antibodies, Monoclonal; Azathioprine; Basiliximab; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Histocompatibility Testing; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Methylprednisolone; Middle Aged; Mycophenolic Acid; Recombinant Fusion Proteins; Reoperation; Retrospective Studies; Treatment Outcome | 2005 |
A randomized trial of inhaled cyclosporine in lung-transplant recipients.
Topics: Acute Disease; Administration, Inhalation; Chronic Disease; Cyclosporine; Double-Blind Method; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Infections; Lung Transplantation; Male; Middle Aged; Multivariate Analysis; Regression Analysis; Survival Analysis | 2006 |
Addition of cyclosporin-A to chemotherapy in secondary (post-MDS) AML in the elderly. A multicenter randomized trial of the Leukemia Working Group of the Hellenic Society of Hematology.
Topics: Acute Disease; Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Cytarabine; Data Interpretation, Statistical; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Greece; Humans; Idarubicin; Infusions, Intravenous; Leukemia, Myeloid; Male; Middle Aged; Neoplasms, Second Primary; Remission Induction; Societies, Medical; Survival Analysis; Treatment Outcome | 2006 |
Cyclosporin A disposition following acute traumatic brain injury.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Brain; Brain Injuries; Cohort Studies; Cyclosporine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Humans; Male; Metabolic Clearance Rate; Middle Aged; Neuroprotective Agents; Placebos; Prospective Studies; Time Factors | 2006 |
Antithymocyte globulin and cyclosporine A as combination therapy for low-risk non-sideroblastic myelodysplastic syndromes.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anemia, Refractory; Anemia, Refractory, with Excess of Blasts; Aneuploidy; Antilymphocyte Serum; Atrial Fibrillation; Cyclosporine; Disease Progression; Female; Humans; Hypotension; Immunosuppressive Agents; Karyotyping; Leukemia, Myeloid; Male; Middle Aged; Prospective Studies; Remission Induction; Risk; T-Lymphocytes; Treatment Outcome | 2006 |
Superior prevention of acute rejection by tacrolimus vs. cyclosporine in heart transplant recipients--a large European trial.
Topics: Acute Disease; Antilymphocyte Serum; Biopsy; Blood Pressure; Creatinine; Cyclosporine; Graft Rejection; Graft Survival; Heart Transplantation; Humans; Immunosuppressive Agents; Myocardium; Tacrolimus; Time Factors | 2006 |
Paired kidney analysis of tacrolimus and cyclosporine microemulsion-based therapy in Chinese cadaveric renal transplant recipients.
Topics: Acute Disease; Adult; China; Cyclosporine; Emulsions; Female; Graft Rejection; Graft Survival; Humans; Hypercholesterolemia; Hypertension; Immunosuppressive Agents; Kidney; Kidney Transplantation; Male; Middle Aged; Prospective Studies; Survival Rate; Tacrolimus | 2006 |
Reduced-exposure cyclosporine is safe and efficacious in de novo renal transplant recipients treated with enteric-coated mycophenolic acid and basiliximab.
Topics: Acute Disease; Adolescent; Adult; Aged; Antibodies, Monoclonal; Basiliximab; Belgium; Biopsy; Creatinine; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Therapy, Combination; Emulsions; Enzyme Inhibitors; Female; Follow-Up Studies; Germany; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Recombinant Fusion Proteins; Survival Rate; Tablets, Enteric-Coated; Time Factors; Treatment Outcome | 2007 |
Cyclosporine monitoring in the early post-transplant period in pediatric liver transplant recipients.
Topics: Acute Disease; Child, Preschool; Cyclosporine; Dose-Response Relationship, Drug; Drug Monitoring; Female; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Liver Transplantation; Male; Postoperative Period; Spain; Survival Rate; Treatment Outcome | 2007 |
Tacrolimus as prophylaxis for acute graft-versus-host disease in reduced intensity cord blood transplantation for adult patients with advanced hematologic diseases.
Topics: Acute Disease; Adult; Aged; Cord Blood Stem Cell Transplantation; Cyclosporine; Female; Graft Survival; Graft vs Host Disease; Hematologic Diseases; Humans; Immunosuppressive Agents; Male; Middle Aged; Prognosis; Tacrolimus | 2007 |
Prospective comparison of the use of sirolimus and cyclosporine in recipients of a kidney from an expanded criteria donor.
Topics: Acute Disease; Adolescent; Adult; Aged; Cyclosporine; Dose-Response Relationship, Drug; Graft Rejection; Humans; Immunosuppressive Agents; Kidney; Kidney Transplantation; Middle Aged; Pilot Projects; Sirolimus; Tissue Donors | 2008 |
Treatment of acute graft-versus-host disease with methylprednisolone and cyclosporine with or without an anti-interleukin-2 receptor monoclonal antibody. A multicenter phase III study.
Topics: Acute Disease; Adolescent; Adult; Antibodies, Monoclonal; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Double-Blind Method; Female; Graft vs Host Disease; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Placebos; Transplantation, Homologous | 1995 |
Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. European FK506 Multicentre Liver Study Group.
Topics: Acute Disease; Adolescent; Adrenal Cortex Hormones; Adult; Aged; Chronic Disease; Cyclosporine; Female; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Incidence; Infections; Liver Transplantation; Male; Middle Aged; Survival Rate; Tacrolimus | 1994 |
Distinct intragraft cytokine gene expression patterns during acute hepatic rejection under cyclosporine versus FK 506 primary immunosuppression.
Topics: Acute Disease; Biopsy; Cyclosporine; Cytokines; Gene Expression; Graft Rejection; Humans; Interleukin-2; Interleukin-4; Interleukin-5; Interleukin-6; Liver Transplantation; Polymerase Chain Reaction; RNA, Messenger; Tacrolimus; Transplantation, Homologous; Tumor Necrosis Factor-alpha | 1994 |
OKT3 vs FK 506 rescue management of acute steroid-resistant and chronic rejection.
Topics: Acute Disease; Chronic Disease; Cyclosporine; Drug Resistance; Drug Therapy, Combination; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Liver Transplantation; Muromonab-CD3; Steroids; Tacrolimus | 1995 |
The superior immunosuppressant according to diagnosis: FK 506 or cyclosporine A.
Topics: Acute Disease; Cyclosporine; Drug Monitoring; Graft Rejection; Humans; Immunosuppression Therapy; Incidence; Liver Transplantation; Survival Rate; Tacrolimus; Time Factors | 1995 |
Clinical trial of tacrolimus versus cyclosporine in lung transplantation.
Topics: Acute Disease; Adult; Bronchiolitis Obliterans; Cross-Over Studies; Cyclosporine; Female; Follow-Up Studies; Fungemia; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Lung Transplantation; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Risk Factors; Survival Rate; Tacrolimus | 1995 |
The optimal immunosuppressant after liver transplantation according to diagnosis: cyclosporine A or FK506?
Topics: Acute Disease; Cyclosporine; Graft Rejection; Humans; Immunosuppressive Agents; Kidney; Liver Transplantation; Nervous System Diseases; Tacrolimus | 1995 |
FK506 treatment of graft-versus-host disease developing or exacerbating during prophylaxis and therapy with cyclosporin and/or other immunosuppressants. Japanese FK506 BMT Study Group.
Topics: Acute Disease; Adolescent; Adult; Azathioprine; Bone Marrow Transplantation; Child; Chronic Disease; Cyclosporine; Female; Flushing; Graft vs Host Disease; Humans; Immunosuppressive Agents; Kidney Diseases; Male; Methotrexate; Middle Aged; Nausea; Prednisolone; Tacrolimus; Treatment Outcome | 1995 |
Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group.
Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Antilymphocyte Serum; Biopsy; Cadaver; Cyclosporine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Kidney; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Treatment Failure | 1995 |
In vivo/ex vivo T cell depletion reduces the morbidity of allogeneic bone marrow transplantation in patients with acute leukaemias in first remission without increasing the risk of treatment failure: comparison with cyclosporin/methotrexate.
Topics: Acute Disease; Adolescent; Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cyclosporine; Cytomegalovirus Infections; Disease-Free Survival; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia; Male; Methotrexate; Middle Aged; Recurrence; Remission Induction; Retrospective Studies; Risk Factors; T-Lymphocytes; Transplantation, Homologous; Treatment Outcome | 1995 |
Outcome analysis of FK 506 therapy for acute and chronic rejection.
Topics: Acute Disease; Azathioprine; Chronic Disease; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppression Therapy; Male; Tacrolimus; Time Factors; Treatment Outcome | 1993 |
Use of Prograf (FK 506) as rescue therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group.
Topics: Acute Disease; Acute Kidney Injury; Adrenal Cortex Hormones; Bilirubin; Chronic Disease; Communicable Diseases; Cyclosporine; Female; Follow-Up Studies; Glomerular Filtration Rate; Graft Rejection; Graft Survival; Humans; Liver Function Tests; Liver Transplantation; Male; Muromonab-CD3; Renal Dialysis; Survival Analysis; Tacrolimus; Time Factors | 1993 |
Interferon and cyclosporin A in the treatment of fulminant viral hepatitis.
Topics: Acute Disease; Adolescent; Adult; Aged; Combined Modality Therapy; Cyclosporine; Female; Hepatic Encephalopathy; Hepatitis B; Hepatitis C; Hepatitis E; Hepatitis, Viral, Human; Humans; Infant; Interferon-beta; Liver; Male; Middle Aged; Necrosis | 1995 |
Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. European Mycophenolate Mofetil Cooperative Study Group.
Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Aged; Cyclosporine; Double-Blind Method; Drug Combinations; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Placebos; Survival Rate; Treatment Failure | 1995 |
High-dose cyclosporine A induction therapy in liver transplant recipients with normal postoperative renal function: a prospective study.
Topics: Acute Disease; Azathioprine; Bilirubin; Biopsy, Needle; Chronic Disease; Creatinine; Cyclosporine; Follow-Up Studies; Graft Rejection; Humans; Kidney; Kidney Transplantation; Liver Transplantation; Methylprednisolone; Muromonab-CD3; Prospective Studies; Steroids; Time Factors | 1995 |
Cyclosporine blood levels predict the likelihood of rejection and toxicity after simultaneous pancreas-kidney transplantation.
Topics: Acute Disease; Adult; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Drug Monitoring; Female; Graft Rejection; Graft Survival; Humans; Incidence; Kidney Transplantation; Male; Pancreas Transplantation; Probability; Survival Rate | 1995 |
Effect of anti-IL-2-receptor monoclonal antibody BT 563 in treatment of acute interstitial renal rejection.
Topics: Acute Disease; Adult; Antibodies, Monoclonal; Antigens, CD; Azathioprine; Combined Modality Therapy; Cyclosporine; Enzyme-Linked Immunosorbent Assay; Graft Rejection; Humans; Immunosuppression Therapy; Kidney Transplantation; Methylprednisolone; Receptors, Interleukin-2; T-Lymphocyte Subsets | 1995 |
Cyclosporin monotherapy (after 3 months) in liver transplant patients: a prospective randomized trial.
Topics: Acute Disease; Adult; Chronic Disease; Cyclosporine; Female; Graft Rejection; Humans; Immunosuppression Therapy; Incidence; Liver Transplantation; Male; Middle Aged; Steroids; Survival Rate | 1994 |
Limited utility of early trough cyclosporine level monitoring to predict the rate of acute rejection in the first three months after cardiac transplantation.
Topics: Acute Disease; Analysis of Variance; Biopsy, Needle; Creatinine; Cyclosporine; Drug Monitoring; Female; Graft Rejection; Heart Transplantation; Humans; Immunosuppression Therapy; Male; Methylprednisolone; Middle Aged; Retrospective Studies; Survival Rate; Time Factors; Transplantation, Homologous | 1994 |
Induction therapy with cyclosporine and without cytolytic agents results in a low incidence of acute rejection without significant renal impairment in heart transplant patients.
Topics: Acute Disease; Creatinine; Cyclosporine; Dose-Response Relationship, Drug; Follow-Up Studies; Graft Rejection; Heart Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Incidence; Prevalence; Time Factors | 1994 |
Misoprostol in renal transplant recipients: a prospective, randomized, controlled study on the prevention of acute rejection episodes and cyclosporin A nephrotoxicity.
Topics: Acute Disease; Administration, Oral; Cyclosporine; Female; Graft Rejection; Humans; Incidence; Kidney; Kidney Diseases; Kidney Function Tests; Kidney Transplantation; Male; Misoprostol; Prospective Studies | 1994 |
Phase I/II trial of cyclosporine as a chemotherapy-resistance modifier in acute leukemia.
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carrier Proteins; Child; Child, Preschool; Cyclosporine; Daunorubicin; Drug Resistance; Female; Gene Expression; Humans; Leukemia, Myeloid; Male; Membrane Glycoproteins; Middle Aged; Neoplasm Proteins; Phenotype; Survival Analysis; Treatment Outcome | 1993 |
Management of the renal allograft recipient: immunosuppressive protocols for long-term success.
Topics: Acute Disease; Azathioprine; Chronic Disease; Cyclosporine; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Prednisone | 1994 |
Allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission: the effect of FAB classification and GVHD prophylaxis.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Dose-Response Relationship, Drug; Female; Graft vs Host Disease; Humans; Infant; Leukemia, Myeloid; Male; Multivariate Analysis; Recurrence; Remission Induction; Retrospective Studies; Survival Rate; Time Factors; Transplantation, Homologous | 1994 |
A randomized trial of roxithromycin in patients with acute leukemia and bone marrow transplant recipients receiving fluoroquinolone prophylaxis.
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Infective Agents; Bone Marrow Transplantation; Cyclosporine; Drug Combinations; Female; Fever; Humans; Leukemia; Male; Middle Aged; Neutropenia; Ofloxacin; Patient Compliance; Premedication; Prospective Studies; Roxithromycin; Streptococcal Infections | 1994 |
Cyclosporine combined with methylprednisolone or methotrexate in prophylaxis of moderate to severe acute graft-versus-host disease.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Incidence; Japan; Leukemia, Myeloid; Male; Methotrexate; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Severity of Illness Index | 1993 |
Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-versus-host disease.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chi-Square Distribution; Child; Child, Preschool; Chronic Disease; Cyclosporine; Drug Administration Schedule; Female; Graft vs Host Disease; Humans; Infant; Male; Methotrexate; Middle Aged; Prednisone; Recurrence; Regression Analysis; Treatment Outcome | 1993 |
Acute vascular rejection with hemolytic uremic syndrome in kidneys from non-heart-beating donors: associated with secondary grafts and early cyclosporine treatment?
Topics: Acute Disease; Adult; Brain Death; Cyclosporine; Female; Graft Rejection; Graft Survival; Heart Arrest; Hemolytic-Uremic Syndrome; Histocompatibility Testing; Humans; Kidney Transplantation; Male; Retrospective Studies; Survival Analysis; Time Factors; Tissue Donors | 1993 |
Monoclonal antibodies in prophylactic immunosuppression after liver transplantation. A randomized controlled trial comparing OKT3 and anti-IL-2 receptor monoclonal antibody LO-Tact-1.
Topics: Acute Disease; Adult; Antibodies, Monoclonal; Antilymphocyte Serum; Azathioprine; Child; Child, Preschool; Cyclosporine; Female; Graft Rejection; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Methylprednisolone; Middle Aged; Receptors, Interleukin-2; Time Factors | 1993 |
Rescue therapy with Tacrolimus (FK506) in renal transplant recipients--a multicenter analysis.
Topics: Acute Disease; Adolescent; Adult; Child; Cyclosporine; Female; Graft Rejection; Humans; Kidney Transplantation; Male; Middle Aged; Tacrolimus | 1995 |
Immunoprophylaxis with a monoclonal anti-IL-2 receptor antibody in liver transplant patients.
Topics: Acute Disease; Adult; Aged; Animals; Antibodies, Monoclonal; Antilymphocyte Serum; Azathioprine; Bacterial Infections; Candidiasis; Cyclosporine; Female; Graft Rejection; Humans; Immunoglobulin M; Immunosuppressive Agents; Liver Transplantation; Male; Mice; Middle Aged; Prospective Studies; Rabbits; Receptors, Interleukin-2 | 1996 |
Tacrolimus (FK 506) therapy is associated with a significant reduction in immunosuppressive treatment failures following primary liver transplantation.
Topics: Actuarial Analysis; Acute Disease; Adolescent; Adult; Aged; Chronic Disease; Cyclosporine; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Survival Rate; Tacrolimus; Time Factors; Treatment Failure | 1996 |
Transplantation of allogeneic CD34+ blood cells.
Topics: Acute Disease; Adult; Antigens, CD34; Bone Marrow; Cell Division; Cyclosporine; Erythropoietin; Female; Filgrastim; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Immunosuppressive Agents; Leukapheresis; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Male; Methotrexate; Middle Aged; Platelet Transfusion; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Recombinant Proteins; T-Lymphocytes; Transplantation, Homologous | 1996 |
Dietary fish oil in renal transplant recipients treated with cyclosporin-A: no beneficial effects shown.
Topics: Acute Disease; Adult; Aged; Blood Pressure; Coconut Oil; Cyclosporine; Dietary Fats; Double-Blind Method; Fatty Acids, Omega-3; Female; Fish Oils; Graft Rejection; Graft Survival; Humans; Immunohistochemistry; Immunosuppressive Agents; Incidence; Kidney; Kidney Transplantation; Male; Middle Aged; Plant Oils; Prospective Studies; Transplantation, Homologous | 1996 |
Immunomagnetic CD4+ and CD8+ cell depletion for patients at high risk for severe acute GVHD.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; CD4 Lymphocyte Count; CD8-Positive T-Lymphocytes; Child; Child, Preschool; Cyclosporine; Female; Fever; Graft vs Host Disease; Humans; Immunomagnetic Separation; Incidence; Male; Middle Aged; Risk Factors; Syndrome; Transplantation, Homologous | 1996 |
A multicenter trial of FK506 (tacrolimus) therapy in refractory acute renal allograft rejection. A report of the Tacrolimus Kidney Transplantation Rescue Study Group.
Topics: Acute Disease; Adult; Cyclosporine; Cytomegalovirus Infections; Drug Resistance; Evaluation Studies as Topic; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Lymphoproliferative Disorders; Male; Middle Aged; Tacrolimus; Treatment Outcome | 1996 |
Role of preoperative donor-specific transfusion and cyclosporine in haplo-identical living related renal transplant recipients.
Topics: Acute Disease; Adult; Blood Donors; Blood Transfusion; Cyclosporine; Cytotoxicity, Immunologic; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Haplotypes; HLA Antigens; Humans; Immunosuppressive Agents; Kidney Transplantation; Living Donors; Lymphocyte Count; Male; Middle Aged; Postoperative Complications; Preoperative Care; Prospective Studies; Treatment Outcome | 1997 |
Treatment of refractory acute allograft rejection with aerosolized cyclosporine in lung transplant recipients.
Topics: Acute Disease; Adult; Aerosols; Cyclosporine; Female; Graft Rejection; Humans; Immunosuppressive Agents; Lung Transplantation; Male; Middle Aged; Respiratory Function Tests; Transplantation, Homologous; Treatment Outcome | 1997 |
[Treatment of acute a steroid-resistant ulcerative colitis with continuous venous infusion of cyclosporine].
Topics: Acute Disease; Adolescent; Adult; Colitis, Ulcerative; Cyclosporine; Drug Resistance; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Infusions, Intravenous; Male; Methylprednisolone; Middle Aged | 1996 |
A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group.
Topics: Acute Disease; Adult; Antilymphocyte Serum; Cadaver; Cause of Death; Clinical Protocols; Creatinine; Cross-Over Studies; Cyclosporine; Diabetes Mellitus; Female; Graft Rejection; Humans; Immunosuppressive Agents; Insulin; Kidney Transplantation; Male; Patient Selection; Regression Analysis; Tacrolimus | 1997 |
The long-acting dopamine agonist bromocriptine mesylate as additive immunosuppressive drug after kidney transplantation.
Topics: Acute Disease; Adult; Aged; Bacterial Infections; Bromocriptine; Cyclosporine; Drug Therapy, Combination; Female; Glucocorticoids; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Prednisolone; Prolactin; Prospective Studies | 1997 |
Effect of cilastatin on cyclosporine-induced acute nephrotoxicity in kidney transplant recipients.
Topics: Acute Disease; Adult; Cadaver; Cilastatin; Creatinine; Cyclosporine; Female; Graft Survival; Humans; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Prospective Studies; Protease Inhibitors | 1997 |
Induction of graft-versus-host disease as immunotherapy of leukemia relapsing after allogeneic transplantation: single-center experience of 32 adult patients.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Agents; Bone Marrow Transplantation; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunotherapy, Adoptive; Interferon alpha-2; Interferon-alpha; Interleukin-2; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Lymphoid; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Leukocytes; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recombinant Proteins; Recurrence; Remission Induction | 1997 |
Interleukin 6 and interferon-gamma gene expression in lung transplant recipients with refractory acute cellular rejection: implications for monitoring and inhibition by treatment with aerosolized cyclosporine.
Topics: Acute Disease; Adolescent; Adult; Aerosols; Bronchoalveolar Lavage Fluid; Cell Count; Cyclosporine; Female; Gene Expression; Graft Rejection; Humans; Immunity, Cellular; Immunosuppressive Agents; Interferon-gamma; Interleukin-6; Leukocytes, Mononuclear; Lung Transplantation; Male; Middle Aged; Monitoring, Immunologic; RNA, Messenger; Transplantation, Homologous | 1997 |
FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study.
Topics: Acute Disease; Bacterial Infections; Cardiac Catheterization; Coronary Disease; Cyclosporine; Diabetes Mellitus; Female; Follow-Up Studies; Graft Rejection; Heart Transplantation; Humans; Hypertension; Immunosuppressive Agents; Incidence; Kidney; Liver; Lymphocyte Subsets; Male; Middle Aged; Nervous System; Prevalence; Prospective Studies; Survival Rate; Tacrolimus; Treatment Outcome | 1997 |
Efficacy and side-effects of cyclosporine dose monitoring with levels 6 h after the morning dose in heart transplant patients.
Topics: Acute Disease; Administration, Oral; Adult; Blood Pressure; Creatinine; Cyclosporine; Drug Administration Schedule; Drug Costs; Drug Monitoring; Enzyme Multiplied Immunoassay Technique; Female; Follow-Up Studies; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Incidence; Kidney; Male; Middle Aged; Prospective Studies; Stroke Volume; Ventricular Function, Left | 1997 |
A placebo controlled study of mycophenolate mofetil used in combination with cyclosporine and corticosteroids for the prevention of acute rejection in renal allograft recipients: 1-year results. The European Mycophenolate Mofetil Cooperative Study Group.
Topics: Acute Disease; Adolescent; Adrenal Cortex Hormones; Adult; Aged; Antilymphocyte Serum; Cyclosporine; Double-Blind Method; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Muromonab-CD3; Mycophenolic Acid; Transplantation, Homologous | 1998 |
Prednisone withdrawal 14 days after liver transplantation with mycophenolate: a prospective trial of cyclosporine and tacrolimus.
Topics: Acute Disease; Adult; Cyclosporine; Diabetes Mellitus; Drug Administration Schedule; Graft Rejection; Graft Survival; Humans; Hypertension; Immunosuppression Therapy; Immunosuppressive Agents; Liver; Liver Transplantation; Mycophenolic Acid; Prednisone; Prospective Studies; Survival Analysis; Tacrolimus; Time Factors | 1997 |
A randomized trial comparing cyclosporine and steroids with cyclosporine, azathioprine, and steroids in cadaveric renal transplantation.
Topics: Acute Disease; Adolescent; Adult; Azathioprine; Cyclosporine; Disease-Free Survival; Drug Combinations; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Kidney; Kidney Transplantation; Male; Middle Aged; Multivariate Analysis; Prednisone; Regression Analysis; Time Factors | 1998 |
Low transplant mortality in allogeneic bone marrow transplantation for acute myeloid leukemia: a randomized study of low-dose cyclosporin versus low-dose cyclosporin and low-dose methotrexate.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Dose-Response Relationship, Drug; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Male; Methotrexate; Middle Aged; Recurrence; Survival Analysis; Time Factors | 1998 |
Tacrolimus therapy for refractory acute renal allograft rejection: a 4-year experience with an aggressive approach.
Topics: Acute Disease; Adolescent; Adult; Aged; Azathioprine; Biopsy, Needle; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Muromonab-CD3; Survival Rate; Tacrolimus | 1998 |
Placebo-controlled study of a humanized anti-TAC monoclonal antibody in dual therapy for prevention of acute rejection after renal transplantation.
Topics: Acute Disease; Adrenal Cortex Hormones; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cadaver; Cyclosporine; Daclizumab; Double-Blind Method; Graft Rejection; Humans; Immunoglobulin G; Immunosuppressive Agents; Kidney Transplantation; Placebos; Tissue Donors | 1998 |
Metabolic findings after liver transplantation within a randomised trial with or without steroids.
Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Azathioprine; Blood Glucose; Cholesterol; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Liver Transplantation; Male; Methylprednisolone; Prednisone; Triglycerides | 1998 |
Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group.
Topics: Acute Disease; Adult; Aged; Antibodies, Monoclonal; Basiliximab; Cadaver; Cyclosporine; Double-Blind Method; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Incidence; Kidney Transplantation; Male; Middle Aged; Receptors, Interleukin-2; Recombinant Fusion Proteins; Time Factors | 1997 |
Mycophenolate mofetil-based, cyclosporine-free induction and maintenance immunosuppression: first-3-months analysis of efficacy and safety in two cohorts of renal allograft recipients.
Topics: Acute Disease; Adult; Cyclosporine; Female; Graft Rejection; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Retreatment | 1998 |
A randomized, placebo-controlled trial with anti-interleukin-2 receptor antibody for immunosuppressive induction therapy after liver transplantation.
Topics: Acute Disease; Adolescent; Adult; Aged; Antibodies, Monoclonal; Azathioprine; Cholangitis; Cyclosporine; Cytomegalovirus Infections; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Incidence; Liver Transplantation; Male; Middle Aged; Placebos; Pneumonia; Prednisolone; Receptors, Interleukin-2; Sepsis; Survival Rate; Urinary Tract Infections | 1998 |
Low incidence of acute cellular rejection in liver transplantation with Neoral.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Azathioprine; Cyclosporine; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Incidence; Liver Transplantation; Male; Methylprednisolone; Middle Aged; Survival Rate | 1998 |
Neoral versus Sandimmun: clinical impact and modification of immunosuppressive therapy in cardiac transplantation.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Azathioprine; Creatinine; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Incidence; Infusions, Intravenous; Male; Middle Aged; Postoperative Complications; Prednisone | 1998 |
Mycophenolate mofetil, ATG, and cyclosporine in the induction treatment of renal transplant recipients minimizes the incidence of acute rejection episodes.
Topics: Acute Disease; Adult; Antilymphocyte Serum; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Prednisone | 1998 |
[Outcomes of 50 leukemia patients who received bone marrow transplants from unrelated donors].
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Female; Germ-Free Life; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia; Male; Risk; Survival Rate; Tissue Donors; Treatment Outcome | 1998 |
Long-term outcome of a prospective randomized trial of conversion from cyclosporine to azathioprine treatment one year after renal transplantation.
Topics: Acute Disease; Adolescent; Adult; Aged; Azathioprine; Blood Pressure; Cardiovascular Diseases; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Infections; Kidney; Kidney Transplantation; Male; Middle Aged; Prospective Studies; Time Factors; Treatment Outcome | 1998 |
Effect of deoxyspergualin on acute and chronic rejection in renal transplantation.
Topics: Acute Disease; Adult; Azathioprine; Child; Child, Preschool; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Guanidines; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Methylprednisolone; Prednisolone; Ribonucleosides | 1998 |
The use of combined intravenous pulse methylprednisolone and oral cyclosporin A in the treatment of corneal graft rejection: a preliminary study.
Topics: Acute Disease; Adult; Aged; Anti-Inflammatory Agents; Corneal Transplantation; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Graft Rejection; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Prospective Studies | 1998 |
Efficacy and safety of mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant recipient.
Topics: Acute Disease; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia; Living Donors; Mycophenolic Acid; Nuclear Family; Prednisolone | 1998 |
High dose chemotherapy with busulfan, cyclophosphamide, and etoposide as conditioning regimen for allogeneic bone marrow transplantation for patients with acute myeloid leukemia in first complete remission.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Etoposide; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Male; Methotrexate; Methylprednisolone; Middle Aged; Remission Induction; Time Factors; Transplantation, Homologous | 1997 |
Impact of cyclosporine and methylprednisolone dose used for prophylaxis and therapy of graft-versus-host disease on survival and relapse after allogeneic bone marrow transplantation.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Humans; Lung Diseases, Interstitial; Male; Methylprednisolone; Middle Aged; Postoperative Complications; Recurrence; Risk Factors; Survival Rate; Transplantation, Homologous | 1999 |
Influence of drug formulation on utilization and outcomes: Neoral and monitoring by sparse sample area under the curve.
Topics: Acute Disease; Area Under Curve; Chemistry, Pharmaceutical; Cyclosporine; Drug Monitoring; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Therapeutic Equivalency; Treatment Outcome | 1999 |
A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation.
Topics: Acute Disease; Administration, Oral; Adult; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Incidence; Kidney; Kidney Transplantation; Logistic Models; Male; Middle Aged; Mycophenolic Acid; Opportunistic Infections; Pharmacokinetics; Pharmacology; Prednisone; Severity of Illness Index; Survival Rate | 1999 |
Clear benefit of mycophenolate mofetil-based triple therapy in reducing the incidence of acute rejection after living donor renal transplantations.
Topics: Acute Disease; Adult; Cohort Studies; Cyclosporine; Drug Therapy, Combination; Ethnicity; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Korea; Living Donors; Middle Aged; Mycophenolic Acid; Steroids; Survival Rate | 1999 |
The potential role of rapamycin in pediatric transplantation as observed from adult studies.
Topics: Acute Disease; Adult; Age Factors; Antibodies, Monoclonal; Basiliximab; Child; Cohort Studies; Cyclosporine; Drug Monitoring; Fingolimod Hydrochloride; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Propylene Glycols; Protein-Tyrosine Kinases; Recombinant Fusion Proteins; Sirolimus; Sphingosine; Time Factors; Tyrphostins | 1999 |
Daclizumab: novel biologic immunoprophylaxis for prevention of acute rejection in renal transplantation.
Topics: Acute Disease; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Calcineurin Inhibitors; Cyclosporine; Daclizumab; Drug Therapy, Combination; Graft Rejection; Humans; Immunoglobulin G; Immunosuppressive Agents; Kidney Transplantation; Prednisolone | 1999 |
Mycophenolate mofetil, along with ATG and cyclosporine, significantly lowers the incidence of acute rejection episodes in renal transplant recipients.
Topics: Acute Disease; Adult; Antilymphocyte Serum; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid | 1999 |
Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prevention of acute graft-vs.-host disease: effect on chronic graft-vs.-host disease and long-term survival.
Topics: Acute Disease; Adolescent; Adult; Anti-Inflammatory Agents; Bone Marrow Transplantation; Cause of Death; Child; Child, Preschool; Chronic Disease; Communicable Diseases; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infant; Leukemia; Longitudinal Studies; Male; Methotrexate; Middle Aged; Prednisone; Recurrence; Survival Rate; Transplantation, Homologous | 1999 |
Comparison of microemulsion and conventional formulations of cyclosporine A in preventing acute rejection in de novo kidney transplant patients. The U.K. Neoral Renal Study Group.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Chemistry, Pharmaceutical; Cyclosporine; Emulsions; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Injections, Intravenous; Kidney Transplantation; Male; Middle Aged | 1999 |
A new marrow T cell depletion method using anti-CD6 monoclonal antibody-conjugated magnetic beads and its clinical application for prevention of acute graft-vs.-host disease in allogeneic bone marrow transplantation: results of a phase I-II trial.
Topics: Acute Disease; Adenoviridae Infections; Adult; Antibodies, Monoclonal; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Antiviral Agents; Bone Marrow Transplantation; Cyclosporine; Cystitis; Cytomegalovirus Infections; Female; Fungemia; Ganciclovir; Graft vs Host Disease; Histocompatibility; Humans; Immunomagnetic Separation; Immunosuppressive Agents; Leukemia; Lung Diseases, Interstitial; Lymphocyte Depletion; Male; Methotrexate; Safety; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 1999 |
Graft versus host disease prophylaxis with low-dose cyclosporine-A reduces the risk of relapse in children with acute leukemia given HLA-identical sibling bone marrow transplantation: results of a randomized trial.
Topics: Acute Disease; Adolescent; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Dose-Response Relationship, Drug; Female; Graft Survival; Graft vs Host Disease; Graft vs Leukemia Effect; Histocompatibility; Humans; Immunosuppressive Agents; Infant; Italy; Leukemia; Male; Neoplasm Recurrence, Local; Nuclear Family; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Risk; Tissue Donors; Transplantation Conditioning; Treatment Outcome | 2000 |
Effect of acute rejection on expression of fibrosis associated genes in renal transplant recipients.
Topics: Acute Disease; Adult; Collagen; Cyclosporine; Female; Fibrosis; Gene Expression Regulation; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Glomerulus; Kidney Transplantation; Male; Matrix Metalloproteinase 2; Reverse Transcriptase Polymerase Chain Reaction; Tacrolimus; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2; Transcription, Genetic; Transforming Growth Factor beta | 2000 |
New strategies using 'low-dose' mycophenolate mofetil to reduce acute rejection in patients following kidney transplantation.
Topics: Acute Disease; Adult; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Prospective Studies; Survival Analysis; Tacrolimus | 1999 |
Mycophenolate mofetil for the prophylaxis of acute GVHD in HLA-mismatched bone marrow transplant patients.
Topics: Acute Disease; Adolescent; Adult; Aged; Bone Marrow Transplantation; Cyclosporine; Drug Combinations; Female; Glucocorticoids; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility; HLA Antigens; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Pilot Projects; Prednisolone; Safety; Survival Rate; Tissue Donors | 2000 |
Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients.
Topics: Acute Disease; Adolescent; Adult; Aged; Child; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Sirolimus; Transplantation, Homologous | 2000 |
Equivalence of 2 effective graft-versus-host disease prophylaxis regimens: results of a prospective double-blind randomized trial.
Topics: Acute Disease; Adolescent; Adult; Anti-Inflammatory Agents; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Double-Blind Method; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infant; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Methotrexate; Middle Aged; Prednisone; Prospective Studies; Survival Analysis; Transplantation, Homologous; Treatment Outcome | 2000 |
Azathioprine withdrawal in stable lung and heart/lung recipients receiving cyclosporine-based immunosuppression.
Topics: Acute Disease; Adult; Azathioprine; Bronchiolitis Obliterans; Cyclosporine; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Graft Rejection; Heart-Lung Transplantation; Humans; Immunosuppressive Agents; Lung Transplantation; Lymphoproliferative Disorders; Male; Middle Aged; Prospective Studies; Respiratory Function Tests; Safety | 2000 |
Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study. The Rapamune US Study Group.
Topics: Acute Disease; Adolescent; Adult; Azathioprine; Biopsy; Cyclosporine; Double-Blind Method; Drug Combinations; Female; Follow-Up Studies; Glucocorticoids; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Prednisone; Prospective Studies; Sirolimus; Survival Rate; Treatment Outcome | 2000 |
Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Bone Marrow Transplantation; Child; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Injections, Intravenous; Male; Methotrexate; Middle Aged; Tacrolimus; Transplantation, Homologous; Treatment Outcome | 2000 |
Cyclosporine, methotrexate, and methylprednisolone compared with cyclosporine and methotrexate for the prevention of graft-versus-host disease in bone marrow transplantation from HLA-identical sibling donor: a prospective randomized study.
Topics: Acute Disease; Adolescent; Adult; Blood Transfusion; Bone and Bones; Bone Marrow Transplantation; Cause of Death; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Histocompatibility Testing; Hospitalization; Humans; Infections; Male; Methotrexate; Methylprednisolone; Middle Aged; Necrosis; Nuclear Family; Prospective Studies; Recurrence; Survival Rate | 2000 |
Avoidance of cyclosporine in renal transplantation: effects of daclizumab, mycophenolate mofetil, and steroids.
Topics: Acute Disease; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cyclosporine; Daclizumab; Female; Graft Rejection; Graft Survival; Humans; Immunoglobulin G; Immunosuppressive Agents; Incidence; Kidney; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Prospective Studies; Retreatment; Steroids; Survival Analysis; Time Factors | 2000 |
Tacrolimus for rescue therapy in refractory renal allograft rejection.
Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Biopsy; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Tacrolimus; Time Factors | 2000 |
A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts.
Topics: Acute Disease; Adolescent; Adult; Cadaver; Cyclosporine; Double-Blind Method; Female; Graft Rejection; Histocompatibility Testing; Humans; Kidney Transplantation; Male; Middle Aged; Sirolimus | 2001 |
Tacrolimus versus cyclosporine after lung transplantation: a prospective, open, randomized two-center trial comparing two different immunosuppressive protocols.
Topics: Acute Disease; Adult; Aged; Bronchiolitis Obliterans; Chronic Disease; Creatinine; Cyclosporine; Drug Combinations; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Infections; Lung Transplantation; Male; Middle Aged; Mycophenolic Acid; Prospective Studies; Survival Rate; Tacrolimus; Time Factors; Treatment Outcome | 2001 |
A randomized double-blind comparative study of mycophenolate mofetil and azathioprine in combination with cyclosporine and corticosteroids in primary liver transplant recipients.
Topics: Acute Disease; Adolescent; Adrenal Cortex Hormones; Adult; Azathioprine; Biopsy; Cyclosporine; Double-Blind Method; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Mycophenolic Acid; Survival Analysis | 2001 |
The value of routine monitoring of mycophenolic acid plasma levels after clinical heart transplantation.
Topics: Acute Disease; Biopsy; Cyclosporine; Drug Monitoring; Follow-Up Studies; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Mycophenolic Acid; Tacrolimus; Time Factors | 2001 |
Basiliximab in the therapy of acute rejection after organ transplantation.
Topics: Acute Disease; Adult; Antibodies, Monoclonal; Basiliximab; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Liver Transplantation; Male; Pancreas Transplantation; Patient Selection; Receptors, Interleukin-2; Recombinant Fusion Proteins; Tacrolimus; Treatment Outcome | 2001 |
Comparison of 'sequential' versus 'standard' chemotherapy as re-induction treatment, with or without cyclosporine, in refractory/relapsed acute myeloid leukaemia (AML): results of the UK Medical Research Council AML-R trial.
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclosporine; Cytarabine; Daunorubicin; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Male; Middle Aged; Remission Induction | 2001 |
RAD in de novo renal transplantation: comparison of three doses on the incidence and severity of acute rejection.
Topics: Acute Disease; Adolescent; Adrenal Cortex Hormones; Adult; Aged; Cyclosporine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Everolimus; Female; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Male; Middle Aged; Severity of Illness Index; Sirolimus; Treatment Outcome | 2001 |
Median effect analysis of efficacy versus adverse effects of immunosuppressants.
Topics: Acute Disease; Cyclosporine; Dose-Response Relationship, Drug; Drug Synergism; Graft Rejection; Humans; Hypertriglyceridemia; Immunosuppressive Agents; Incidence; Kidney Transplantation; Sirolimus; Thrombocytopenia; Treatment Outcome | 2001 |
Improved primary transplant success rates using a triple regimen of cyclosporine microemulsion, mycophenolate mofetil and prednisone.
Topics: Acute Disease; Acyclovir; Antiviral Agents; Cadaver; Cyclosporine; Cytomegalovirus Infections; Drug Therapy, Combination; Emulsions; Graft Rejection; Histocompatibility Testing; Humans; Immunosuppressive Agents; Kidney Transplantation; Living Donors; Muromonab-CD3; Mycophenolic Acid; Prednisone; Reoperation; Time Factors; Treatment Outcome | 2001 |
Results of 3-year phase III clinical trials with daclizumab prophylaxis for prevention of acute rejection after renal transplantation.
Topics: Acute Disease; Adrenal Cortex Hormones; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Cyclosporine; Daclizumab; Graft Rejection; Graft Survival; Humans; Immunoglobulin G; Immunosuppressive Agents; Kidney Transplantation; Lymphoproliferative Disorders; Neoplasms; Receptors, Interleukin-2; Survival Rate; Time Factors | 2001 |
A pilot study of steroid-free immunosuppression in the prevention of acute rejection in renal allograft recipients.
Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antihypertensive Agents; Clinical Protocols; Cyclosporine; Daclizumab; Female; Graft Rejection; Graft Survival; Humans; Hypoglycemic Agents; Immunoglobulin G; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Pilot Projects; Prospective Studies; Survival Rate | 2001 |
Absorption profiling of cyclosporine microemulsion (neoral) during the first 2 weeks after renal transplantation.
Topics: Absorption; Acute Disease; Adult; Cyclosporine; Dose-Response Relationship, Drug; Emulsions; Female; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Male; Middle Aged; Postoperative Period; Prospective Studies; Time Factors | 2001 |
Cyclosporine elimination in the presence of TOR inhibitors: effects on renal function, acute rejection, and safety.
Topics: Acute Disease; Blood Pressure; Cyclosporine; Drug Therapy, Combination; Glomerular Filtration Rate; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney; Kidney Function Tests; Kidney Transplantation; Sirolimus; Treatment Outcome | 2001 |
Topical treatment of acute adenoviral keratoconjunctivitis with 0.2% cidofovir and 1% cyclosporine: a controlled clinical pilot study.
Topics: Acute Disease; Adenovirus Infections, Human; Adenoviruses, Human; Administration, Topical; Adult; Aged; Aged, 80 and over; Antiviral Agents; Cidofovir; Cyclosporine; Cytosine; DNA Primers; DNA, Viral; Double-Blind Method; Drug Evaluation; Drug Therapy, Combination; Eye Infections, Viral; Female; Humans; Immunosuppressive Agents; Keratoconjunctivitis; Male; Middle Aged; Ophthalmic Solutions; Organophosphonates; Organophosphorus Compounds; Pilot Projects; Polymerase Chain Reaction; Treatment Outcome | 2001 |
Assessment of myocardial hypertrophy by echocardiography in adult patients receiving tacrolimus or cyclosporine therapy for prevention of acute GVHD.
Topics: Acute Disease; Adult; Bone Marrow Transplantation; Cyclosporine; Echocardiography; Female; Graft vs Host Disease; Humans; Hypertrophy, Left Ventricular; Immunosuppressive Agents; Male; Middle Aged; Tacrolimus | 2001 |
Open randomized trial comparing early withdrawal of either cyclosporine or mycophenolate mofetil in stable renal transplant recipients initially treated with a triple drug regimen.
Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Aged; Blood Pressure; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Kidney; Kidney Transplantation; Lipids; Male; Middle Aged; Mycophenolic Acid; Survival Analysis | 2002 |
Phase I trial with escalating doses of idarubicin and multidrug resistance reversal by short-course cyclosporin A, sequential high-dose cytosine arabinoside, and granulocyte colony-stimulating factor for adult patients with refractory acute leukemia.
Topics: Acute Disease; Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Cytarabine; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Female; Granulocyte Colony-Stimulating Factor; Humans; Idarubicin; Leukemia; Male; Maximum Tolerated Dose; Middle Aged; Salvage Therapy; Treatment Outcome | 2002 |
[Combination of mycophenolate mofetil with cyclosporine A and methotrexate as acute GVHD prophylaxis after unrelated donor allogeneic bone marrow transplantation].
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Child; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Leukemia; Male; Methotrexate; Mycophenolic Acid; Transplantation, Heterologous; Young Adult | 2001 |
Randomized trial of tacrolimus versus cyclosporin microemulsion in renal transplantation.
Topics: Acute Disease; Adolescent; Child; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Prospective Studies; Tacrolimus | 2002 |
The effects of cidofovir 1% with and without cyclosporin a 1% as a topical treatment of acute adenoviral keratoconjunctivitis: a controlled clinical pilot study.
Topics: Acute Disease; Adenovirus Infections, Human; Adenoviruses, Human; Adult; Aged; Aged, 80 and over; Antiviral Agents; Cidofovir; Conjunctiva; Cyclosporine; Cytosine; DNA Primers; DNA, Viral; Drug Therapy, Combination; Eye Infections, Viral; Eyelids; Female; Humans; Immunosuppressive Agents; Keratoconjunctivitis; Male; Middle Aged; Ophthalmic Solutions; Organophosphonates; Organophosphorus Compounds; Pilot Projects; Polymerase Chain Reaction; Safety | 2002 |
Pharmacokinetic interactions of cyclosporine with etoposide and mitoxantrone in children with acute myeloid leukemia.
Topics: Acute Disease; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Child; Child, Preschool; Chromatography, High Pressure Liquid; Cyclosporine; Drug Interactions; Drug Resistance, Multiple; Etoposide; Female; Humans; Infant; Leukemia, Myeloid; Male; Metabolic Clearance Rate; Mitoxantrone | 2002 |
Plasma exchange vs cyclosporine retrieval therapy in steroid-resistant acute rejection of renal allografts.
Topics: Acute Disease; Azathioprine; Cyclosporine; Drug Resistance; Follow-Up Studies; Graft Rejection; Humans; Immunosuppression Therapy; Kidney Transplantation; Plasma Exchange; Prednisolone; Transplantation, Homologous | 1992 |
Sri Lankan experience with three immunosuppressive protocols in living related donor kidney transplantation.
Topics: Acute Disease; Azathioprine; Costs and Cost Analysis; Cyclosporine; Family; Follow-Up Studies; Graft Rejection; Humans; Immunosuppression Therapy; Kidney Transplantation; Postoperative Complications; Prednisolone; Sri Lanka; Tissue Donors | 1992 |
Cyclosporine immunosuppression in non-heart-beating cadaver donors.
Topics: Acute Disease; Antilymphocyte Serum; Azathioprine; Cadaver; Cyclosporine; Graft Rejection; Humans; Immunosuppression Therapy; Kidney Transplantation; Tissue Donors | 1992 |
[The pleiotropic drug resistance phenotype: role of reverting agents "in vitro" and "in vivo"].
Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carrier Proteins; Cefoperazone; Child; Cyclosporine; Doxorubicin; Drug Evaluation; Drug Synergism; Humans; Leukemia; Membrane Glycoproteins; Neoplasm Proteins; Neoplastic Stem Cells; Nicardipine; Phenotype; RNA, Messenger; RNA, Neoplasm; Verapamil | 1991 |
Phase II study of FK 506 for allogeneic bone marrow transplantation.
Topics: Acute Disease; Adult; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Diarrhea; Drug Evaluation; Female; Graft vs Host Disease; Humans; Male; Tacrolimus; Transplantation, Homologous | 1991 |
A prospective randomised trial of cyclosporin and methotrexate versus cyclosporin, methotrexate and prednisolone for prevention of graft-versus-host disease after HLA-identical sibling marrow transplantation for haematological malignancy.
Topics: Actuarial Analysis; Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Family; Female; Graft vs Host Disease; HLA Antigens; Humans; Incidence; Leukemia; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Neoplasm Recurrence, Local; Prednisolone; Prospective Studies; Survival Analysis; Treatment Outcome | 1991 |
523 other study(ies) available for cyclosporine and Acute Disease
| Article | Year |
|---|---|
The combination of four main components in Xuebijing injection improved the preventive effects of Cyclosporin A in acute graft-versus-host disease mice by protecting intestinal microenvironment.
Topics: Acute Disease; Animals; Cyclosporine; Drugs, Chinese Herbal; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Mice | 2022 |
Clinical Manifestations and Treatment of Vogt-Koyanagi-Harada Disease during Pregnancy and after Birth: A Case Report.
Topics: Acute Disease; Choroid; Cyclosporine; Disease Progression; Female; Humans; Pregnancy; Uveomeningoencephalitic Syndrome | 2023 |
Lower levels of cyclosporine between days 0 and +21 may reduce later relapses without increasing graft-versus-host disease in children and adolescents with acute lymphoblastic leukemia who undergo myeloablative TBI-based allogeneic hematopoietic cell tran
Topics: Acute Disease; Adolescent; Child; Chronic Disease; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Recurrence; Retrospective Studies; Transplantation Conditioning; Transplantation, Homologous | 2022 |
Toward optimization of cyclosporine concentration target to prevent acute graft-versus-host disease following myeloablative allogeneic stem cell transplant.
Topics: Acute Disease; Adult; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Neoplasm Recurrence, Local; Retrospective Studies; Stem Cell Transplantation; Transplantation Conditioning | 2022 |
Outcomes of initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease occurred during pregnancy.
Topics: Acute Disease; Adrenal Cortex Hormones; Cyclosporine; Female; Humans; Inflammation; Male; Pregnancy; Retrospective Studies; Uveitis; Uveomeningoencephalitic Syndrome | 2023 |
Understanding Flares in Patients With Generalized Pustular Psoriasis Documented in US Electronic Health Records.
Topics: Acute Disease; Adult; Chronic Disease; Cohort Studies; Cyclosporine; Electronic Health Records; Female; Humans; Methotrexate; Middle Aged; Psoriasis; Retrospective Studies; Skin Diseases, Vesiculobullous; Tacrolimus | 2022 |
Transcriptomic responses of peripheral blood mononuclear cells to cyclosporin and etanercept in a female infant with juvenile generalized pustular psoriasis.
Topics: Acute Disease; CARD Signaling Adaptor Proteins; Chronic Disease; Cyclosporine; Etanercept; Female; Guanylate Cyclase; Humans; Infant; Interleukins; Leukocytes, Mononuclear; Membrane Proteins; Psoriasis; Transcriptome; Tumor Necrosis Factor Inhibitors | 2023 |
IgG4-Related Membranous Nephropathy with Acute Nephrotic Syndrome During Successful Steroid Maintenance Treatment for Type 1 Autoimmune Pancreatitis.
Topics: Acute Disease; Autoimmune Pancreatitis; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunoglobulin G4-Related Disease; Insulin; Male; Methylprednisolone; Nephrotic Syndrome; Proteinuria; Steroids | 2023 |
Keeping mitochondria happy - benefits of a pore choice in acute pancreatitis.
Topics: Acute Disease; Cyclosporine; Humans; Isoleucine; Mitochondria; Pancreatitis | 2019 |
Berberine combined with cyclosporine A alleviates acute graft-versus-host disease in murine models.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents; Berberine; Bone Marrow Transplantation; Cyclosporine; Disease Models, Animal; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Lymphocyte Transfusion; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; NF-kappa B; Oxidative Stress; Signal Transduction | 2020 |
Low cyclosporine concentrations in children and time to acute graft versus host disease.
Topics: Acute Disease; Child; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Retrospective Studies | 2020 |
Cyclosporine A: a valid candidate to treat COVID-19 patients with acute respiratory failure?
Topics: Acute Disease; Coronavirus Infections; COVID-19; Cyclosporine; Humans; Pandemics; Pneumonia, Viral; Respiratory Insufficiency; Treatment Outcome | 2020 |
Long-Term Observation of Cyclosporine as Second-Line Therapy in Adults for Severe Acute Autoimmune Hepatitis.
Topics: Acute Disease; Administration, Intravenous; Adult; Calcineurin Inhibitors; Cyclosporine; Drug Monitoring; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Function Tests; Long-Term Care; Male; Retrospective Studies; Severity of Illness Index; Time; Treatment Outcome | 2021 |
Calcineurin inhibitors suppress acute graft-versus-host disease via NFAT-independent inhibition of T cell receptor signaling.
Topics: Acute Disease; Animals; Calcineurin Inhibitors; CD8-Positive T-Lymphocytes; Cyclosporine; Graft vs Host Disease; Mice; Mice, Knockout; NFATC Transcription Factors; Receptors, Antigen, T-Cell; Signal Transduction | 2021 |
Comparison of outcomes of cyclosporine A and infliximab for steroid-refractory acute severe ulcerative colitis.
Topics: Acute Disease; Colitis, Ulcerative; Cyclosporine; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Severity of Illness Index; Steroids; Treatment Outcome | 2021 |
Long-Term Efficacy and Safety of Cyclosporine in a Cohort of Steroid-Refractory Acute Severe Ulcerative Colitis Patients from the ENEIDA Registry (1989-2013): A Nationwide Multicenter Study.
Topics: Acute Disease; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Child; Colectomy; Colitis, Ulcerative; Cyclosporine; Female; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infections; Infliximab; Male; Middle Aged; Mortality; Registries; Severity of Illness Index; Treatment Outcome; Young Adult | 2017 |
Postoperative course of laparoscopic subtotal colectomy is affected by prolonged preoperative anti-TNF therapy in patients with acute colitis complicating inflammatory bowel disease.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Colectomy; Colitis; Cyclosporine; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Laparoscopy; Male; Middle Aged; Postoperative Complications; Preoperative Care; Steroids; Time Factors; Tumor Necrosis Factor-alpha; Young Adult | 2017 |
Bone marrow stem cells modified with human interleukin 10 attenuate acute rejection in rat lung allotransplantation.
Topics: Acute Disease; Animals; Bone Marrow Cells; Combined Modality Therapy; Cyclosporine; Enzyme-Linked Immunosorbent Assay; Graft Rejection; Humans; Immunosuppressive Agents; Interleukin-10; Lung Transplantation; Male; Mesenchymal Stem Cell Transplantation; Random Allocation; Rats; Rats, Inbred F344; Transplantation, Homologous; Treatment Outcome | 2018 |
Everolimus for pediatric patients with acute graft-versus-host disease after hematopoietic stem cell transplantation: A pilot study.
Topics: Acute Disease; Adolescent; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Everolimus; Feasibility Studies; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Hypertriglyceridemia; Immunosuppressive Agents; Infant; Male; Pilot Projects; Retrospective Studies; Steroids; Thrombotic Microangiopathies; Treatment Outcome; Young Adult | 2017 |
Novel treatment regimen of Vogt-Koyanagi-Harada disease with a reduced dose of corticosteroids combined with immunosuppressive agents.
Topics: Acute Disease; Azathioprine; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Fluorescein Angiography; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Off-Label Use; Prednisone; Recurrence; Retrospective Studies; Treatment Outcome; Uveomeningoencephalitic Syndrome; Visual Acuity | 2018 |
CXCR3 blockade combined with cyclosporine A alleviates acute graft-versus-host disease by inhibiting alloreactive donor T cell responses in a murine model.
Topics: Acute Disease; Animals; Cyclosporine; Disease Models, Animal; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Receptors, CXCR3; T-Lymphocytes; Tissue Donors; Transplantation Conditioning | 2018 |
Exosomal miRNA Signatures for Late-Onset Acute Graft-Versus-Host Disease in Allogenic Hematopoietic Stem Cell Transplantation.
Topics: Acute Disease; Adult; Aged; Area Under Curve; Biomarkers, Tumor; Calcineurin Inhibitors; Case-Control Studies; Cyclosporine; Exosomes; Female; Gene Expression Profiling; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Methotrexate; MicroRNAs; Middle Aged; Myeloablative Agonists; ROC Curve; Survival Analysis; Tacrolimus; Transplantation, Homologous | 2018 |
Ciclosporin Therapy After Infliximab Failure in Hospitalized Patients With Acute Severe Colitis is Effective and Safe.
Topics: Acute Disease; Adult; Colitis, Ulcerative; Cyclosporine; Gastrointestinal Agents; Hospitalization; Humans; Immunosuppressive Agents; Infliximab; Male; Retrospective Studies; Treatment Failure; Treatment Outcome; Young Adult | 2019 |
Cyclosporine A trough concentrations are associated with acute GvHD after non-myeloablative allogeneic hematopoietic cell transplantation.
Topics: Acute Disease; Adult; Aged; Calcineurin Inhibitors; Cohort Studies; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Kidney; Liver; Male; Middle Aged; Netherlands; Retrospective Studies; Transplantation, Homologous; Treatment Outcome; Water-Electrolyte Imbalance; Young Adult | 2019 |
Impact of cyclosporine A concentration on acute graft-vs-host disease incidence after haploidentical hematopoietic cell transplantation.
Topics: Acute Disease; Adolescent; Adult; Aged; Cyclophosphamide; Cyclosporine; Drug Monitoring; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Recurrence; Risk Factors; Time-to-Treatment; Transplantation Conditioning; Transplantation, Haploidentical; Treatment Outcome; Young Adult | 2019 |
Acute Severe Ulcerative Colitis: The Oxford Criteria No Longer Predict In-Hospital Colectomy Rates.
Topics: Acute Disease; Administration, Intravenous; Adult; C-Reactive Protein; Colectomy; Colitis, Ulcerative; Cyclosporine; Defecation; Female; Gastrointestinal Agents; Glucocorticoids; Hospitalization; Humans; Immunosuppressive Agents; Infliximab; Male; Middle Aged; Retrospective Studies; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2020 |
The carnitine-butyrobetaine-TMAO pathway after cardiac transplant: Impact on cardiac allograft vasculopathy and acute rejection.
Topics: Acute Disease; Adult; Aged; Betaine; Carnitine; Coronary Artery Disease; Cyclosporine; Everolimus; Female; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Methylamines; Microbiota; Middle Aged; Postoperative Complications | 2019 |
Outcomes and Predictors of Response in Steroid-Refractory Acute Graft-versus-Host Disease.
Topics: Acute Disease; Adolescent; Adult; Aged; Antilymphocyte Serum; Child; Child, Preschool; Cyclosporine; Dexamethasone; Disease-Free Survival; Drug Resistance; Etanercept; Female; Graft vs Host Disease; Humans; Infant; Male; Middle Aged; Mycophenolic Acid; Predictive Value of Tests; Prospective Studies; Survival Rate | 2019 |
Prevention of acute GVHD in mice by treatment with Tripterygium hypoglaucum Hutch combined with cyclosporin A.
Topics: Acute Disease; Animals; Cyclosporine; Female; Forkhead Transcription Factors; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Plant Extracts; Random Allocation; Survival Analysis; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Tripterygium | 2013 |
A time-to-event model for acute rejections in paediatric renal transplant recipients treated with ciclosporin A.
Topics: Acute Disease; Adolescent; Adult; Area Under Curve; Child; Child, Preschool; Cyclosporine; Female; Graft Rejection; Humans; Immunosuppressive Agents; Infant; Kaplan-Meier Estimate; Kidney Transplantation; Male; Models, Biological; Predictive Value of Tests; Retrospective Studies; Young Adult | 2013 |
Extracorporeal photopheresis: a useful therapy for patients with steroid-refractory acute graft-versus-host disease but not for the prevention of the chronic form.
Topics: Acute Disease; Adult; Allografts; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Hematologic Diseases; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Photopheresis; Retrospective Studies; Stem Cell Transplantation; Steroids; Transplantation Conditioning | 2013 |
Prognostic factors for clinical outcomes in patients with Vogt-Koyanagi-Harada disease treated with high-dose corticosteroids.
Topics: Acute Disease; Adolescent; Adult; Child; Child, Preschool; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Fluorescein Angiography; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Prognosis; Recurrence; Retrospective Studies; Treatment Outcome; Uveomeningoencephalitic Syndrome; Visual Acuity; Young Adult | 2013 |
Functional outcomes following multiple acute rejections in experimental vascularized composite allotransplantation.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents; Cyclosporine; Dexamethasone; Graft Rejection; Hindlimb; Immunosuppressive Agents; Locomotion; Male; Muscular Atrophy; Nerve Regeneration; Neural Conduction; Postoperative Complications; Pulse Therapy, Drug; Rats; Rats, Inbred BN; Rats, Inbred Lew; Recovery of Function; Sciatic Nerve; Transplantation, Homologous | 2013 |
Successful combination therapy with corticosteroids, biweekly intravenous pulse cyclophosphamide and cyclosporin A for acute interstitial pneumonia in patients with dermatomyositis : report of three cases.
Topics: Acute Disease; Adrenal Cortex Hormones; Aged; Cyclophosphamide; Cyclosporine; Dermatomyositis; Drug Therapy, Combination; Female; Humans; Lung Diseases, Interstitial; Male; Middle Aged; Pulse Therapy, Drug | 2013 |
Preventing graft-versus-host disease: transplanters glimpse hope beyond immunosuppressants.
Topics: Acute Disease; Bone Marrow Transplantation; Boronic Acids; Bortezomib; Chronic Disease; Clinical Trials as Topic; Cyclohexanes; Cyclophosphamide; Cyclosporine; Evidence-Based Medicine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Hydroxamic Acids; Immunosuppressive Agents; Maraviroc; Methotrexate; Pentostatin; Peripheral Blood Stem Cell Transplantation; Pyrazines; Quality of Life; Tacrolimus; Triazoles; Vorinostat | 2013 |
Immunosuppressive therapy with horse anti-thymocyte globulin and cyclosporine as treatment for fulminant aplastic anemia in children.
Topics: Acute Disease; Adolescent; Anemia, Aplastic; Animals; Antilymphocyte Serum; Child; Child, Preschool; Cyclosporine; Female; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Horses; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Male; Neutrophils; Prospective Studies; Severity of Illness Index; Survival Analysis; Treatment Outcome | 2014 |
Cyclosporine for acute encephalopathy with biphasic seizures and late reduced diffusion.
Topics: Acute Disease; Brain Diseases; Child, Preschool; Cyclosporine; Female; Humans; Immunosuppressive Agents; Infant; Magnetic Resonance Imaging; Male; Retrospective Studies; Seizures; Syndrome | 2014 |
The patient with acute muscular weakness.
Topics: Acute Disease; Adult; Anti-Inflammatory Agents; Creatine Kinase; Cyclosporine; Dermatomyositis; Diagnosis, Differential; Humans; Immunosuppressive Agents; Male; Methotrexate; Muscle Weakness; Prednisolone; Treatment Outcome; Young Adult | 2014 |
Analysis of various factors on the relapse of acute neurological attacks in Behçet's disease.
Topics: Acute Disease; Adult; Behcet Syndrome; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Recurrence; Retrospective Studies; Risk Factors; Surveys and Questionnaires | 2014 |
Cyclosporine in combination with mycophenolate mofetil versus methotrexate for graft versus host disease prevention in myeloablative HLA-identical sibling donor allogeneic hematopoietic cell transplantation.
Topics: Acute Disease; Adolescent; Adult; Aged; Blood Platelets; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Myeloablative Agonists; Neutrophils; Recurrence; Retrospective Studies; Siblings; Survival Analysis; Tissue Donors; Transplantation, Homologous | 2015 |
Cyclosporine and methotrexate-related pharmacogenomic predictors of acute graft-versus-host disease.
Topics: Acute Disease; Adult; Biomarkers, Tumor; Canada; Chronic Disease; Cohort Studies; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Male; Methotrexate; Middle Aged; Neoplasm Staging; Pharmacogenetics; Polymorphism, Single Nucleotide; Prognosis; Survival Rate; Young Adult | 2015 |
Algorithm for managing severe ulcerative colitis.
Topics: Acute Disease; Adrenal Cortex Hormones; Algorithms; Antibodies, Monoclonal; Colectomy; Colitis, Ulcerative; Counseling; Cyclosporine; Emergencies; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Infusions, Intravenous; Monitoring, Physiologic; Nutritional Support; Remission Induction; Tacrolimus | 2014 |
Association between the ulcerative colitis endoscopic index of severity (UCEIS) and outcomes in acute severe ulcerative colitis.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Colectomy; Colitis, Ulcerative; Colonoscopy; Cyclosporine; Female; Follow-Up Studies; Humans; Hydrocortisone; Immunosuppressive Agents; Infliximab; Male; Middle Aged; Prognosis; Retreatment; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Young Adult | 2015 |
Calcineurin Inhibitor Minimization With Ixazomib, an Investigational Proteasome Inhibitor, for the Prevention of Antibody Mediated Rejection in a Preclinical Model.
Topics: Acute Disease; Animals; B-Lymphocytes; Biomarkers; Boron Compounds; Calcineurin Inhibitors; Cyclosporine; Disease Models, Animal; Drug Therapy, Combination; Gene Expression Regulation; Glycine; Graft Rejection; Graft Survival; Immunity, Humoral; Immunosuppressive Agents; Isoantibodies; Kidney; Kidney Transplantation; Male; Proteasome Inhibitors; Rats, Inbred BN; Rats, Inbred Lew; Signal Transduction; T-Lymphocytes | 2015 |
Transplantation-Associated Thrombotic Microangiopathy in Patients Treated With Sirolimus and Cyclosporine as Salvage Therapy for Graft-Versus-Host Disease.
Topics: Acute Disease; Adult; Calcineurin Inhibitors; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Male; Recurrence; Retrospective Studies; Salvage Therapy; Sirolimus; Thrombotic Microangiopathies | 2015 |
Risk Factors for Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation with Umbilical Cord Blood and Matched Sibling Donors.
Topics: Acute Disease; Adolescent; Adult; Child; Child, Preschool; Chronic Disease; Cord Blood Stem Cell Transplantation; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infant; Infant, Newborn; Male; Middle Aged; Mycophenolic Acid; Risk Factors; Siblings; Tissue Donors | 2016 |
Impact of Tacrolimus Compared With Cyclosporin on the Incidence of Acute Allograft Rejection in Human Immunodeficiency Virus-Positive Kidney Transplant Recipients.
Topics: Acute Disease; Aged; Allografts; Calcineurin Inhibitors; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; HIV Infections; Humans; Immunosuppressive Agents; Incidence; Kaplan-Meier Estimate; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Patient Selection; Proportional Hazards Models; Risk Assessment; Risk Factors; Tacrolimus; Time Factors; Treatment Outcome; United Kingdom | 2016 |
Acute Severe Hepatitis and Hemophagocytosis in Adult Onset Still's Disease.
Topics: Acute Disease; Adult; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Bone Marrow; Cyclosporine; Ferritins; Hepatitis; Humans; Liver; Male; Remission Induction; Steroids; Still's Disease, Adult-Onset | 2015 |
[Prophylaxis of acute graft-versus-host disease].
Topics: Acute Disease; Allografts; Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Methotrexate | 2015 |
[Efficacy analysis of unrelated cord blood transplantation for 58 acute myelogenous leukemia patients].
Topics: Acute Disease; Adolescent; Cyclosporine; Disease-Free Survival; Fetal Blood; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Leukemia, Myeloid, Acute; Mycophenolic Acid; Quality of Life; Recurrence; Remission Induction; Retrospective Studies | 2015 |
Cytokine Profile of Engraftment Syndrome in Pediatric Hematopoietic Stem Cell Transplant Recipients.
Topics: Acute Disease; Adolescent; Alemtuzumab; Antibodies, Monoclonal, Humanized; Antilymphocyte Serum; Child; Child, Preschool; Cyclosporine; Cytokines; Female; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Inflammasomes; Male; Myeloablative Agonists; Prospective Studies; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous; Young Adult | 2016 |
A comparison of tacrolimus and cyclosporine combined with methotrexate for graft-versus-host disease prophylaxis, stratified by stem cell source: a retrospective nationwide survey.
Topics: Acute Disease; Adolescent; Adult; Aged; Cohort Studies; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Retrospective Studies; Tacrolimus; Young Adult | 2016 |
Endoscopic and histologic response to cyclosporine in ulcerative colitis and their impact on disease outcome: A cohort study.
Topics: Acute Disease; Administration, Intravenous; Adolescent; Adult; Aged; Colitis, Ulcerative; Colonoscopy; Cyclosporine; Female; France; Humans; Immunosuppressive Agents; Intestinal Mucosa; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Multivariate Analysis; Prognosis; Recurrence; Remission Induction; Retrospective Studies; Severity of Illness Index; Young Adult | 2016 |
New Grading System and Treatment Guidelines for the Acute Ocular Manifestations of Stevens-Johnson Syndrome.
Topics: Acute Disease; Amnion; Anti-Bacterial Agents; Combined Modality Therapy; Cyclosporine; Dexamethasone; Dry Eye Syndromes; Eyelid Diseases; Female; Fluorophotometry; Fluoroquinolones; Glucocorticoids; Guidelines as Topic; Humans; Middle Aged; Moxifloxacin; Prospective Studies; Severity of Illness Index; Stevens-Johnson Syndrome; Tobramycin; Visual Acuity | 2016 |
Outcome of acute severe ulcerative colitis in patients previously exposed to immunosuppressive therapy.
Topics: Acute Disease; Adult; Colectomy; Colitis, Ulcerative; Cyclosporine; Disease-Free Survival; Female; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Multivariate Analysis; Retrospective Studies; Steroids; Treatment Outcome; Young Adult | 2016 |
Graft-Versus-Host Disease in Adolescents and Young Adults (15-24 Years Old) After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Leukemia in First Complete Remission.
Topics: Acute Disease; Adolescent; Adult; Child; Chronic Disease; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Intestinal Diseases; Leukemia, Myeloid, Acute; Methotrexate; Mortality; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proportional Hazards Models; Quality of Life; Remission Induction; Severity of Illness Index; Skin Diseases; Survival Rate; Transplantation, Homologous; Young Adult | 2017 |
The combination of cyclosporine and mycophenolate mofetil is less effective than cyclosporine and methotrexate in the prevention of acute graft-versus host disease after stem-cell transplantation from unrelated donors.
Topics: Acute Disease; Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Cyclosporine; Female; Graft Survival; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Mortality; Mycophenolic Acid; Neutrophils; Premedication; Retrospective Studies; Stem Cell Transplantation; Unrelated Donors; Young Adult | 2017 |
Comparison of clinical outcome with different treatment regimens in acute adenoviral keratoconjunctivitis.
Topics: Acute Disease; Adenovirus Infections, Human; Cyclosporine; Eye Infections, Viral; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Keratoconjunctivitis; Lubricant Eye Drops; Male; Ophthalmic Solutions; Prednisolone; Retrospective Studies; Treatment Outcome; Visual Acuity | 2017 |
Juvenile generalized pustular psoriasis is a chronic recalcitrant disease: an analysis of 27 patients seen in a tertiary hospital in Johor, Malaysia.
Topics: Acitretin; Acute Disease; Adolescent; Adult; Age of Onset; CARD Signaling Adaptor Proteins; Child; Child, Preschool; Chronic Disease; Cyclosporine; Dermatologic Agents; Female; Guanylate Cyclase; Humans; Interleukins; Keratolytic Agents; Malaysia; Male; Membrane Proteins; Pregnancy; Pregnancy Complications; Psoriasis; Respiratory Tract Infections; Retrospective Studies; Risk Factors; Severity of Illness Index; Steroids; Stress, Psychological; Tertiary Care Centers; Vaccination; Young Adult | 2017 |
A child with human parvovirus B19 infection induced aplastic anemia and acute hepatitis: effectiveness of immunosuppressive therapy.
Topics: Acute Disease; Anemia, Aplastic; Anti-Inflammatory Agents; Antilymphocyte Serum; Child; Cyclosporine; Female; Hepatitis, Viral, Human; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Methylprednisolone; Parvoviridae Infections; Parvovirus B19, Human | 2008 |
Factors associated with proteinuria in renal transplant recipients treated with sirolimus.
Topics: Acute Disease; Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Body Mass Index; Cyclosporine; Diabetes Mellitus; Drug Therapy, Combination; Female; Graft Rejection; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Kidney Transplantation; Lipids; Male; Middle Aged; Nephrons; Prevalence; Proteinuria; Sex Factors; Sirolimus; Vasoconstriction | 2009 |
[Infliximab as rescue therapy after cyclosporin in an acute ulcerative colitis flare].
Topics: Acute Disease; Adrenal Cortex Hormones; Antibodies, Monoclonal; Azathioprine; Colitis, Ulcerative; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Infliximab; Male; Middle Aged | 2008 |
Dendriform filamentary keratopathy.
Topics: Acute Disease; Arthritis, Rheumatoid; Cornea; Corneal Diseases; Cyclosporine; Diagnosis, Differential; Drug Administration Schedule; Epithelium, Corneal; Humans; Male; Middle Aged; Prednisolone; Severity of Illness Index | 2009 |
Toll-like receptor expression in patients with renal allograft dysfunction.
Topics: Acute Disease; Biopsy; Chronic Disease; Cyclosporine; DNA Primers; Gene Expression Regulation; Glomerulonephritis, IGA; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Toll-Like Receptors | 2008 |
[Retrospective analysis of posterior reversible encephalopathy syndrome after allogeneic stem cell transplantation].
Topics: Acute Disease; Adolescent; Adult; Calcineurin Inhibitors; Creatinine; Cyclosporine; Encephalitis; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Middle Aged; Prognosis; Retrospective Studies; Risk Factors; Stem Cell Transplantation; Syndrome; Tacrolimus; Transplantation, Homologous; Young Adult | 2009 |
Longitudinal assessment of morbidity and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation: retrospective analysis of a multicenter phase III study.
Topics: Acute Disease; Clinical Trials, Phase III as Topic; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Gastrointestinal Diseases; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Liver Diseases; Methotrexate; Organ Specificity; Postoperative Complications; Randomized Controlled Trials as Topic; Retrospective Studies; Skin Diseases; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous | 2009 |
The risk, prevention, and outcome of cytomegalovirus after pediatric lung transplantation.
Topics: Acute Disease; Bronchiolitis Obliterans; Child; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; Europe; Female; Graft Rejection; Heart-Lung Transplantation; Humans; Immunosuppressive Agents; Incidence; Lung Transplantation; Male; Multivariate Analysis; North America; Retrospective Studies; Survival Analysis; Survivors; Tacrolimus | 2009 |
Suppression of acute and chronic cardiac allograft rejection in mice by inhibition of chemokine receptor 5 in combination with cyclosporine A.
Topics: Acute Disease; Animals; Antibodies, Monoclonal; CCR5 Receptor Antagonists; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Receptors, CCR5; T-Lymphocytes; Transplantation, Homologous | 2009 |
Influence of lactate dehydrogenase and cyclosporine A level on the incidence of acute graft-versus-host disease after allogeneic stem cell transplantation.
Topics: Acute Disease; Adult; Cyclosporine; Female; Graft vs Host Disease; Humans; L-Lactate Dehydrogenase; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Retrospective Studies; Risk Factors; Stem Cell Transplantation; Transplantation, Homologous | 2009 |
Decreased acute rejection and improved renal allograft survival using sirolimus and low-dose calcineurin inhibitors without induction therapy.
Topics: Acute Disease; Adult; Calcineurin Inhibitors; Clinical Trials as Topic; Cyclosporine; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Sirolimus; Tacrolimus; Time Factors; Transplantation, Homologous; Treatment Outcome | 2009 |
Role of medical rescue therapy in the management of acute severe ulcerative colitis: the surgical perspective.
Topics: Acute Disease; Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antibodies, Monoclonal; Colitis, Ulcerative; Colonic Pouches; Cyclosporine; Digestive System Surgical Procedures; Drug Resistance; Gastrointestinal Agents; Humans; Infliximab; Patient Selection; Proctocolectomy, Restorative; Recurrence; Severity of Illness Index; Treatment Outcome | 2009 |
Long-term efficacy and safety of conversion to tacrolimus in heart transplant recipients with ongoing or recurrent acute cellular rejection.
Topics: Acute Disease; Adult; Biopsy; Cyclosporine; Female; Graft Rejection; Graft Survival; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Recurrence; Retrospective Studies; Tacrolimus; Time Factors; Treatment Outcome | 2010 |
Comparison of infliximab versus ciclosporin during the initial 6-month treatment period in Behçet disease.
Topics: Acute Disease; Adult; Antibodies, Monoclonal; Behcet Syndrome; Cyclosporine; Drug Evaluation; Female; Humans; Immunosuppressive Agents; Infliximab; Male; Middle Aged; Retrospective Studies; Secondary Prevention; Treatment Outcome; Tumor Necrosis Factor-alpha; Uveitis; Visual Acuity | 2010 |
Comparison of pharmacokinetics of cyclosporine A in cadaveric and living-related renal transplant recipients and in an experimental rat model of renal failure.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Animals; Area Under Curve; Child; Cyclosporine; Cytochrome P-450 CYP3A; Disease Models, Animal; Drug Monitoring; Duodenum; Female; Graft Rejection; Humans; Immunosuppressive Agents; Injections, Intravenous; Intestinal Absorption; Kidney Transplantation; Living Donors; Male; Midazolam; Middle Aged; Rats; Rats, Wistar; Renal Insufficiency; Reperfusion Injury; Retrospective Studies; Substrate Specificity; Young Adult | 2009 |
Whole blood genomic biomarkers of acute cardiac allograft rejection.
Topics: Acute Disease; Adult; Aged; Cyclosporine; Female; Genetic Markers; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Longitudinal Studies; Male; Middle Aged; Oligonucleotide Array Sequence Analysis; RNA; Tacrolimus | 2009 |
Antiapoptotic properties of recombinant human erythropoietin protects against tubular cyclosporine toxicity.
Topics: Acute Disease; Animals; Apoptosis; Biomarkers; Blotting, Western; Caspase 3; Creatinine; Cyclosporine; Cytoprotection; Disease Models, Animal; Erythropoietin; Humans; In Situ Nick-End Labeling; Kidney Cortex Necrosis; Kidney Tubules; Male; Necrosis; Phosphorylation; Protective Agents; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Signal Transduction | 2010 |
Cost-effectiveness of infliximab for the treatment of acute exacerbations of ulcerative colitis.
Topics: Acute Disease; Anti-Inflammatory Agents; Antibodies, Monoclonal; Bayes Theorem; Colectomy; Colitis, Ulcerative; Cost-Benefit Analysis; Cyclosporine; Decision Support Techniques; Gastrointestinal Agents; Hospitalization; Humans; Immunosuppressive Agents; Infliximab; Models, Economic; Models, Statistical; Monte Carlo Method; Quality-Adjusted Life Years; Treatment Outcome; United Kingdom | 2010 |
CsA exposure is associated with acute GVHD and relapse in children after SCT.
Topics: Acute Disease; Adolescent; Area Under Curve; Child; Child, Preschool; Cyclosporine; Drug Monitoring; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Male; Recurrence; Retrospective Studies; Survival Rate; Treatment Outcome | 2010 |
Treatment of fulminant ulcerative colitis with cyclosporine A.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Colitis, Ulcerative; Cyclosporine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Time Factors; Treatment Outcome; Young Adult | 2009 |
Ocular manifestations in a community-based cohort of patients with inflammatory bowel disease.
Topics: Acute Disease; Adalimumab; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Cohort Studies; Cyclosporine; Dry Eye Syndromes; Eye Diseases; Female; Humans; Inflammatory Bowel Diseases; Infliximab; Male; Mesalamine; Methotrexate; Middle Aged; Steroids; Treatment Outcome | 2010 |
Impact of cyclosporine-A concentration on the incidence of severe acute graft-versus-host disease after allogeneic stem cell transplantation.
Topics: Acute Disease; Adolescent; Adult; Aged; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Retrospective Studies; Severity of Illness Index; Statistics as Topic; Stem Cell Transplantation; Time Factors; Transplantation Conditioning; Transplantation, Homologous; Young Adult | 2010 |
ATP-binding cassette subfamily B member 1 polymorphisms do not determine cyclosporin exposure, acute rejection or nephrotoxicity after heart transplantation.
Topics: Acute Disease; Adolescent; Adult; Aged; ATP Binding Cassette Transporter 1; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Transporters; Cyclosporine; Female; Genotype; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Polymerase Chain Reaction; Polymorphism, Genetic; Predictive Value of Tests; Retrospective Studies; Young Adult | 2010 |
Cyclosporin A in the treatment of acute exacerbation of idiopathic pulmonary fibrosis.
Topics: Acute Disease; Aged; Aged, 80 and over; Cyclosporine; Disease Progression; Female; Humans; Idiopathic Pulmonary Fibrosis; Male; Middle Aged; Retrospective Studies; Survival Rate; Treatment Outcome | 2010 |
Comparing an early corticosteroid/late calcineurin-free immunosuppression protocol to a sirolimus-, cyclosporine A-, and prednisone-based regimen for pancreas-kidney transplantation.
Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Antibodies, Monoclonal; Antilymphocyte Serum; Blood Glucose; Calcineurin Inhibitors; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Pancreas Transplantation; Prednisone; Sirolimus; Time Factors; Treatment Outcome | 2010 |
180-day screening study for predicting the risk factors for developing acute oral Graft-versus-Host disease in paediatric patients subjected to allogenic haematopoietic stem cells transplantation.
Topics: Acute Disease; Adolescent; Antigens, Viral; Child; Child, Preschool; Cyclosporine; Cytomegalovirus; Female; Follow-Up Studies; Forecasting; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; HLA Antigens; Humans; Immunosuppressive Agents; Infant; Male; Mouth Diseases; Oral Hemorrhage; Oral Ulcer; Predictive Value of Tests; Prospective Studies; Risk Factors; Sex Factors; Stomatitis; Transplantation Conditioning; Transplantation, Homologous; Xerostomia | 2010 |
Efficacy of topical cyclosporine A in the treatment of severe trachomatous dry eye: comment.
Topics: Acute Disease; Administration, Topical; Adult; Cyclosporine; Dry Eye Syndromes; Female; Humans; Immunosuppressive Agents; Ophthalmic Solutions; Stevens-Johnson Syndrome; Treatment Outcome | 2010 |
Treatment of canine atopic dermatitis: 2010 clinical practice guidelines from the International Task Force on Canine Atopic Dermatitis.
Topics: Acute Disease; Administration, Oral; Administration, Topical; Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Baths; Chronic Disease; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Dog Diseases; Dogs; Drug Therapy, Combination; Glucocorticoids; Tacrolimus | 2010 |
Clinical relevance of curcumin-induced immunosuppression in living-related donor renal transplant: an in vitro analysis.
Topics: Acute Disease; Adult; Case-Control Studies; Cells, Cultured; Chronic Disease; Curcumin; Cyclosporine; Dose-Response Relationship, Drug; Female; Flow Cytometry; Graft Rejection; Humans; Immunosuppressive Agents; India; Interferon-gamma; Interleukin-4; Kidney Transplantation; Living Donors; Lymphocytes; Male; Middle Aged; Mitogens; NF-kappa B; Tetradecanoylphorbol Acetate; Time Factors; Young Adult | 2010 |
Increased Th17 rather than Th1 alloimmune response is associated with cardiac allograft vasculopathy after hypothermic preservation in the rat.
Topics: Acute Disease; Animals; Antigens, CD; CD83 Antigen; Chronic Disease; Cyclosporine; Dendritic Cells; Graft Rejection; Heart Transplantation; Immunoglobulins; Immunosuppressive Agents; Membrane Glycoproteins; Organ Preservation; Rats; Rats, Inbred Strains; Rats, Inbred WF; Reperfusion; RNA, Messenger; Th1 Cells; Th17 Cells; Time Factors; Transplantation, Homologous | 2010 |
Astilbin suppresses acute heart allograft rejection by inhibiting maturation and function of dendritic cells in mice.
Topics: Acute Disease; Animals; Blotting, Western; Cell Proliferation; Cells, Cultured; Cyclosporine; Dendritic Cells; Dose-Response Relationship, Drug; Drug Therapy, Combination; Flavonols; Flow Cytometry; Graft Rejection; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Injections, Intraperitoneal; Lymphocyte Activation; Lymphocyte Culture Test, Mixed; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; T-Lymphocytes; Time Factors; Transplantation, Homologous | 2010 |
Establishment of a chronic rejection model for orthotopic liver transplantation in the rat.
Topics: Acute Disease; Animals; Chronic Disease; Cyclosporine; Disease Models, Animal; Female; Graft Rejection; Hydrocortisone; Immunosuppressive Agents; Liver Transplantation; Male; Rats; Rats, Inbred BN; Rats, Inbred Lew; Rats, Sprague-Dawley; Species Specificity; Transplantation, Homologous | 2011 |
Long-term efficacy and safety of cyclosporine as a rescue therapy in acute, steroid-refractory severe ulcerative colitis: switching to infliximab is more effective than treating with concomitant immunomodulators.
Topics: Acute Disease; Adolescent; Adult; Aged; Antibodies, Monoclonal; Colectomy; Colitis, Ulcerative; Cyclosporine; Drug Therapy, Combination; Female; Hospitalization; Humans; Immunosuppressive Agents; Infliximab; Length of Stay; Male; Mercaptopurine; Middle Aged; Salvage Therapy; Severity of Illness Index; Time Factors; Young Adult | 2011 |
Combination with corticosteroids and cyclosporin-A improves pulmonary function test results and chest HRCT findings in dermatomyositis patients with acute/subacute interstitial pneumonia.
Topics: Acute Disease; Adult; Aged; Cyclosporine; Dermatomyositis; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Male; Middle Aged; Prednisolone; Respiratory Function Tests; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
A prognostic score with pretransplant serum ferritin and disease status predicts outcome following reduced-intensity SCT.
Topics: Acute Disease; Adult; Aged; Cyclosporine; Disease-Free Survival; Female; Ferritins; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia; Male; Middle Aged; Retrospective Studies; Survival Rate; Transplantation Conditioning | 2012 |
Indoleamine 2,3-dioxygenase as a predictor of acute rejection after orthotopic liver transplantation in rat model.
Topics: Acute Disease; Alkaline Phosphatase; Animals; Aspartate Aminotransferases; Bilirubin; Biomarkers; Cyclosporine; Disease Models, Animal; Early Diagnosis; Graft Rejection; Immunosuppressive Agents; Indoleamine-Pyrrole 2,3,-Dioxygenase; Liver Transplantation; Male; Predictive Value of Tests; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors | 2011 |
Management of acute, severe ulcerative colitis.
Topics: Acute Disease; Antibodies, Monoclonal; Colectomy; Colitis, Ulcerative; Cyclosporine; Exsanguination; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Neoplasms; Severity of Illness Index | 2012 |
Genetic and clinical determinants of early, acute calcineurin inhibitor-related nephrotoxicity: results from a kidney transplant consortium.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Calcineurin Inhibitors; Cyclosporine; Cytochrome P-450 CYP3A; Female; Follow-Up Studies; Genetic Predisposition to Disease; Genotype; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Polymorphism, Single Nucleotide; Postoperative Complications; Proportional Hazards Models; Prospective Studies; Risk Factors; Tacrolimus; Young Adult | 2012 |
[Clinical characteristics of acute encephalopathies associated with influenza H1N1-2009 in children].
Topics: Acute Disease; Adolescent; Antiviral Agents; Child; Child, Preschool; Cyclosporine; Encephalitis; Female; Humans; Hypothermia, Induced; Infant; Influenza A Virus, H1N1 Subtype; Influenza, Human; Magnetic Resonance Angiography; Male; Methylprednisolone; Practice Guidelines as Topic; Pulse Therapy, Drug; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
[Basiliximab in the treatment of acute steroid-resistant rejection after liver transplantation].
Topics: Acute Disease; Antibodies, Monoclonal; Basiliximab; Carcinoma, Hepatocellular; Cyclosporine; Drug Resistance; Graft Rejection; Humans; Immunosuppressive Agents; Liver Cirrhosis, Alcoholic; Liver Function Tests; Liver Neoplasms; Liver Transplantation; Male; Methylprednisolone; Middle Aged; Mycophenolic Acid; Pregnenediones; Receptors, Interleukin-2; Recombinant Fusion Proteins; Tacrolimus | 2012 |
Treatment of acquired aplastic anemia in patients with acute liver failure occurring concurrently: a case series.
Topics: Acute Disease; Adolescent; Anemia, Aplastic; Antilymphocyte Serum; Biopsy; Blood Coagulation Tests; Blood Transfusion; Bone Marrow; Child, Preschool; Cyclosporine; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Humans; Immunosuppressive Agents; Liver Failure; Liver Function Tests; Male; T-Lymphocytes; Vitamin K | 2012 |
Risk factors for steroid-resistant T-cell-mediated acute cellular rejection and their effect on kidney graft and patient outcome.
Topics: Acute Disease; Adolescent; Chronic Disease; Creatinine; Cyclosporine; Drug Resistance; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Length of Stay; Male; Middle Aged; Prevalence; Renal Dialysis; Risk Factors; Steroids; T-Lymphocytes; Treatment Outcome; Young Adult | 2012 |
Protocol biopsies in pediatric renal transplant recipients on cyclosporine versus tacrolimus-based immunosuppression.
Topics: Acute Disease; Adolescent; Biomarkers; Biopsy; Child; Child, Preschool; Clinical Protocols; Creatinine; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Infant; Kidney; Kidney Transplantation; Male; Paris; Predictive Value of Tests; Prospective Studies; Tacrolimus; Time Factors; Treatment Outcome | 2013 |
Acute calcineurin inhibitor overdose: analysis of cases reported to a national poison center between 1995 and 2011.
Topics: Acute Disease; Adolescent; Adult; Aged; Ambulatory Care; Calcineurin Inhibitors; Child; Child, Preschool; Cyclosporine; Decontamination; Drug Overdose; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Infant; Male; Middle Aged; Poison Control Centers; Prognosis; Retrospective Studies; Risk Factors; Switzerland; Tacrolimus; Time Factors; Tissue Distribution; Young Adult | 2013 |
Cyclosporine A impairs nucleotide binding oligomerization domain (Nod1)-mediated innate antibacterial renal defenses in mice and human transplant recipients.
Topics: Acute Disease; Animals; Bone Marrow Cells; Cell Movement; Chemokines; Cyclosporine; Dendritic Cells; Disease Models, Animal; Female; Gene Silencing; Humans; Immunity, Innate; Immunosuppressive Agents; Kidney; Kidney Transplantation; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Neutrophils; NFATC Transcription Factors; Nod1 Signaling Adaptor Protein; Organ Culture Techniques; Phagocytosis; Pyelonephritis | 2013 |
Acute cellular rejection in liver transplant recipients under cyclosporine immunosuppression: predictive factors of response to antirejection therapy.
Topics: Acute Disease; Adolescent; Adult; Cyclosporine; Female; Graft Rejection; Histocompatibility Testing; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged | 2002 |
[Combination of mycophenolate mofetil with cyclosporine A and methotrexate for the prophylaxes of acute graft versus host disease in allogeneic peripheral stem cell transplantation].
Topics: Acute Disease; Adult; Anemia, Aplastic; Blood Platelets; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Male; Methotrexate; Middle Aged; Mouth Mucosa; Mycophenolic Acid; Neutrophils; Transplantation, Homologous; Treatment Outcome | 2002 |
[Hyperacute graft versus host disease after allo-stem cell transplantation, analysis of 118 cases].
Topics: Acute Disease; Adolescent; Adult; Child; Child, Preschool; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Male; Methotrexate; Middle Aged; Retrospective Studies; Risk Factors; Transplantation, Homologous | 2002 |
Histopathological findings according to Banff-97 classification system comparing tacrolimus versus cyclosporine.
Topics: Acute Disease; Adult; Chronic Disease; Cyclosporine; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Middle Aged; Pathology; Tacrolimus | 2002 |
Enhanced response to basiliximab in a patient with aplastic anemia after treatment with standard immunosuppression.
Topics: Acute Disease; Adult; Anemia, Aplastic; Antibodies, Monoclonal; Antilymphocyte Serum; Basiliximab; Cyclosporine; Drug Therapy, Combination; Hepatitis; Humans; Immunosuppressive Agents; Male; Mycophenolic Acid; Recombinant Fusion Proteins; Remission Induction; T-Lymphocytes | 2002 |
Cyclosporin therapy in severe ulcerative colitis: is it worth the effort?
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Colitis, Ulcerative; Cyclosporine; Female; Humans; Immunosuppressive Agents; Infusions, Intravenous; Male; Middle Aged; Retrospective Studies; Severity of Illness Index; Treatment Outcome | 2002 |
Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease.
Topics: Acute Disease; Anemia, Sickle Cell; Blood Platelets; Child; Child, Preschool; Chronic Disease; Cord Blood Stem Cell Transplantation; Cyclosporine; Disease-Free Survival; Female; Graft Survival; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infant; Male; Methotrexate; Neutrophils; Survival Rate; Thalassemia; Transplantation, Homologous; Treatment Outcome | 2003 |
Preventing acute rejection with basiliximab and triple immunosuppression after renal transplantation.
Topics: Acute Disease; Adolescent; Adult; Antibodies, Monoclonal; Basiliximab; Child; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Histocompatibility Testing; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Recombinant Fusion Proteins; Reoperation; Treatment Outcome | 2002 |
The efficacy of mycophenolate mofetil treatment in the prevention of acute renal rejection is related to plasma level of mycophenolic acid.
Topics: Acute Disease; Adult; Area Under Curve; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Leukopenia; Male; Metabolic Clearance Rate; Mycophenolic Acid; Postoperative Complications | 2002 |
Hepatic graft-versus-host disease resembling acute hepatitis: additional treatment with ursodeoxycholic acid.
Topics: Acute Disease; Adult; Bile Duct Diseases; Bone Marrow Transplantation; Cholagogues and Choleretics; Cyclosporine; Diagnosis, Differential; Drug Therapy, Combination; Graft vs Host Disease; Hepatitis; Humans; Immunosuppressive Agents; Liver Cirrhosis; Male; Prednisolone; Treatment Outcome; Ursodeoxycholic Acid | 2002 |
Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
Topics: Acute Disease; Adult; Anti-Inflammatory Agents; Azathioprine; Colchicine; Creatinine; Cyclosporine; Familial Mediterranean Fever; Female; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Incidence; Kidney Failure, Chronic; Kidney Transplantation; Male; Methylprednisolone; Proteinuria; Retrospective Studies; Treatment Outcome | 2002 |
Kidney transplantation from donors without a heartbeat.
Topics: Acute Disease; Analysis of Variance; Antilymphocyte Serum; Cyclosporine; Graft Rejection; Graft Survival; Heart Arrest; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Risk Factors; Time Factors; Tissue Donors | 2002 |
The rheumatoid arthritis patient in the clinic: comparing more than 1,300 consecutive DMARD courses.
Topics: Acute Disease; Aged; Antimalarials; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Chronic Disease; Clinical Protocols; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Organogold Compounds; Penicillamine; Sulfasalazine; Treatment Outcome | 2002 |
Acute rhabdomyolysis after cardiac transplantation: a diagnostic conundrum.
Topics: Acute Disease; Adolescent; Anesthetics, Intravenous; Creatinine; Cyclosporine; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Piperidines; Postoperative Complications; Propofol; Remifentanil; Rhabdomyolysis | 2002 |
Differential effect of diarrhea on FK506 versus cyclosporine A trough levels and resultant prevention of allograft rejection in renal transplant recipients.
Topics: Acute Disease; Cyclosporine; Diarrhea; Graft Rejection; Humans; Immunosuppressive Agents; Intestinal Absorption; Kidney Transplantation; Tacrolimus; Time Factors | 2002 |
Role of endogenous vascular endothelial growth factor in tubular cell protection against acute cyclosporine toxicity.
Topics: Acute Disease; Animals; Antibodies, Monoclonal; bcl-X Protein; Blotting, Western; Cells, Cultured; Cyclosporine; Cytoprotection; Drug Synergism; Endothelial Growth Factors; Female; Immunosuppressive Agents; Intercellular Signaling Peptides and Proteins; Kidney Tubules; Lymphokines; Mice; Proto-Oncogene Proteins c-bcl-2; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2002 |
Rates of acute rejection by recipient race and type of calcineurin inhibitor with mycophenolate mofetil.
Topics: Acute Disease; Adult; Black People; Cadaver; Calcineurin Inhibitors; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Mycophenolic Acid; Pennsylvania; Racial Groups; Reoperation; Retrospective Studies; Survival Analysis; Tacrolimus; Time Factors; Tissue Donors | 2002 |
Different effects of metabolic inhibitors and cyclosporin A on daunorubicin transport in leukemia cells from patients with AML.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carrier Proteins; Cyclosporine; Daunorubicin; Enzyme Inhibitors; Female; Humans; Iodoacetates; Leukemia, Myeloid; Male; Middle Aged; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; RNA, Messenger; Sodium Azide; Vault Ribonucleoprotein Particles | 2003 |
Chronic graft-versus-host disease complicated by acute hepatitis B.
Topics: Acute Disease; Alanine Transaminase; Aspartate Aminotransferases; Bile Ducts; Biopsy; Chronic Disease; Cyclosporine; Graft vs Host Disease; Hepatitis B; Hepatitis B Surface Antigens; Humans; Immunosuppressive Agents; Liver; Male; Middle Aged | 2003 |
Two good reasons for an angiotensin-II type 1 receptor blockade with losartan after cardiac transplantation: reduction of incidence and severity of transplant vasculopathy.
Topics: Acute Disease; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Coronary Artery Disease; Cyclosporine; Graft Rejection; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Incidence; Losartan; Models, Animal; Postoperative Complications; Rats; Rats, Inbred F344; Rats, Inbred Lew; Receptor, Angiotensin, Type 1; Severity of Illness Index | 2003 |
Heart xenograft survival with chimeric pig donors and modest immune suppression.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents; Bone Marrow Transplantation; Cyclosporine; Fetal Tissue Transplantation; Graft Rejection; Heart; Heart Transplantation; Immunologic Deficiency Syndromes; Immunosuppressive Agents; Methylprednisolone Hemisuccinate; Models, Animal; Sheep; Swine; Transplantation Chimera; Transplantation Tolerance; Transplantation, Heterologous; Transplantation, Heterotopic | 2003 |
Efficacy of low-dose mycophenolate mofetil therapy for Taiwanese renal transplantation patients receiving primary cyclosporine immunosuppression.
Topics: Acute Disease; Adolescent; Adult; Aged; Analysis of Variance; Child; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Proportional Hazards Models; Retrospective Studies; Survival Analysis; Taiwan | 2002 |
Formation of donor-specific human leukocyte antigen antibodies after kidney transplantation: correlation with acute rejection and tapering of immunosuppression.
Topics: Acute Disease; Adult; Aged; Autoantibodies; Azathioprine; B-Lymphocytes; Cyclosporine; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Graft Rejection; Histocompatibility Antigens Class I; Histocompatibility Antigens Class II; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; T-Lymphocytes | 2003 |
Acute pancreatitis, acute hepatitis and acute renal failure favourably resolved in two renal transplant recipients.
Topics: Acute Disease; Acute Kidney Injury; Adult; Cyclosporine; Hepatitis; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Pancreatitis; Postoperative Complications | 2003 |
Infliximab salvage therapy after cyclosporine in an acute flare of chronic ulcerative colitis.
Topics: Acute Disease; Adult; Antibodies, Monoclonal; Chronic Disease; Colitis, Ulcerative; Cyclosporine; Drug Administration Schedule; Enzyme Inhibitors; Female; Gastrointestinal Agents; Humans; Infliximab; Treatment Failure | 2003 |
Follow-up of patients with progressive multiple myeloma undergoing allografts after reduced-intensity conditioning.
Topics: Acute Disease; Adult; Aged; Antibiotics, Antineoplastic; Chronic Disease; Cyclosporine; Disease Progression; Disease-Free Survival; Drug Therapy, Combination; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Multiple Myeloma; Mycophenolic Acid; Stem Cell Transplantation; Survival Rate; Transplantation Conditioning; Transplantation, Homologous | 2003 |
Weight changes after renal transplantation: a comparison between patients on 5-mg maintenance steroid therapy and those on steroid-free immunosuppressive therapy.
Topics: Acute Disease; Adult; Age Factors; Cyclosporine; Female; Glucocorticoids; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Longitudinal Studies; Male; Middle Aged; Prednisolone; Retrospective Studies; Weight Gain | 2003 |
[Nephrotoxicity of cyclosporin A after kidney transplantation].
Topics: Acute Disease; Adult; Age Factors; Biopsy; Cadaver; Cyclosporine; Diagnosis, Differential; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney; Kidney Transplantation; Living Donors; Male; Middle Aged; Risk Factors; Tissue Donors | 2003 |
Chronic rejection with or without transplant vasculopathy.
Topics: Acute Disease; Adult; Atrophy; Chronic Disease; Cohort Studies; Cyclosporine; Fibrosis; Graft Rejection; Graft Survival; Humans; Kidney Transplantation; Kidney Tubules; Logistic Models; Risk Factors; Time Factors; Vascular Diseases | 2003 |
Borna disease virus induces acute fatal neurological disorders in neonatal gerbils without virus- and immune-mediated cell destructions.
Topics: Acute Disease; Animals; Animals, Newborn; Borna Disease; Borna disease virus; Brain; Central Nervous System Diseases; Cyclosporine; Cytokines; Disease Models, Animal; Gerbillinae; Immunosuppressive Agents; Interleukin-1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Species Specificity; Virulence; Virus Replication | 2003 |
Impact of diltiazem administration and cyclosporine levels on the incidence of acute rejection in heart transplant patients.
Topics: Acute Disease; Adolescent; Adult; Antihypertensive Agents; Cyclosporine; Diltiazem; Female; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Risk Factors; Time Factors | 2003 |
[Expression of fractalkine and its receptor in acute cardiac allografts rejection].
Topics: Acute Disease; Animals; Chemokine CX3CL1; Chemokines, CX3C; CX3C Chemokine Receptor 1; Cyclosporine; Graft Rejection; Heart Transplantation; Immunohistochemistry; Male; Membrane Proteins; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Cytokine; Receptors, HIV; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transplantation, Homologous | 2003 |
Treatment with a short course of LF 15-0195 and continuous cyclosporin A attenuates acute xenograft rejection in a rat-to-mouse cardiac transplantation model.
Topics: Acute Disease; Animals; Antibodies, Heterophile; Cyclosporine; Drug Synergism; Graft Rejection; Graft Survival; Guanidines; Heart Transplantation; Immunosuppressive Agents; Killer Cells, Natural; Macrophage-1 Antigen; Male; Mice; Mice, Inbred BALB C; Rats; Rats, Inbred Lew; Transplantation, Heterologous | 2003 |
Response to 'comparison of "sequential" versus "standard" chemotherapy as re-induction treatment, with or without cyclosporine, in refractory/relapsed acute myeloid leukaemia (AML): results of the UK Medical Research Council AML-R trial'.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Humans; Leukemia, Myeloid; Research Design | 2003 |
Thalidomide after allogeneic haematopoietic stem cell transplantation: activity in chronic but not in acute graft-versus-host disease.
Topics: Acute Disease; Adolescent; Adrenal Cortex Hormones; Adult; Child; Child, Preschool; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Recurrence; Retrospective Studies; Survival Analysis; Thalidomide; Transplantation, Homologous | 2003 |
Acute headache as a presenting symptom of tacrolimus encephalopathy.
Topics: Acute Disease; Adult; Brain; Brain Diseases; Cyclosporine; Cystic Fibrosis; Diagnosis, Differential; Drug Therapy, Combination; Female; Headache; Humans; Image Enhancement; Immunosuppressive Agents; Lung Transplantation; Magnetic Resonance Imaging; Neurologic Examination; Postoperative Complications; Prednisone; Recurrence; Tacrolimus | 2003 |
Cyclosporin A followed by the treatment of acute exacerbation of idiopathic pulmonary fibrosis with corticosteroid.
Topics: Acute Disease; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Cyclosporine; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Prednisolone; Pulmonary Fibrosis; Retrospective Studies | 2003 |
Long-term results of low-dose intravenous ciclosporin for acute severe ulcerative colitis.
Topics: Acute Disease; Adolescent; Adult; Colectomy; Colitis, Ulcerative; Cyclosporine; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Retreatment; Treatment Outcome | 2003 |
Pancreatitis following heart transplantation: report of a case.
Topics: Acute Disease; Chronic Disease; Cyclosporine; Diagnosis, Differential; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Pancreatic Pseudocyst; Pancreatitis; Risk Factors | 2003 |
Immunosuppression protocols for HLA identical renal transplant recipients.
Topics: Acute Disease; Azathioprine; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Graft Rejection; Histocompatibility Testing; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Prednisone; Retrospective Studies; Time Factors | 2003 |
Mylotarg, fludarabine, cytarabine (ara-C), and cyclosporine (MFAC) regimen as post-remission therapy in acute myelogenous leukemia.
Topics: Acute Disease; Adult; Aged; Aminoglycosides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Cytarabine; Female; Gemtuzumab; Humans; Leukemia, Myeloid; Male; Middle Aged; Recurrence; Remission Induction; Vidarabine | 2003 |
Cytokines regulate the pattern of rejection and susceptibility to cyclosporine therapy in different mouse recipient strains after cardiac allografting.
Topics: Acute Disease; Animals; Antibodies; Antibody Formation; Complement C3; Cyclosporine; Cytokines; Drug Administration Schedule; Drug Resistance; Graft Rejection; Graft Survival; Heart Transplantation; Immunization, Passive; Immunosuppressive Agents; Interferon-gamma; Interleukin-12; Interleukin-4; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Knockout; Sirolimus; Species Specificity; Th1 Cells; Th2 Cells; Transplantation, Homologous | 2003 |
Patients with steroid refractory acute vascular rejection develop agonistic antibodies targeting angiotensin II type 1 receptor.
Topics: Acute Disease; Adrenal Cortex Hormones; Angiotensin II Type 1 Receptor Blockers; Antibody Formation; Biopsy; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Humans; Imidazoles; Immunoglobulin G; Immunosuppressive Agents; Kidney Transplantation; Losartan; Major Histocompatibility Complex; Mycophenolic Acid; Pyridines; Receptor, Angiotensin, Type 1 | 2003 |
Effect of immunosuppressive regimen on acute rejection and liver graft function.
Topics: Acute Disease; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Basiliximab; Cyclosporine; Daclizumab; Drug Therapy, Combination; Graft Rejection; Humans; Immunoglobulin G; Immunosuppressive Agents; Incidence; Liver Function Tests; Liver Transplantation; Mycophenolic Acid; Recombinant Fusion Proteins; Retrospective Studies; Tacrolimus | 2003 |
Gemcitabine with cyclosporine or with tacrolimus exerts a synergistic effect and induces tolerance in the rat.
Topics: Acute Disease; Animals; Cyclosporine; Deoxycytidine; Drug Synergism; Gemcitabine; Graft Rejection; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Isoantigens; Male; Rats; Rats, Inbred Lew; Tacrolimus; Tissue Donors; Transplantation Tolerance | 2003 |
Non-viral human IL-10 gene expression reduces acute rejection in heterotopic auxiliary liver transplantation in rats.
Topics: Acute Disease; Adjuvants, Immunologic; Animals; Cyclosporine; Female; Gene Expression; Genetic Therapy; Genetic Vectors; Graft Rejection; Humans; Immunosuppressive Agents; Interleukin-10; Liver Transplantation; Male; Models, Animal; Rats; Rats, Inbred Lew | 2003 |
CD34 positive selection as prophylaxis against graft versus host disease in allogeneic peripheral blood stem cell transplantation.
Topics: Acute Disease; Adolescent; Adult; Antigens, CD34; Cyclophosphamide; Cyclosporine; Female; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cells; Humans; Immunomagnetic Separation; Immunophenotyping; Immunosuppressive Agents; Leucovorin; Leukemia, Myeloid; Lymphocyte Depletion; Male; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; T-Lymphocytes, Cytotoxic; Transplantation Conditioning; Transplantation, Homologous; Whole-Body Irradiation | 2003 |
Two doses of daclizumab in conjunction with low-dose cyclosporine, mycophenolate mofetil and steroids resulted in a low incidence of acute rejection after renal transplantation.
Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cyclosporine; Daclizumab; Drug Therapy, Combination; Female; Graft Rejection; Graft Survival; Humans; Immunoglobulin G; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid | 2003 |
Increased incidence of acute graft-versus-host disease with the continuous infusion of cyclosporine A compared to twice-daily infusion.
Topics: Acute Disease; Adult; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Infusions, Intravenous; Kidney Diseases; Leukemia; Male; Multivariate Analysis; Retrospective Studies; Risk Factors; Treatment Outcome | 2004 |
Abnormal permeability of inner and outer mitochondrial membranes contributes independently to mitochondrial dysfunction in the liver during acute endotoxemia.
Topics: Acid-Base Equilibrium; Acute Disease; Animals; Cats; Cyclosporine; Endotoxemia; Intracellular Membranes; Lipopolysaccharides; Male; Mitochondria, Liver; Oxygen; Permeability | 2004 |
The peripheral benzodiazepine receptor ligand PK11195 overcomes different resistance mechanisms to sensitize AML cells to gemtuzumab ozogamicin.
Topics: Acute Disease; Aminoglycosides; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; bcl-X Protein; Cyclosporine; Drug Resistance, Neoplasm; Gemtuzumab; Gene Expression Regulation, Leukemic; HL-60 Cells; Humans; Immunosuppressive Agents; Isoquinolines; Leukemia, Myeloid; Leukotriene Antagonists; Ligands; Mice; Mice, Inbred NOD; Mice, SCID; Propionates; Proto-Oncogene Proteins c-bcl-2; Quinolines; Receptors, GABA-A; Xenograft Model Antitumor Assays | 2004 |
Leukocyte-targeted myocardial contrast echocardiography can assess the degree of acute allograft rejection in a rat cardiac transplantation model.
Topics: Acute Disease; Animals; Contrast Media; Cyclosporine; Echocardiography; Graft Rejection; Heart Transplantation; Immunosuppressive Agents; Leukocytes; Macrophages; Male; Microbubbles; Myocardium; Phagocytosis; Rats; Rats, Inbred BN; Rats, Inbred Lew; T-Lymphocytes; Transplantation, Heterotopic | 2004 |
[Pure red cell aplasia occurring during the course of chronic myelogenous leukemia].
Topics: Acute Disease; Antineoplastic Agents; Blood Transfusion; Cyclosporine; Hepatitis C; Humans; Hydroxyurea; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Red-Cell Aplasia, Pure | 2004 |
The impact of cyclosporine on the development of immunosuppressive therapy for pediatric liver transplantation.
Topics: Acute Disease; Child; Chronic Disease; Cyclosporine; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Liver Neoplasms; Retrospective Studies; Survival Analysis | 2004 |
International experience with conversion from cyclosporine to tacrolimus for acute and chronic lung allograft rejection.
Topics: Acute Disease; Adult; Australia; Azathioprine; Bronchiolitis Obliterans; Canada; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Europe; Female; Follow-Up Studies; Forced Expiratory Volume; Graft Rejection; Humans; Hypertension, Pulmonary; Immunosuppressive Agents; Incidence; Kidney; Lung Transplantation; Male; Middle Aged; Postoperative Complications; Pulmonary Disease, Chronic Obstructive; Pulmonary Fibrosis; Retrospective Studies; Tacrolimus; Time Factors; Treatment Outcome | 2004 |
Acute toxoplasmosis in two cats on cyclosporin therapy.
Topics: Acute Disease; Animals; Cat Diseases; Cats; Cyclosporine; Diagnosis, Differential; Immunocompromised Host; Immunosuppressive Agents; Toxoplasmosis, Animal | 2003 |
Bone marrow transplantation for therapy-related acute myeloid leukemia in congenital retinoblastoma associated with 13q deletion syndrome.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chromosome Deletion; Chromosomes, Human, Pair 13; Cryosurgery; Cryotherapy; Cyclosporine; DNA-Binding Proteins; Enzyme Inhibitors; Eye Neoplasms; Female; Histone-Lysine N-Methyltransferase; Humans; Infant, Newborn; Leukemia, Myeloid; Myeloid-Lymphoid Leukemia Protein; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Peripheral Blood Stem Cell Transplantation; Proto-Oncogenes; Remission Induction; Retinoblastoma; Teniposide; Topoisomerase II Inhibitors; Transcription Factors; Vincristine | 2004 |
Acute polymyositis following renal transplantation.
Topics: Acute Disease; Anti-Inflammatory Agents; Antigens; Creatine Kinase; Cyclosporine; Electrolytes; Electromyography; HLA Antigens; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Inflammation; Kidney Transplantation; Male; Middle Aged; Muscles; Mycophenolic Acid; Myositis; Polymyositis; Prednisolone; Time Factors | 2004 |
Tacrolimus instead of cyclosporine used for prophylaxis against graft-versus-host disease improves outcome after hematopoietic stem cell transplantation from unrelated donors, but not from HLA-identical sibling donors: a nationwide survey conducted in Jap
Topics: Acute Disease; Adolescent; Adult; Aged; Chronic Disease; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Histocompatibility Testing; Humans; Immunosuppressive Agents; Japan; Male; Middle Aged; Siblings; Stem Cell Transplantation; Tacrolimus; Time Factors; Tissue Donors; Treatment Outcome | 2004 |
[Chronic active ulcerative colitis. Efficacy of intravenous followed by oral cyclosporine combined with azathioprine].
Topics: Acute Disease; Administration, Oral; Adult; Aged; Attitude of Health Personnel; Attitude to Health; Azathioprine; Chronic Disease; Colitis, Ulcerative; Cyclosporine; Drug Administration Schedule; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Infusions, Intravenous; Male; Middle Aged; Remission Induction; Retrospective Studies; Severity of Illness Index; Time Factors; Treatment Outcome | 2004 |
[Immunosuppressive-associated encephalopathy in bone marrow transplant recipients].
Topics: Acute Disease; Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Brain Diseases; Cyclosporine; Female; Humans; Immunosuppressive Agents; Leukemia; Male; Middle Aged; Myelodysplastic Syndromes; Tacrolimus | 2004 |
Early experience with two-dose daclizumab in the prevention of acute rejection in cardiac transplantation.
Topics: Acute Disease; Adolescent; Adult; Aged; Ambulatory Care; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cyclosporine; Daclizumab; Drug Costs; Follow-Up Studies; Graft Rejection; Half-Life; Heart Transplantation; Humans; Immunoglobulin G; Immunosuppressive Agents; IMP Dehydrogenase; Middle Aged; Mycophenolic Acid; Prednisone; Prodrugs; Receptors, Interleukin-2; Retrospective Studies; Tacrolimus | 2004 |
Current immunosuppressive agents in pediatric renal transplantation: efficacy, side-effects and utilization.
Topics: Acute Disease; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Child; Cyclosporine; Daclizumab; Graft Rejection; Humans; Immunoglobulin G; Immunosuppressive Agents; Kidney Transplantation; Muromonab-CD3; Mycophenolic Acid; Sirolimus; Tacrolimus; Treatment Outcome | 2004 |
Nonmyeloablative stem cell transplantation in patients with ALL and AML results in low nonrelapse mortality despite high rate of infections and GVHD.
Topics: Acute Disease; Adult; Antilymphocyte Serum; Busulfan; Contraindications; Cyclosporine; Female; Follow-Up Studies; Graft Survival; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infection Control; Infections; Leukemia, Myeloid; Male; Middle Aged; Mycophenolic Acid; Mycoses; Myeloablative Agonists; Peripheral Blood Stem Cell Transplantation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Risk; Survival Rate; T-Lymphocytes; Transplantation Conditioning; Treatment Outcome; Vidarabine; Whole-Body Irradiation | 2004 |
[Ulcerative colitis. Acute episode].
Topics: Acute Disease; Administration, Oral; Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Azathioprine; Colitis, Ulcerative; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Humans; Immunosuppressive Agents; Mesalamine; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Time Factors | 2004 |
Role of postdose cyclosporine monitoring in living renal transplant recipients.
Topics: Acute Disease; Azathioprine; Cyclosporine; Drug Monitoring; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Living Donors; Male; Prednisolone | 2004 |
Hypoplastic myelodysplastic syndrome transformed in acute myeloid leukemia after androgens and cyclosporin. A treatment.
Topics: Acute Disease; Adult; Antineoplastic Agents, Alkylating; Cyclosporine; Female; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Melphalan; Myelodysplastic Syndromes; Treatment Failure | 2003 |
Gemcitabine does not prevent acute rejection of the transplanted liver in rats.
Topics: Acute Disease; Animals; Creatinine; Cyclosporine; Deoxycytidine; Gemcitabine; Graft Rejection; Immunosuppressive Agents; Liver; Liver Transplantation; Male; Rats; Rats, Inbred Lew; Rats, Inbred Strains; Treatment Failure; Urea | 2005 |
The effect of soluble complement receptor type 1 on acute humoral xenograft rejection in hDAF-transgenic pig-to-primate life-supporting kidney xenografts.
Topics: Acute Disease; Animals; Animals, Genetically Modified; CD55 Antigens; Complement Inactivator Proteins; Complement Membrane Attack Complex; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Graft Survival; Immunosuppressive Agents; Kidney Transplantation; Macaca fascicularis; Mycophenolic Acid; Receptors, Complement; Steroids; Swine; Transplantation, Heterologous | 2005 |
Ciclosporin use in acute ulcerative colitis: a long-term experience.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Azathioprine; Colitis, Ulcerative; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydrocortisone; Immunosuppressive Agents; Injections, Intravenous; Male; Middle Aged; Retrospective Studies; Survival Analysis; Treatment Outcome | 2005 |
Basiliximab lowers the cyclosporine therapeutic threshold in the early post-kidney transplant period.
Topics: Acute Disease; Antibodies, Monoclonal; Basiliximab; Cadaver; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Kidney Transplantation; Living Donors; Male; Middle Aged; Mycophenolic Acid; Prednisone; Recombinant Fusion Proteins; Retrospective Studies | 2005 |
Diagnostic validity of hepatocyte growth factor as marker for rejection in the follow-up of patients after heart transplantation.
Topics: Acute Disease; Adolescent; Adult; Aged; Azathioprine; Biomarkers; Biopsy; Cyclosporine; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Follow-Up Studies; Glucocorticoids; Graft Rejection; Heart Transplantation; Hepatocyte Growth Factor; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardium; Neopterin; Postoperative Period; Prednisone; Prognosis; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index | 2005 |
Two-hour post-dose cyclosporine levels in renal transplantation in Argentina: a cost-effective strategy for reducing acute rejection.
Topics: Acute Disease; Argentina; Azathioprine; Costs and Cost Analysis; Cyclosporine; Decision Support Techniques; Drug Therapy, Combination; Emulsions; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Time Factors | 2005 |
Causes of acute thrombotic microangiopathy in patients receiving kidney transplantation.
Topics: Acute Disease; Adult; Antiphospholipid Syndrome; Cyclosporine; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Lupus Erythematosus, Systemic; Male; Microcirculation; Middle Aged; Postoperative Period; Retrospective Studies; Tacrolimus; Thrombosis | 2004 |
Prevention of acute vascular rejection by a functionally blocking anti-C5 monoclonal antibody combined with cyclosporine.
Topics: Acute Disease; Animals; Antibodies, Monoclonal; Blood Vessels; Complement C5; Cyclosporine; Flow Cytometry; Graft Rejection; Heart Transplantation; Isoantibodies; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Transplantation, Homologous | 2005 |
Acute rejection after rat renal transplantation leads to downregulation of NA+ and water channels in the collecting duct.
Topics: Acute Disease; Animals; Aquaporin 2; Aquaporins; Cyclosporine; Down-Regulation; Endosomal Sorting Complexes Required for Transport; Epithelial Sodium Channels; Graft Rejection; Immediate-Early Proteins; Kidney Transplantation; Kidney Tubules, Collecting; Male; Nedd4 Ubiquitin Protein Ligases; Nuclear Proteins; Potassium Channels; Protein Isoforms; Protein Serine-Threonine Kinases; Rats; Rats, Inbred BN; Rats, Inbred Lew; Receptors, Mineralocorticoid; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sodium Channels; Sodium-Potassium-Exchanging ATPase; Ubiquitin-Protein Ligases | 2005 |
Synergistic effect of low dose cyclosporine A and human interleukin 10 overexpression on acute rejection in rat lung allotransplantation.
Topics: Acute Disease; Animals; Cyclosporine; Drug Administration Schedule; Drug Synergism; Electroporation; Gene Expression; Gene Transfer Techniques; Graft Rejection; Immunosuppressive Agents; Injections, Intramuscular; Interleukin-10; Lung Transplantation; Male; Rats; Rats, Inbred BN; Rats, Inbred F344; Transplantation, Homologous | 2005 |
Influence of the intensity of the conditioning regimen on the characteristics of acute and chronic graft-versus-host disease after allogeneic transplantation.
Topics: Acute Disease; Adult; Chronic Disease; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Myeloablative Agonists; Peripheral Blood Stem Cell Transplantation; Premedication; Retrospective Studies; Statistics, Nonparametric; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2005 |
[Improved outcome with sirolimus-cyclosporine regimen in high-risk renal transplant recipients].
Topics: Acute Disease; Adult; Black or African American; Cyclosporine; Female; Graft Rejection; Hispanic or Latino; Humans; Immunosuppressive Agents; Incidence; Infections; Kidney Transplantation; Male; Middle Aged; Retrospective Studies; Risk Assessment; Sirolimus; Texas; Treatment Outcome; White People | 2005 |
Effective prevention of lethal acute graft-versus-host disease by combined immunosuppressive therapy with prodigiosin and cyclosporine A.
Topics: Acute Disease; Animals; Arthritis, Experimental; Bacteria; Cell Proliferation; Cyclosporine; Disease Models, Animal; Drug Administration Schedule; Drug Evaluation, Preclinical; Drug Therapy, Combination; Female; Graft vs Host Disease; Immunosuppressive Agents; Interleukin-2; Interleukin-2 Receptor alpha Subunit; Lymphocytes; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Prodigiosin; Receptors, Interleukin; T-Cell Antigen Receptor Specificity; Time Factors | 2005 |
A case of tubulointerstitial nephritis and uveitis syndrome with severe immunologic dysregulation.
Topics: Acute Disease; Autoantibodies; beta 2-Microglobulin; Biopsy; CD4-Positive T-Lymphocytes; Child; Cyclosporine; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Kidney; Male; Nephritis, Interstitial; Prednisolone; Reoperation; Syndrome; Time Factors; Treatment Outcome; Uveitis, Anterior | 2005 |
Early acute rejection episodes in renal transplantation in relation to immunosuppression protocols: an audit of 100 cases.
Topics: Acute Disease; Antilymphocyte Serum; Cyclosporine; Graft Rejection; Histocompatibility Testing; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Incidence; Kidney Transplantation; Medical Audit; Mycophenolic Acid; Risk Factors; Sirolimus; Time Factors | 2005 |
Sirolimus-associated hepatotoxicity in the kidney graft recipient.
Topics: Acute Disease; Adult; Chemical and Drug Induced Liver Injury; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Mycophenolic Acid; Sirolimus; Steroids | 2005 |
CD80/CD86 costimulation regulates acute vascular rejection.
Topics: Acute Disease; Animals; Antibodies; B7-1 Antigen; B7-2 Antigen; Cyclosporine; Graft Rejection; Graft Survival; Heart Transplantation; Immunoglobulin G; Interferon-gamma; Interleukin-12; Mice; Mice, Inbred C57BL; Rats; Rats, Inbred Lew; T-Lymphocytes; Transplantation, Heterologous | 2005 |
Graft versus host disease in allogeneic stem cell transplantation--3 1/2 years experience.
Topics: Acute Disease; Adolescent; Adult; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Graft vs Host Disease; Hematologic Diseases; Humans; Immunosuppressive Agents; Incidence; Infant; Male; Middle Aged; Pakistan; Retrospective Studies; Stem Cell Transplantation; Transplantation, Homologous; Treatment Outcome | 2005 |
Graft versus host disease.
Topics: Acute Disease; Adrenal Cortex Hormones; Chronic Disease; Cyclosporine; Developing Countries; Graft vs Host Disease; Humans | 2005 |
Acute cyclosporine nephrotoxicity in a patient with oral pemphigus vulgaris and HIV infection on antiretroviral therapy.
Topics: Acute Disease; Adult; Antiretroviral Therapy, Highly Active; Cyclosporine; HIV Infections; Humans; Immunosuppressive Agents; Kidney Diseases; Male; Mouth Diseases; Pemphigus | 2005 |
Combination treatment with donor-specific transfusions and cyclosporine a induces long-term survival of cardiac allografts in miniature Swine.
Topics: Acute Disease; Animals; Apoptosis; Blood Transfusion; CD8-Positive T-Lymphocytes; Cell Proliferation; Coronary Vessels; Cyclosporine; Graft Rejection; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Swine; Swine, Miniature; T-Lymphocytes, Cytotoxic; Time Factors; Tissue Donors; Transplantation Tolerance; Transplantation, Homologous | 2005 |
Cyclosporin treatment in steroid-resistant and acutely exacerbated interstitial pneumonia.
Topics: Acute Disease; Aged; Cyclosporine; Drug Resistance; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Male; Middle Aged; Respiratory Function Tests; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2005 |
Late acute cardiac allograft rejection: new therapeutic options?
Topics: Acute Disease; Cyclosporine; Drug Therapy, Combination; Everolimus; Female; Follow-Up Studies; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Sirolimus; Time Factors; Transplantation, Homologous | 2005 |
Differential expression of tissue factor (TF) in calcineurin inhibitor-induced nephrotoxicity and rejection--implications for development of a possible diagnostic marker.
Topics: Acute Disease; Animals; Biomarkers; Blood Coagulation; Calcineurin Inhibitors; Chronic Disease; Cyclosporine; Graft Rejection; Humans; Kidney; Kidney Glomerulus; Kidney Transplantation; Rabbits; Thromboplastin | 2005 |
Evidence that donor intrinsic response to G-CSF is the best predictor of acute graft-vs-host disease following allogeneic peripheral blood stem cell transplantation.
Topics: Acute Disease; Adolescent; Adult; Aged; Antibiotic Prophylaxis; Antigens, CD34; Cell Count; Cohort Studies; Cyclosporine; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cells; Humans; Male; Methotrexate; Middle Aged; Multivariate Analysis; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Risk Factors; Transplantation, Homologous | 2006 |
Distinct subsets of dendritic cells regulate the pattern of acute xenograft rejection and susceptibility to cyclosporine therapy.
Topics: Acute Disease; Animals; Antibodies; CD8 Antigens; Coronary Vessels; Cyclosporine; Cytokines; Dendritic Cells; Graft Rejection; Graft Survival; Heart Transplantation; Male; Mice; Myocardium; Rats; Survival Rate; Time Factors; Transplantation, Heterologous | 2006 |
Coexisting subacute and systemic lupus erythematosus after terbinafine administration: successful treatment with mycophenolate mofetil.
Topics: Acute Disease; Adult; Antifungal Agents; Cyclosporine; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Methylprednisolone; Mycophenolic Acid; Naphthalenes; Onychomycosis; Terbinafine | 2006 |
Ciclosporin aggravates tissue damage in ischemia reperfusion-induced acute pancreatitis.
Topics: Acute Disease; Animals; Blood Pressure; Cyclosporine; Disease Models, Animal; Heart Rate; Immunosuppressive Agents; Pancreas; Pancreas Transplantation; Pancreatitis; Rats; Reperfusion Injury; Tacrolimus | 2006 |
JC-1, a sensitive probe for a simultaneous detection of P-glycoprotein activity and apoptosis in leukemic cells.
Topics: Acute Disease; Annexin A5; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzimidazoles; Carbocyanines; Cell Line, Tumor; Cyclosporine; Cytoplasm; Flow Cytometry; Fluorescent Dyes; Humans; Leukemia, Myeloid; Mitochondria; Propidium; Rhodamine 123; Staining and Labeling; Tumor Cells, Cultured | 2006 |
Human leucocyte antigen-identical haematopoietic stem cell transplantation in major histocompatiblity complex class II immunodeficiency: reduced survival correlates with an increased incidence of acute graft-versus-host disease and pre-existing viral infe
Topics: Acute Disease; Child, Preschool; Cyclosporine; Female; Follow-Up Studies; Genotype; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Antigens Class II; Humans; Immunologic Deficiency Syndromes; Immunosuppressive Agents; Incidence; Infant; Male; Methotrexate; Retrospective Studies; Survival Rate; Transplantation Conditioning; Transplantation, Isogeneic; Treatment Outcome; Virus Diseases | 2006 |
Cyclosporine C2 target levels and acute cellular rejection after lung transplantation.
Topics: Acute Disease; Adolescent; Adult; Bronchiolitis Obliterans; Cyclosporine; Female; Graft Rejection; Heart-Lung Transplantation; Humans; Immunosuppressive Agents; Lung Transplantation; Male; Middle Aged | 2006 |
Pharmacological profile of a novel phosphodiesterase 7A and -4 dual inhibitor, YM-393059, on acute and chronic inflammation models.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Acute Disease; Animals; Anti-Inflammatory Agents; Carrageenan; Chronic Disease; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclic Nucleotide Phosphodiesterases, Type 7; Cyclosporine; Dermatitis, Contact; Edema; Erythrocytes; Fumarates; Hypersensitivity, Delayed; Immunosuppressive Agents; Indoles; Inflammation; Male; Mice; Mice, Inbred BALB C; Peritonitis; Phosphodiesterase Inhibitors; Rats; Rats, Sprague-Dawley; Sheep; Sulfonamides; Toluene 2,4-Diisocyanate; Zymosan | 2006 |
Unrelated versus related allogeneic stem cell transplantation after reduced intensity conditioning.
Topics: Acute Disease; Antifungal Agents; Cause of Death; Chronic Disease; Cyclosporine; Cytomegalovirus Infections; Graft Rejection; Graft vs Host Disease; Humans; Immunosuppressive Agents; Mycoses; Siblings; Stem Cell Transplantation; Survival Analysis; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Treatment Failure; Treatment Outcome; Vidarabine | 2006 |
Surfactant as a carrier: influence of immunosuppressive agents on surfactant activity.
Topics: Acute Disease; Animals; Blood Gas Analysis; Cyclosporine; Disease Models, Animal; Drug Delivery Systems; Immunosuppressive Agents; Male; Oxygen; Partial Pressure; Pharmaceutical Preparations; Positive-Pressure Respiration; Pulmonary Gas Exchange; Pulmonary Surfactants; Rats; Rats, Sprague-Dawley; Respiratory Insufficiency; Sirolimus; Surface Tension | 2006 |
Concurrent relapsing central nervous system and ocular involvement in a case of life-threatening Adamantiades-Behçet Disease (ABD).
Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Azathioprine; Behcet Syndrome; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Recurrence; Retinal Vasculitis; Vitreous Body | 2006 |
[Myelodysplastic syndrome with cyclosporine A-induced encephalopathy presenting with a mass effect on the right basal ganglia after cord blood transplantation].
Topics: Acute Disease; Adolescent; Basal Ganglia; Brain Edema; Cord Blood Stem Cell Transplantation; Cyclosporine; Diffusion Magnetic Resonance Imaging; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Myelodysplastic Syndromes; Neurotoxicity Syndromes; Syndrome | 2006 |
Air-leak syndrome associated with bronchiolitis obliterans after allogeneic peripheral blood stem cell transplantation.
Topics: Acute Disease; Adult; Anti-Inflammatory Agents; Bronchiolitis Obliterans; Cyclosporine; Cytomegalovirus Infections; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Mediastinal Emphysema; Peripheral Blood Stem Cell Transplantation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Radiography; Syndrome | 2007 |
Inhibition of mitochondrial permeability transition improves functional recovery and reduces mortality following acute myocardial infarction in mice.
Topics: Acute Disease; Animals; Calcium; Cyclosporine; Disease Models, Animal; Ischemic Preconditioning, Myocardial; Male; Mice; Mitochondria, Heart; Myocardial Infarction; Permeability; Reperfusion Injury; Survival Analysis; Ventricular Dysfunction, Left | 2007 |
[The significance and expresssion of fractalkine in acute rejection after rat orthotopic liver transplantation].
Topics: Acute Disease; Animals; Chemokine CX3CL1; Cyclosporine; Female; Graft Rejection; Immunosuppressive Agents; Liver; Liver Transplantation; Male; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Transplantation, Homologous | 2007 |
[The anti-calcineurins (cyclosporin and tacrolimus)].
Topics: Acute Disease; Calcineurin Inhibitors; Chronic Disease; Cyclosporine; Drug Interactions; Graft Rejection; Humans; Immunosuppressive Agents; Patient Selection; Tacrolimus; Transplantation Immunology | 2007 |
Risk factors for acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: retrospective analysis of 73 patients who received cyclosporin A.
Topics: Acute Disease; Adolescent; Adult; Cyclosporine; Drug Monitoring; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Methotrexate; Middle Aged; Premedication; Retrospective Studies; Risk Factors | 2007 |
Decreased incidence of acute graft-versus-host disease by continuous infusion of cyclosporine with a higher target blood level.
Topics: Acute Disease; Adult; Antineoplastic Agents; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Incidence; Infusions, Intravenous; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Living Donors; Male; Methotrexate; Middle Aged; Transplantation, Homologous; Whole-Body Irradiation | 2008 |
Early treatment of acute rejections gives favorable long-term function after renal transplantation in small children.
Topics: Acute Disease; Adolescent; Azathioprine; Biopsy, Needle; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Infant; Kidney Failure, Chronic; Kidney Transplantation; Male; Methylprednisolone; Prospective Studies; Risk Factors; Survival Rate; Time Factors; Treatment Outcome | 2007 |
Attenuation of acute mitochondrial dysfunction after traumatic brain injury in mice by NIM811, a non-immunosuppressive cyclosporin A analog.
Topics: Acute Disease; Aldehydes; Animals; Biomarkers; Brain Injuries; Cyclosporine; Dose-Response Relationship, Drug; Immunoblotting; Lipid Peroxidation; Male; Mice; Mitochondrial Diseases; Oxidative Stress; Oxygen Consumption; Structure-Activity Relationship; Tyrosine | 2008 |
Atypical acute graft-versus-host disease.
Topics: Acute Disease; Adult; Bone Marrow Transplantation; Cyclosporine; Erythema; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Methotrexate; Necrosis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Skin Diseases; Treatment Outcome | 2007 |
[Allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia].
Topics: Acute Disease; Adolescent; Adult; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia; Male; Methotrexate; Middle Aged; Multivariate Analysis; Myelodysplastic Syndromes; Retrospective Studies; Risk Factors; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous | 2007 |
Peripheral blood versus bone marrow as a source of hematopoietic stem cells for allogeneic transplantation in children with class I and II beta thalassemia major.
Topics: Acute Disease; Adolescent; beta-Thalassemia; Blood Platelets; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Female; Follow-Up Studies; Graft vs Host Disease; Histocompatibility Testing; Humans; Immunosuppressive Agents; Leukocyte Count; Male; Methotrexate; Myeloablative Agonists; Neutrophils; Peripheral Blood Stem Cell Transplantation; Recovery of Function; Retrospective Studies; Survival Rate; Transplantation Conditioning; Transplantation, Homologous | 2008 |
Acute acquired toxoplasmic retinochoroiditis in a patient with anterior uveitis, amplified by immunosuppressive therapy.
Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Animals; Anterior Chamber; Chorioretinitis; Cyclosporine; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Polymerase Chain Reaction; Toxoplasma; Toxoplasmosis; Uveitis, Anterior; Visual Acuity | 2009 |
Validation of murine dextran sulfate sodium-induced colitis using four therapeutic agents for human inflammatory bowel disease.
Topics: Acute Disease; Animals; Antibodies; CD3 Complex; Chronic Disease; Colitis; Cyclosporine; Dextran Sulfate; Disease Models, Animal; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Interleukin-12 Subunit p40; Methotrexate; Mice; Mice, Inbred C57BL | 2008 |
[Blood levels of cyclosporine, acute rejections and the prognosis of the allografts in pediatric renal allograft recipients].
Topics: Acute Disease; Adolescent; Child; Child, Preschool; Cyclosporine; Graft Rejection; Graft Survival; Humans; Kidney Transplantation; Prognosis; Retrospective Studies; Transplantation, Homologous | 1995 |
Influence of intrarenal deposits of ciclosporin A on acute renal transplant rejection.
Topics: Acute Disease; Adult; Biopsy; Creatinine; Cyclosporine; Female; Graft Rejection; Humans; Immunohistochemistry; Immunosuppressive Agents; Kidney Glomerulus; Kidney Transplantation; Macrophages; Male; Middle Aged; Prognosis; T-Lymphocyte Subsets | 1995 |
Acute pancreatitis induced by cyclosporin A under stimulation of pancreas by caerulein.
Topics: Acute Disease; Amylases; Animals; Ceruletide; Cyclosporine; DNA; Male; Necrosis; Organ Size; Pancreas; Pancreatitis; Proteins; Rats; Rats, Wistar; Vacuoles | 1993 |
FK506 conversion for intractable rejection of the liver allograft.
Topics: Acute Disease; Administration, Oral; Adult; Bilirubin; Child; Child, Preschool; Chronic Disease; Cyclosporine; Graft Rejection; Graft Survival; Humans; Injections, Intravenous; Liver Transplantation; Salvage Therapy; Tacrolimus; Transplantation, Homologous | 1993 |
Conversion from cyclosporin to FK 506 after liver transplantation.
Topics: Acute Disease; Adolescent; Adult; Aged; Chronic Disease; Cyclosporine; Drug Resistance; Glucocorticoids; Graft Rejection; Graft Survival; Humans; Infusions, Intravenous; Liver Transplantation; Middle Aged; Salvage Therapy; Survival Rate; Tacrolimus | 1993 |
[Rejection of a liver allograft. Diagnosis and treatment].
Topics: Acute Disease; Adrenal Cortex Hormones; Azathioprine; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Humans; Liver Transplantation; Postoperative Complications; Tacrolimus; Transplantation, Homologous | 1994 |
Effects of cyclosporine and tacrolimus (FK 506) on acute pancreatitis in mice.
Topics: Acute Disease; Animals; Ceruletide; Choline Deficiency; Cyclosporine; Edema; Ethionine; Female; Male; Mice; Necrosis; Pancreatitis; Tacrolimus | 1995 |
Acute necrotico-hemorrhagic pancreatitis after famciclovir prescription.
Topics: 2-Aminopurine; Acute Disease; Alanine Transaminase; Amylases; Antiviral Agents; Bilirubin; Cyclosporine; DNA, Viral; Famciclovir; Fatal Outcome; Hemorrhage; Hepatitis B; Hepatitis B virus; Humans; Kidney Transplantation; Leukocyte Count; Lipase; Male; Middle Aged; Necrosis; Pancreatitis; Postoperative Complications; Prodrugs | 1995 |
Modulation of multidrug resistance in de novo adult acute myeloid leukemia: variable efficacy of reverting agents in vitro. Eastern Cooperative Oncology Group.
Topics: Acute Disease; Antigens, CD; Antigens, CD34; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporine; Dexamethasone; Drug Resistance, Multiple; Humans; Leukemia, Myeloid; Rhodamines; Tumor Cells, Cultured; Verapamil | 1995 |
Correlation of multidrug resistance (MDR1) protein expression with functional dye/drug efflux in acute myeloid leukemia by multiparameter flow cytometry: identification of discordant MDR-/efflux+ and MDR1+/efflux- cases.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Antigens, CD; Antigens, CD34; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Carbocyanines; Cryopreservation; Cyclosporine; Drug Resistance, Multiple; Female; Flow Cytometry; Fluorescent Dyes; Gene Expression Regulation, Leukemic; Humans; Leukemia, Myeloid; Male; Middle Aged; Multicenter Studies as Topic; Neoplasm Proteins; Neoplastic Stem Cells | 1995 |
Experimental tracheal allograft revascularization and transplantation.
Topics: Acute Disease; Animals; Cyclosporine; Fascia; Feasibility Studies; Graft Rejection; Graft Survival; Methylprednisolone; Rabbits; Surgical Flaps; Time Factors; Trachea; Transplantation, Homologous | 1995 |
Induction therapy with cyclosporine without cytolytic agents results in a low incidence of acute rejection without significant renal impairment in heart transplant patients.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Antilymphocyte Serum; Azathioprine; Creatinine; Cyclosporine; Female; Follow-Up Studies; Glucocorticoids; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Incidence; Injections, Intravenous; Kidney; Male; Methylprednisolone; Middle Aged; Muromonab-CD3; Prednisone; Premedication; Renal Dialysis; Survival Rate | 1995 |
Diffuse alveolar haemorrhage associated with microangiopathy after allogeneic bone marrow transplantation.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Endothelium, Vascular; Fatal Outcome; Female; Hemolytic-Uremic Syndrome; Hemorrhage; Humans; Leukemia, Myeloid; Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative; Lung Diseases; Lymphoma, Non-Hodgkin; Male; Plasma; Plasmapheresis; Platelet Transfusion; Pulmonary Alveoli; Purpura, Thrombotic Thrombocytopenic; Respiratory Insufficiency; Transplantation, Homologous; Vascular Diseases | 1995 |
Acute hemolysis during cyclosporine therapy successfully treated with vitamin E.
Topics: Acute Disease; Adolescent; Anemia, Aplastic; Anemia, Hemolytic; Bone Marrow Transplantation; Cyclosporine; Humans; Immunosuppressive Agents; Male; Vitamin E | 1995 |
Whether methotrexate administration in graft-versus-host disease prophylaxis significantly delays the engraftment in allogeneic peripheral blood progenitor cell transplantation.
Topics: Acute Disease; Adolescent; Adrenal Cortex Hormones; Adult; Bone Marrow Transplantation; Cyclosporine; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Male; Methotrexate; Middle Aged | 1995 |
Immunosuppression is not related to the response to steroids in acute liver rejection.
Topics: Acute Disease; Antilymphocyte Serum; Cyclosporine; Drug Resistance; Graft Rejection; Humans; Immunosuppressive Agents; Liver Transplantation; Muromonab-CD3; Retrospective Studies; Steroids | 1995 |
Successful treatment of ongoing intestinal allograft rejection permits recovery of graft structure and function.
Topics: Acute Disease; Animals; Antilymphocyte Serum; Biopsy; Cyclosporine; Graft Rejection; Graft Survival; Intestine, Small; Male; Rats; Rats, Inbred BN; Rats, Inbred Lew; Tacrolimus | 1993 |
Prognostic factors for successful conversion from cyclosporine to FK 506-based immunosuppressive therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group.
Topics: Acute Disease; Age Factors; Analysis of Variance; Chronic Disease; Cyclosporine; Drug Resistance; Female; Graft Rejection; Humans; Immunosuppressive Agents; Liver Function Tests; Liver Transplantation; Male; Multivariate Analysis; Prognosis; Sex Characteristics; Survival Analysis; Tacrolimus | 1993 |
The immunopharmacology of immunosuppression by 15-deoxyspergualin.
Topics: Acute Disease; Animals; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Epitopes; Graft Rejection; Graft Survival; Guanidines; Heart Transplantation; Immunosuppressive Agents; Isoantigens; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Transplantation, Heterotopic; Transplantation, Homologous | 1993 |
FK 506 treatment of intractable rejection after liver transplantation.
Topics: Acute Disease; Adult; Alanine Transaminase; Bilirubin; Chronic Disease; Creatinine; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Humans; Liver Transplantation; Male; Tacrolimus | 1993 |
Treatment of acute severe exacerbation of chronic hepatitis B with cyclosporin A and interferon-beta: a case report.
Topics: Acute Disease; Adult; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Hepatitis B; Humans; Interferon-beta; Male | 1995 |
Cyclosporine A toxicity presenting with acute cerebellar edema and brainstem compression. Case report.
Topics: Acute Disease; Adult; Blindness; Brain Edema; Brain Stem; Cerebellar Diseases; Cyclosporine; Cystic Fibrosis; Humans; Lung Transplantation; Magnetic Resonance Imaging; Male; Nerve Compression Syndromes; Postoperative Care | 1995 |
Risk factors for chronic transplant failure after kidney transplantation.
Topics: Acute Disease; Adolescent; Adult; Age Factors; Cyclosporine; Cytomegalovirus Infections; Graft Rejection; Graft Survival; Histocompatibility; HLA Antigens; Humans; Kidney Transplantation; Organ Preservation; Risk Factors; Tissue Donors | 1995 |
Cyclosporine as an alternative to surgery in children with inflammatory bowel disease.
Topics: Acute Disease; Adolescent; Adrenal Cortex Hormones; Child; Colitis, Ulcerative; Cyclosporine; Humans; Male; Prednisone; Treatment Failure | 1994 |
Use of OKT3 monoclonal antibody as induction therapy for control of rejection in liver transplantation.
Topics: Acute Disease; Adolescent; Adult; Aged; Cyclosporine; Female; Graft Rejection; Humans; Liver Transplantation; Male; Middle Aged; Muromonab-CD3; Recurrence; Survival Rate | 1995 |
Reusable influence diagrams.
Topics: Acute Disease; Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Artificial Intelligence; Bayes Theorem; Bone Marrow Transplantation; Child; Cyclosporine; Decision Support Techniques; Expert Systems; Graft vs Host Disease; Humans; Leukemia, Myeloid; Methotrexate; Models, Biological; Neural Networks, Computer; Patient Care Planning; Prognosis; Sex Factors; Systems Integration | 1994 |
Correlation between Banff classification, acute renal rejection scores, and reversal of rejection.
Topics: Acute Disease; Antilymphocyte Serum; Azathioprine; Creatinine; Cyclosporine; Graft Rejection; Humans; Immunosuppression Therapy; Kidney Transplantation; Muromonab-CD3; Steroids | 1995 |
Acute rejection under triple immunosuppressive therapy does not increase the risk of late first cadaveric renal allograft loss.
Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Azathioprine; Cadaver; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Retrospective Studies; Risk Factors; Time Factors; Transplantation, Homologous; Treatment Failure | 1995 |
Pharmacokinetic behavior of cyclosporine A in liver dysfunction.
Topics: Acute Disease; Adolescent; Adult; Cyclosporine; Female; Graft Rejection; Hepatitis; Humans; Kidney Transplantation; Liver Cirrhosis, Biliary; Male; Middle Aged | 1994 |
In vitro drug resistance in acute myeloid and chronic B-lymphocytic leukaemic blasts and in normal blood and marrow populations.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blast Crisis; Bone Marrow; Bone Marrow Cells; Cell Survival; Cells, Cultured; Cyclosporine; Daunorubicin; Drug Resistance; Drug Resistance, Multiple; Female; Fluorescent Antibody Technique; Humans; Idarubicin; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid; Male; Middle Aged; Monocytes; Reference Values | 1994 |
Inhibition of calcineurin phosphatase activity in adult bone marrow transplant patients treated with cyclosporine A.
Topics: Acute Disease; Adult; Bone Marrow; Bone Marrow Transplantation; Calcineurin; Calmodulin-Binding Proteins; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Humans; Male; Middle Aged; Phosphoprotein Phosphatases; T-Lymphocytes, Cytotoxic; Time Factors | 1994 |
The relationship between fever and acute rejection or infection following renal transplantation in the cyclosporin era.
Topics: Acute Disease; Bacterial Infections; Candidiasis; Cohort Studies; Cyclosporine; Cytomegalovirus Infections; Female; Fever; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Kidney Transplantation; Male; Middle Aged; Time Factors; Virus Diseases | 1994 |
Recurrent acute inflammatory demyelinating polyradiculitis after allogeneic bone marrow transplantation.
Topics: Acute Disease; Adult; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Demyelinating Diseases; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Polyradiculopathy; Prednisone; Recurrence; Transplantation, Homologous | 1994 |
Elective cyclosporine withdrawal 1 year after renal transplantation.
Topics: Acute Disease; Adult; Azathioprine; Cyclosporine; Drug Administration Schedule; Female; Graft Rejection; Humans; Kidney Transplantation; Male; Middle Aged; Prednisone; Retrospective Studies; Risk Factors; Substance Withdrawal Syndrome; Survival Analysis; Treatment Outcome | 1994 |
Relevance of Tc-99m DMSA scintigraphy in renal transplant parenchymal imaging.
Topics: Acute Disease; Adult; Azathioprine; Creatinine; Cyclosporine; Edema; Female; Fibrosis; Glucocorticoids; Graft Rejection; Humans; Infarction; Kidney; Kidney Transplantation; Kidney Tubules; Male; Middle Aged; Organotechnetium Compounds; Radionuclide Imaging; Succimer; Technetium Tc 99m Dimercaptosuccinic Acid | 1994 |
15-Deoxyspergualin controls cyclosporin- and steroid-resistant intestinal acute graft-versus-host disease after allogeneic bone marrow transplantation.
Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Bone Marrow Transplantation; Cyclosporine; Drug Resistance; Graft vs Host Disease; Guanidines; Humans; Immunosuppressive Agents; Intestinal Diseases; Male; Transplantation, Homologous | 1994 |
Addition of low-dose folinic acid to a methotrexate/cyclosporin A regimen for prevention of acute graft-versus-host disease.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Graft vs Host Disease; Humans; Leucovorin; Leukemia; Male; Methotrexate; Middle Aged; Transplantation, Homologous | 1994 |
Early diagnosis of acute rejection by pulmonary hemodynamics after single-lung transplantation.
Topics: Acute Disease; Animals; Azathioprine; Blood Pressure; Cardiac Output; Cyclosporine; Dogs; Endothelium, Vascular; Graft Rejection; Hemodynamics; Lung Transplantation; Methylprednisolone; Pulmonary Artery; Regional Blood Flow; Respiration; Transplantation, Autologous; Transplantation, Homologous; Vascular Resistance | 1994 |
[Pulsed Doppler ultrasonography in the month following renal transplantation].
Topics: Acute Disease; Child; Cohort Studies; Cyclosporine; Female; Graft Rejection; Humans; Kidney Diseases; Kidney Transplantation; Kidney Tubular Necrosis, Acute; Male; Postoperative Period; Prospective Studies; Renal Artery; Ultrasonography | 1993 |
Transforming growth factor beta 1 in renal allograft recipients.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Biomarkers; Chronic Disease; Creatinine; Cyclosporine; Female; Glomerulonephritis, Membranous; Graft Rejection; Humans; Kidney Transplantation; Male; Middle Aged; Reference Values; Regression Analysis; Transforming Growth Factor beta; Transplantation, Homologous | 1994 |
New issues in therapy after renal transplantation.
Topics: Acute Disease; Chronic Disease; Cyclosporine; Drug Monitoring; Glomerular Filtration Rate; Graft Rejection; Humans; Immunosuppression Therapy; Kidney; Kidney Transplantation | 1994 |
Acute rejection episodes--best predictor of long-term primary cadaveric renal transplant survival.
Topics: Acute Disease; Cadaver; Cohort Studies; Cyclosporine; Follow-Up Studies; Forecasting; Graft Rejection; Graft Survival; Humans; Kidney Transplantation; Muromonab-CD3; Ohio; Retrospective Studies; Survival Rate | 1994 |
Plasma endothelin level following kidney transplantation.
Topics: Acute Disease; Adult; Azathioprine; Creatinine; Cyclosporine; Drug Administration Schedule; Endothelins; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Prednisolone; Reference Values; Ribonucleosides | 1994 |
Proteinuria after renal allograft: assessment based on severity and causes.
Topics: Acute Disease; Adult; Analysis of Variance; Biopsy; Chronic Disease; Creatinine; Cyclosporine; Female; Follow-Up Studies; Glomerulonephritis; Graft Rejection; Humans; Kidney Transplantation; Male; Proteinuria; Retrospective Studies; Time Factors; Transplantation, Homologous | 1994 |
[An experimental model of the effect of uremia on cyclosporin A availability].
Topics: Acute Disease; Animals; Biological Availability; Cyclosporine; Male; Nephrectomy; Rats; Rats, Wistar; Uremia | 1994 |
Cyclosporine A nephrotoxicity.
Topics: Acute Disease; Chronic Disease; Cyclosporine; Humans; Kidney Diseases | 1994 |
Daunorubicin uptake by leukemic cells: correlations with treatment outcome and mdr1 expression.
Topics: Acute Disease; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Carrier Proteins; Cyclosporine; Daunorubicin; Drug Resistance; Gene Expression; Humans; In Vitro Techniques; Leukemia, Myeloid; Membrane Glycoproteins; RNA, Messenger; RNA, Neoplasm; Tumor Cells, Cultured | 1993 |
Occult rejection in renal allografts: preconversion biopsies and postconversion rejection in recipients converted from cyclosporine to azathioprine alone at 6 to 12 months after transplantation.
Topics: Acute Disease; Adult; Azathioprine; Biopsy, Needle; Cyclosporine; Female; Graft Rejection; Humans; Kidney Transplantation; Male | 1994 |
Accuracy and predictive value of ultrasound in acute rejection.
Topics: Acute Disease; Cyclosporine; Diagnosis, Differential; Evaluation Studies as Topic; Graft Rejection; Humans; Kidney; Kidney Transplantation; Kidney Tubular Necrosis, Acute; Sensitivity and Specificity; Ultrasonography | 1994 |
Graft-versus-host disease in children: the AIEOP-BMT Group experience with cyclosporin A.
Topics: Acute Disease; Adolescent; Bone Marrow Transplantation; Child; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Humans; Italy; Leukemia; Male; Registries; Risk Factors; Sex Characteristics; Survival Rate; Tissue Donors; Transplantation, Homologous | 1993 |
Mechanism of cyclosporine-induced sympathetic activation and acute hypertension in rats.
Topics: Acute Disease; Animals; Blood Pressure; Cyclosporine; Female; Hypertension; Rats; Rats, Sprague-Dawley; Reflex; Sympathetic Nervous System; Vagus Nerve | 1994 |
Leflunomide in experimental transplantation. Control of rejection and alloantibody production, reversal of acute rejection, and interaction with cyclosporine.
Topics: Abdomen; Acute Disease; Animals; Antibody Formation; Cyclosporine; Drug Therapy, Combination; Empyema; Graft Rejection; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Isoantibodies; Isoxazoles; Leflunomide; Male; Models, Biological; Rats; Rats, Inbred BN; Rats, Inbred Lew; Rats, Sprague-Dawley; Transplantation, Heterotopic | 1994 |
[Early diagnosis of acute rejection in single lung transplantation from the standpoint of pulmonary hemodynamics].
Topics: Acute Disease; Animals; Azathioprine; Cardiac Output; Cyclosporine; Dogs; Graft Rejection; Hemodynamics; Immunosuppression Therapy; Lung Transplantation; Pulmonary Artery; Pulmonary Circulation; Vascular Resistance | 1994 |
Thromboxane and prostacyclin synthesis in experimental pancreas transplantation. Changes in parenchymal and vascular prostanoids.
Topics: 6-Ketoprostaglandin F1 alpha; Acute Disease; Animals; Aorta; Celiac Artery; Cyclosporine; Epoprostenol; Graft Rejection; Male; Mesenteric Artery, Superior; Pancreas; Pancreas Transplantation; Rats; Rats, Inbred Strains; Thrombosis; Thromboxane A2; Thromboxane B2; Transplantation, Homologous; Transplantation, Isogeneic; Vena Cava, Inferior | 1993 |
A prospective study of technetium-99m-diethylenetriamine pentaacetic acid renal allograft scintigraphy in the diagnostic evaluation of graft dysfunction.
Topics: Acute Disease; Algorithms; Cyclosporine; Female; Graft Rejection; Humans; Kidney; Kidney Transplantation; Male; Prospective Studies; Radionuclide Imaging; Technetium Tc 99m Pentetate | 1993 |
Fatal acute hepatitis B virus infection while receiving immunosuppressants after renal transplantation.
Topics: Acute Disease; Cyclosporine; Fatal Outcome; Hepatitis B; Humans; Immunocompromised Host; Kidney Transplantation; Liver; Liver Failure; Male; Middle Aged; Postoperative Complications; Prednisolone; Renal Insufficiency | 1993 |
Clinical correlations of cyclosporine-specific and -nonspecific assays in stable renal transplants, acute rejection, and cyclosporine nephrotoxicity.
Topics: Acute Disease; Adolescent; Adult; Aged; Child; Chromatography, High Pressure Liquid; Cyclosporine; Dose-Response Relationship, Drug; Female; Fluorescence Polarization Immunoassay; Graft Rejection; Humans; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Sensitivity and Specificity | 1993 |
TNF staining of graft biopsies in renal transplantation.
Topics: Acute Disease; Antibodies, Monoclonal; Biomarkers; Biopsy; Chronic Disease; Cyclosporine; Graft Rejection; Humans; Immunohistochemistry; Kidney Transplantation; Tumor Necrosis Factor-alpha | 1993 |
Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: correlations with acute graft-versus-host disease and relapse.
Topics: Acute Disease; Base Sequence; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Graft vs Host Disease; Humans; Leukemia, Myeloid, Chronic-Phase; Molecular Sequence Data; Oligonucleotide Probes; Polymerase Chain Reaction; Postoperative Period; Transplantation, Homologous | 1993 |
Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin.
Topics: Acute Disease; Animals; Chronic Disease; Colitis, Ulcerative; Colon; Cyclosporine; Dextran Sulfate; Disease Models, Animal; Enema; Female; Mice | 1993 |
Cyclosporine metabolite pattern in blood from patients with acute GVHD after BMT.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Child; Cyclosporine; Female; Graft vs Host Disease; Humans; Liver; Male; Time Factors | 1993 |
In vivo prostanoid formation during acute renal allograft rejection.
Topics: Acute Disease; Adolescent; Child; Child, Preschool; Creatinine; Cyclosporine; Female; Graft Rejection; Humans; Kidney Transplantation; Male; Middle Aged; Prostaglandins; Thromboxane A2; Thromboxane B2; Transplantation, Homologous | 1993 |
Continuously infused cyclosporine at low dose is sufficient to avoid emergency colectomy in acute attacks of ulcerative colitis without the need for high-dose steroids.
Topics: Acute Disease; Adult; Colectomy; Colitis, Ulcerative; Cyclosporine; Drug Therapy, Combination; Emergencies; Female; Humans; Hydrocortisone; Infusions, Intravenous; Male; Middle Aged; Time Factors | 1993 |
Contrasting effects of immunosuppression on herpes simplex virus type I (HSV I) induced central nervous system (CNS) demyelination in mice.
Topics: Acute Disease; Animals; Antibodies, Viral; Brain; Cyclophosphamide; Cyclosporine; Demyelinating Diseases; Encephalitis; Immunocompetence; Immunocompromised Host; Immunologic Deficiency Syndromes; Male; Mice; Mice, Inbred Strains; Mice, Mutant Strains; Mice, Nude; Radiation Injuries, Experimental; Simplexvirus; Species Specificity; Trigeminal Nerve | 1993 |
RS-61443 for treatment-resistant human liver rejection.
Topics: Acute Disease; Azathioprine; Cyclosporine; Drug Resistance; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Liver Transplantation; Mycophenolic Acid; Pilot Projects; Prednisolone | 1993 |
T cells mediating early acute kidney allograft rejection in the rat are different from those responsible for chronic rejection.
Topics: Acute Disease; Animals; CD4 Antigens; Cell Line; Chronic Disease; Cyclosporine; Graft Rejection; Histocompatibility Antigens Class II; Kidney Transplantation; Lymphocyte Culture Test, Mixed; Rats; T-Lymphocyte Subsets; T-Lymphocytes; Transplantation, Homologous | 1993 |
Implications of lymphocyte sensitivity to glucocorticoids in renal transplant recipients.
Topics: Acute Disease; Adult; Azathioprine; Blood Transfusion; Cyclosporine; Graft Rejection; Guanidines; Histocompatibility Testing; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Lymphocytes; Methylprednisolone; Monitoring, Immunologic; Prednisolone; Prognosis | 1993 |
Comparison of fine-needle aspiration biopsy, Doppler ultrasound, and radionuclide scintigraphy in the diagnosis of acute allograft dysfunction in renal transplant recipients: sensitivity, specificity, and cost analysis.
Topics: Acute Disease; Biopsy, Needle; Costs and Cost Analysis; Cyclosporine; Evaluation Studies as Topic; Graft Rejection; Humans; Kidney Transplantation; Kidney Tubular Necrosis, Acute; Radionuclide Imaging; Sensitivity and Specificity; Ultrasonography | 1993 |
Use of an anti-interleukin-2 receptor monoclonal antibody for GVHD prophylaxis in unrelated donor BMT.
Topics: Actuarial Analysis; Acute Disease; Adolescent; Adult; Animals; Antibodies, Monoclonal; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunoglobulin G; Immunosuppression Therapy; Incidence; Infant; Lymphocyte Activation; Male; Middle Aged; Rats; Receptors, Interleukin-2; Survival Rate; Transplantation, Homologous | 1993 |
Risk factors for acute graft-versus-host disease associated with cyclosporine and methotrexate prophylaxis.
Topics: Acute Disease; Adolescent; Adult; Cyclosporine; Graft vs Host Disease; Humans; Methotrexate; Middle Aged; Risk Factors | 1993 |
Use of 15-deoxyspergualin in treatment of acute rejection in kidney transplant patients.
Topics: Acute Disease; Adult; Chronic Disease; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Guanidines; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Male; Methylprednisolone; Ribonucleosides; Time Factors | 1993 |
Contribution of acute rejection to renal allograft loss from chronic rejection.
Topics: Acute Disease; Adult; Antilymphocyte Serum; Cadaver; Chronic Disease; Cyclosporine; Female; Graft Rejection; Humans; Kidney Transplantation; Male; Methylprednisolone; Time Factors; Tissue Donors; Transplantation, Homologous | 1993 |
The fractional excretion of urea: a new diagnostic test for acute renal allograft rejection.
Topics: Acute Disease; Adolescent; Adult; Bacterial Infections; Child; Child, Preschool; Cyclosporine; Diagnosis, Differential; Graft Rejection; Humans; Kidney Diseases; Kidney Transplantation; Sodium; Transplantation, Homologous; Urea; Virus Diseases | 1993 |
Decreased potency of MDR-modulators under serum conditions determined by a functional assay.
Topics: Acute Disease; Antimetabolites, Antineoplastic; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; CD8-Positive T-Lymphocytes; Cyclosporine; Dihydropyridines; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Flow Cytometry; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid; Rhodamine 123; Rhodamines; Verapamil | 1995 |
[Effects of acute rejection on the endothelium-dependent relaxation of coronary arteries of the transplanted heart in dogs].
Topics: Acute Disease; Animals; Coronary Artery Disease; Coronary Vessels; Cyclosporine; Dogs; Endothelium, Vascular; Graft Rejection; Heart Transplantation; Immunosuppressive Agents; Transplantation, Heterotopic; Vasodilation | 1995 |
Long-term leukemia-free survival after allogeneic marrow transplantation in patients with acute myelogenous leukemia.
Topics: Acute Disease; Adult; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Histocompatibility; Humans; Leukemia, Myeloid; Life Tables; Male; Methotrexate; Middle Aged; Neoplasm, Residual; Remission Induction; Salvage Therapy; Survival Rate; Transplantation, Homologous; Whole-Body Irradiation | 1996 |
Hepatotoxicity of intravenous cyclosporin A in patients with acute ulcerative colitis on total parenteral nutrition.
Topics: Acute Disease; Adolescent; Adult; Cholangitis; Colitis, Ulcerative; Cyclosporine; Female; Humans; Immunosuppressive Agents; Infusions, Intravenous; Male; Middle Aged; Parenteral Nutrition, Total; Retrospective Studies; Transaminases | 1995 |
Immunomodulation by an adenylate cyclase activator, NKH477, in vivo and vitro.
Topics: Acute Disease; Adenylyl Cyclases; Adjuvants, Immunologic; Animals; Colforsin; Cyclosporine; Cytotoxicity, Immunologic; Enzyme Activation; Heart Transplantation; Immunity, Cellular; Interleukin-2; Lymphocyte Activation; Lymphocyte Culture Test, Mixed; Male; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred DBA; Spleen; T-Lymphocytes; T-Lymphocytes, Cytotoxic | 1996 |
Teething and acute graft vs. host disease: a clinical observation.
Topics: Acute Disease; Bone Marrow Transplantation; Cyclosporine; Female; Gingiva; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infant; Interleukin-1; Severe Combined Immunodeficiency; Tooth Eruption | 1996 |
Tacrolimus rescue therapy for renal allograft rejection refractory to cyclosporine-based immunosuppression.
Topics: Acute Disease; Adult; Azathioprine; Biopsy; Blood Glucose; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Glycated Hemoglobin; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Pancreas Transplantation; Prednisone; Tacrolimus; Transplantation, Homologous | 1996 |
CTLA4Ig alone or in combination with low-dose cyclosporine fails to reverse acute rejection of renal allograft in the rat.
Topics: Abatacept; Acute Disease; Animals; Antigen-Presenting Cells; Antigens, CD; Antigens, Differentiation; CD28 Antigens; CTLA-4 Antigen; Cyclosporine; Graft Rejection; Immunoconjugates; Immunosuppressive Agents; Kidney Transplantation; Male; Rats; Rats, Inbred BN; Rats, Inbred Lew; Recombinant Fusion Proteins | 1996 |
Delayed development of obliterative bronchiolitis syndrome with OKT3 after unilateral lung transplantation. A plea for multicenter immunosuppressive trials.
Topics: Acute Disease; Antilymphocyte Serum; Azathioprine; Biopsy; Bronchiolitis Obliterans; Bronchoscopy; Chronic Disease; Clinical Trials as Topic; Cohort Studies; Confidence Intervals; Cyclosporine; Cytomegalovirus Infections; Graft Rejection; HLA Antigens; Humans; Immunosuppressive Agents; Lung Transplantation; Multicenter Studies as Topic; Muromonab-CD3; Pneumonia, Viral; Prednisone; Proportional Hazards Models; Retrospective Studies; Spirometry; Syndrome; Time Factors; Transplantation, Homologous | 1996 |
Changes in urinary interleukin-2 in kidney transplant recipients.
Topics: Acute Disease; Adolescent; Adult; Biomarkers; Child; Chronic Disease; Creatinine; Cyclosporine; Diagnosis, Differential; Graft Rejection; Humans; Immunosuppressive Agents; Interleukin-2; Kidney Transplantation; Middle Aged; Monitoring, Physiologic; Reference Values; Regression Analysis | 1996 |
Factors affecting therapeutic effect of anti-CD3 and CD4 monoclonal antibody in acute renal allograft rejection.
Topics: Acute Disease; Adult; Antibodies, Monoclonal; Biopsy, Needle; CD3 Complex; CD4 Antigens; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Reoperation; Transplantation, Homologous | 1996 |
Accelerated acute rejection in renal allograft.
Topics: Acute Disease; Age Factors; Azathioprine; Cadaver; Cyclosporine; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Male; Prednisone; Recurrence; Retrospective Studies; Risk Factors; Time Factors; Tissue Donors | 1996 |
Late onset acute rejection of renal allografts, an indicator of suboptimum cyclosporin dosage.
Topics: Acute Disease; Adult; Azathioprine; Cyclosporine; Dose-Response Relationship, Drug; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Prednisolone; Retrospective Studies; Time Factors | 1996 |
Causes of hospital admission following successful renal transplantation.
Topics: Acute Disease; Adolescent; Adult; Child; Chronic Disease; Cyclosporine; Female; Glomerulonephritis; Graft Rejection; Hospitalization; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Medical Records; Middle Aged; Postoperative Complications; Prednisolone; Retrospective Studies; Time Factors | 1996 |
Delayed xenograft rejection in the concordant hamster heart into Lewis rat model.
Topics: Acute Disease; Animals; Cricetinae; Cyclosporine; Drug Administration Schedule; Graft Rejection; Heart Transplantation; Immunity, Cellular; Immunosuppressive Agents; Isoxazoles; Leflunomide; Rats; Rats, Inbred Lew; Time Factors; Transplantation, Heterologous | 1996 |
Unrelated donor bone marrow transplantation without T cell depletion using a chemotherapy only condition regimen. Low incidence of failed engraftment and severe acute GVHD.
Topics: Actuarial Analysis; Acute Disease; Adult; Anti-Infective Agents; Bone Marrow Transplantation; Busulfan; Cause of Death; Critical Care; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Female; Graft Survival; Graft vs Host Disease; Granulocyte-Macrophage Colony-Stimulating Factor; Hematologic Neoplasms; Hepatic Veno-Occlusive Disease; Histocompatibility; HLA-DR Antigens; Humans; Immunosuppressive Agents; Infections; Lymphocyte Depletion; Male; Methotrexate; Middle Aged; Risk; Survival Analysis; T-Lymphocytes; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 1996 |
Magnetic resonance imaging for the evaluation of rejection of a kidney allograft in the rat.
Topics: Acute Disease; Animals; Chronic Disease; Contrast Media; Cyclosporine; Graft Rejection; Immunosuppressive Agents; Kidney Cortex; Kidney Transplantation; Magnetic Resonance Imaging; Male; Perfusion; Rats; Rats, Inbred Lew; Rats, Inbred Strains; Time Factors; Transplantation, Homologous; Transplantation, Isogeneic | 1996 |
Light microscopic and electron microscopic features of cyclosporine nephrotoxicity in rats.
Topics: Acute Disease; Animals; Body Weight; Chronic Disease; Cyclosporine; Immunosuppressive Agents; Kidney Diseases; Kidney Tubules; Male; Microscopy, Electron; Rats; Rats, Sprague-Dawley | 1995 |
[Polyarticular pain syndrome during treatment with cyclosporine for severe acute colitis].
Topics: Acute Disease; Adult; Antirheumatic Agents; Colectomy; Colitis, Ulcerative; Combined Modality Therapy; Cyclosporine; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Injections, Intravenous; Osteoarthritis; Prednisone | 1996 |
Increased resources are required in patients with low cyclosporine bioavailability.
Topics: Acute Disease; Adolescent; Adult; Aged; Biological Availability; Black or African American; Chronic Disease; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Male; Middle Aged; Patient Readmission; Racial Groups; Retrospective Studies; Time Factors; White People | 1996 |
Management of acute steroid-resistant rejection after liver transplantation.
Topics: Acute Disease; Acute Kidney Injury; Cause of Death; Cyclosporine; Cytomegalovirus Infections; Drug Resistance; Drug Therapy, Combination; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Liver Transplantation; Methylprednisolone; Muromonab-CD3; Reoperation; Retrospective Studies; Survival Rate; Tacrolimus | 1996 |
Treatment of renal allograft acute rejection with methylprednisolone: effect of fixed dose versus dose per body mass index.
Topics: Acute Disease; Adult; Antilymphocyte Serum; Azathioprine; Body Mass Index; Cyclosporine; Female; Glucocorticoids; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Methylprednisolone; Muromonab-CD3; Prednisone; Regression Analysis; Retrospective Studies; Transplantation, Homologous | 1996 |
Allogeneic peripheral blood progenitor cell transplantation: analysis of short-term engraftment and acute GVHD incidence in 33 cases. allo-PBPCT Spanish Group.
Topics: Actuarial Analysis; Acute Disease; Adolescent; Adrenal Cortex Hormones; Adult; Bone Marrow; Catheterization, Central Venous; Child; Cyclosporine; Female; Filgrastim; Graft Survival; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Lenograstim; Leukapheresis; Leukocyte Count; Male; Methotrexate; Middle Aged; Neutrophils; Platelet Count; Recombinant Proteins; Retreatment; Retrospective Studies; Safety; Transplantation, Homologous; Treatment Outcome | 1996 |
CsA-associated neurotoxicity and ineffective prophylaxis with clonazepam in patients transplanted for thalassemia major: analysis of risk factors.
Topics: Acute Disease; Adolescent; Adrenal Cortex Hormones; Adult; Anticonvulsants; beta-Thalassemia; Blood Transfusion; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Clonazepam; Coma; Combined Modality Therapy; Comorbidity; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Hemosiderosis; Humans; Hypertension; Immunosuppressive Agents; Incidence; Infant; Liver Diseases; Magnesium Deficiency; Magnetic Resonance Imaging; Male; Nervous System Diseases; Retrospective Studies; Risk Factors; Seizures; Tomography, X-Ray Computed; Transplantation Conditioning; Treatment Failure; Vision Disorders | 1996 |
Benefits of continued cyclosporine through an indigent drug program.
Topics: Acute Disease; Adult; Black or African American; Cyclosporine; Female; Graft Rejection; Humans; Kidney Transplantation; Male; Medical Assistance; Medical Indigency; White People | 1996 |
[Successful treatment of interstitial pneumonitis with cyclosporin A in a patient with rheumatoid arthritis accompanied by acute interstitial nephritis].
Topics: Acute Disease; Arthritis, Rheumatoid; Cell Adhesion Molecules; Cyclosporine; Endothelium; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Male; Middle Aged; Nephritis, Interstitial | 1996 |
Peritoneal lavage therapy for severe acute pancreatitis after renal transplantation.
Topics: Acute Disease; Adult; Azathioprine; Cyclosporine; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Methylprednisolone; Pancreatitis; Peritoneal Lavage; Postoperative Complications; Ribonucleosides; Tomography, X-Ray Computed | 1996 |
Effect of immunosuppressive drug regimens on acute and chronic murine toxoplasmosis.
Topics: Acute Disease; Animals; Azathioprine; Chronic Disease; Cyclosporine; Disease Models, Animal; Female; Humans; Hydrocortisone; Immunosuppressive Agents; Male; Mice; Toxoplasma; Toxoplasmosis | 1996 |
Acute toxic myopathy due to pyrazinamide in a patient with renal transplantation and cyclosporine therapy.
Topics: Acute Disease; Adult; Antitubercular Agents; Cyclosporine; Drug Interactions; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Muscular Diseases; Pyrazinamide | 1996 |
Determinants of chronic renal allograft rejection in cyclosporine-treated recipients.
Topics: Acute Disease; Adult; Chronic Disease; Cyclosporine; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Risk Factors; Transplantation, Homologous | 1996 |
Acute skin graft rejection can be prevented and treated in rat models by malononitrilamides.
Topics: Acute Disease; Alkynes; Animals; Cyclosporine; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Graft Rejection; Graft Survival; Immunosuppressive Agents; Isoxazoles; Nitriles; Rats; Rats, Inbred F344; Rats, Inbred Lew; Rats, Inbred Strains; Skin Transplantation; Time Factors | 1996 |
Hepatitis B recurrence in relation to immunosuppression and acute allograft rejection.
Topics: Acute Disease; Carcinoma, Hepatocellular; Cause of Death; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Hepatitis B; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Incidence; Liver Neoplasms; Liver Transplantation; Recurrence; Retrospective Studies | 1996 |
Adhesion molecule P-selectin and vascular cell adhesion molecule-1 in enhanced heart allograft arteriosclerosis in the rat.
Topics: Acute Disease; Animals; Chronic Disease; Coronary Artery Disease; Coronary Vessels; Cyclosporine; Endothelium, Vascular; Graft Rejection; Heart Transplantation; Linear Models; P-Selectin; Rats; Rats, Inbred Strains; Rats, Inbred WF; Vascular Cell Adhesion Molecule-1 | 1997 |
Factors on graft survival of living donor kidney transplantation in a single center.
Topics: ABO Blood-Group System; Acute Disease; Adult; Age Factors; Blood Group Incompatibility; Body Composition; Cyclosporine; Diabetes Complications; Female; Graft Rejection; Graft Survival; Hepatitis B; Hepatitis B Surface Antigens; Histocompatibility; HLA Antigens; Humans; Immunosuppressive Agents; Kidney Transplantation; Living Donors; Male; Middle Aged; Nephrons; Prognosis; Regression Analysis; Retrospective Studies; Risk Factors; Sex Factors | 1996 |
A novel energy dependent mechanism reducing daunorubicin accumulation in acute myeloid leukemia.
Topics: Acute Disease; Adenosine Triphosphate; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blast Crisis; Cyclosporine; Daunorubicin; Flow Cytometry; Humans; Leukemia, Myeloid; Potassium Cyanide; RNA, Messenger; Tumor Cells, Cultured | 1997 |
Complete remission of lichen-planus-like graft-versus-host disease (GVHD) with extracorporeal photochemotherapy (ECP).
Topics: Acute Disease; Bone Marrow Transplantation; Cyclosporine; Extracorporeal Circulation; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lichen Planus; Male; Middle Aged; Prednisolone; PUVA Therapy; Remission Induction; Skin Diseases; Transplantation, Homologous | 1997 |
[The importance of the sonographic image in the differential diagnosis of acute rejection in kidney transplantation].
Topics: Acute Disease; Cyclosporine; Diagnosis, Differential; Graft Rejection; Humans; Kidney; Kidney Transplantation; Kidney Tubular Necrosis, Acute; Ultrasonography | 1996 |
A survey of the prophylaxis and treatment of acute GVHD in Europe: a report of the European Group for Blood and Marrow, Transplantation (EBMT). Chronic Leukaemia Working Party of the EBMT.
Topics: Acute Disease; Adrenal Cortex Hormones; Bone Marrow Transplantation; Clinical Protocols; Cyclosporine; Europe; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Methotrexate; Surveys and Questionnaires; Transplantation, Homologous | 1997 |
Dose-related reversal of acute lung rejection by aerosolized cyclosporine.
Topics: Acute Disease; Administration, Inhalation; Adult; Aerosols; Bronchoalveolar Lavage Fluid; Cyclosporine; Dose-Response Relationship, Drug; Female; Forced Expiratory Flow Rates; Forced Expiratory Volume; Graft Rejection; Humans; Immunosuppressive Agents; Interleukin-6; Lung; Lung Transplantation; Male; Middle Aged; RNA, Messenger; Vital Capacity | 1997 |
[Clinicopathological features of interstitial pneumonia associated with amyopathic dermatomyositis].
Topics: Acute Disease; Adult; Aged; Anti-Inflammatory Agents; Cyclosporine; Dermatomyositis; Female; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Male; Middle Aged; Prednisolone; Treatment Outcome | 1997 |
Late acute rejection occurring in liver allograft recipients.
Topics: Acute Disease; Adolescent; Adult; Biopsy; Cyclosporine; Female; Glucocorticoids; Graft Rejection; Humans; Immunosuppressive Agents; Liver Function Tests; Liver Transplantation; Male; Middle Aged; Prednisolone; Retrospective Studies; Transplantation, Homologous; Treatment Outcome | 1996 |
Causes of renal allograft loss in black vs. white transplant recipients in the cyclosporine era.
Topics: Acute Disease; Adult; Age Factors; Analysis of Variance; Black People; Chronic Disease; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Histocompatibility; HLA Antigens; Humans; Immunosuppressive Agents; Kidney Transplantation; Longitudinal Studies; Male; Ohio; Reoperation; Retrospective Studies; Sex Factors; Survival Rate; Tissue and Organ Procurement; Transplantation, Homologous; White People | 1997 |
Steroid withdrawal in mycophenolate mofetil-treated renal allograft recipients.
Topics: Acute Disease; Adult; Creatinine; Cyclosporine; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Steroids; Substance Withdrawal Syndrome | 1997 |
Late-onset fatal acute leucoencephalopathy in liver transplant recipient.
Topics: Acute Disease; Adult; Brain Diseases; Cyclosporine; Fatal Outcome; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Liver Transplantation; Male | 1997 |
Long-term graft outcome is not necessarily affected by delayed onset of graft function and early acute rejection.
Topics: Acute Disease; Adult; Azathioprine; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Graft Survival; Half-Life; Humans; Kidney Transplantation; Methylprednisolone; Middle Aged; Reoperation; Risk Factors; Time Factors; Treatment Outcome | 1997 |
Myelodysplastic syndrome and acute myelogenous leukemia as a late clonal complication in children with acquired aplastic anemia.
Topics: Acute Disease; Adolescent; Anemia, Aplastic; Bone Marrow Transplantation; Child; Child, Preschool; Chromosomes, Human, Pair 7; Clone Cells; Combined Modality Therapy; Cyclosporine; Drug Synergism; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cells; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Incidence; Infant; Leukemia, Myeloid; Life Tables; Male; Monosomy; Myelodysplastic Syndromes; Recombinant Proteins; Retrospective Studies; Risk Factors; Survival Analysis; Survival Rate | 1997 |
Cyclosporin A-induced ocular flutter after marrow transplantation.
Topics: Acute Disease; Adult; Bone Marrow Transplantation; Cyclosporine; Female; Graft Rejection; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Ocular Motility Disorders; Transplantation, Homologous | 1997 |
Graft outcome in cadaver renal transplants treated with full-dose cyclosporine induction without antibody, irrespective of graft function.
Topics: Acute Disease; Adult; Cadaver; Cause of Death; Cyclosporine; Female; Follow-Up Studies; Forecasting; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Logistic Models; Male; Muromonab-CD3; Regression Analysis; Retrospective Studies; Risk Factors; Sex Factors; Time Factors; Tissue Donors; Tissue Preservation; Treatment Outcome; Wounds and Injuries | 1997 |
Treatment of steroid-resistant and recurrent acute cardiac transplant rejection with a short course of antibody therapy.
Topics: Acute Disease; Antilymphocyte Serum; Arteriosclerosis; Azathioprine; Bacterial Infections; Biopsy; Cost-Benefit Analysis; Cyclosporine; Drug Administration Schedule; Drug Resistance; Female; Follow-Up Studies; Glucocorticoids; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Incidence; Male; Methylprednisolone; Middle Aged; Muromonab-CD3; Prednisone; Randomized Controlled Trials as Topic; Recurrence; Survival Rate; Treatment Outcome | 1997 |
Induction immunosuppressive therapy is associated with a low rejection rate after liver transplantation.
Topics: Acute Disease; Acyclovir; Adolescent; Adult; Aged; Antilymphocyte Serum; Antiviral Agents; Azathioprine; Biopsy; Cyclosporine; Cytomegalovirus Infections; Female; Follow-Up Studies; Glucocorticoids; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Incidence; Liver Transplantation; Male; Methylprednisolone; Middle Aged; Muromonab-CD3; Retrospective Studies; T-Lymphocytes; Transplantation, Homologous; Treatment Outcome | 1997 |
[Graft-versus-leukemia effect induced by abrupt discontinuation of cyclosporine A following allogeneic bone marrow transplantation].
Topics: Acute Disease; Adult; Bone Marrow Transplantation; Cyclosporine; Female; Graft vs Host Disease; Humans; Leukemia; Male; Middle Aged | 1997 |
Acute cellular rejection after liver transplantation: variability, morbidity, and mortality.
Topics: Acute Disease; Adolescent; Adult; Child; Child, Preschool; Cyclosporine; Dose-Response Relationship, Drug; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Length of Stay; Liver Transplantation; Morbidity; Retrospective Studies; Survival Rate | 1995 |
Influence of steroid withdrawal on proteinuria in renal allograft recipients.
Topics: Acute Disease; Analysis of Variance; Anti-Inflammatory Agents; Azathioprine; Chi-Square Distribution; Chronic Disease; Creatinine; Cyclosporine; Female; Follow-Up Studies; Glucocorticoids; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Linear Models; Logistic Models; Male; Middle Aged; Multivariate Analysis; Prednisone; Proteinuria; Recurrence; Transplantation, Homologous | 1997 |
The significance of the IgG anti-B-cell crossmatch on renal transplant outcome.
Topics: Acute Disease; Antibodies; Azathioprine; B-Lymphocytes; Case-Control Studies; Chronic Disease; Cyclosporine; Female; Follow-Up Studies; Glucocorticoids; Graft Rejection; Graft Survival; Histocompatibility; Histocompatibility Antigens Class I; Histocompatibility Antigens Class II; Humans; Immunoglobulin G; Immunosuppressive Agents; Incidence; Kidney Transplantation; Male; Muromonab-CD3; Prednisone; Retrospective Studies; Transplantation, Homologous; Treatment Outcome | 1997 |
Expression of c-Kit and functional drug efflux are correlated in de novo acute myeloid leukaemia.
Topics: Acute Disease; Antimetabolites, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporine; Daunorubicin; Drug Resistance, Multiple; Fluorescent Antibody Technique, Indirect; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Phenotype; Proto-Oncogene Proteins c-kit; Rhodamine 123; Rhodamines; Tumor Cells, Cultured | 1997 |
Delayed xenograft rejection of pig-to-baboon cardiac transplants after cobra venom factor therapy.
Topics: Acute Disease; Animals; Cyclophosphamide; Cyclosporine; Elapid Venoms; Graft Rejection; Heart Transplantation; Immunosuppressive Agents; Methotrexate; Methylprednisolone; Myocardium; Papio; Splenectomy; Swine; Transplantation, Heterologous | 1997 |
Long-term renal function in type I diabetics after kidney or kidney-pancreas transplantation: influence of number, timing, and treatment of acute rejection episodes.
Topics: Acute Disease; Adult; Creatinine; Cyclosporine; Diabetes Mellitus, Type 1; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney; Kidney Transplantation; Linear Models; Male; Middle Aged; Pancreas Transplantation; Time Factors | 1997 |
Vascular effects of cyclosporin A and acute rejection in canine heart transplantation.
Topics: Acetylcholine; Acute Disease; Adenosine Diphosphate; Animals; Coronary Artery Disease; Coronary Circulation; Coronary Vessels; Cyclosporine; Dinoprost; Dogs; Dose-Response Relationship, Drug; Endothelium, Vascular; Factor VIII; Graft Rejection; Heart Transplantation; Immunoenzyme Techniques; Immunoglobulin G; Immunoglobulin M; Immunosuppressive Agents; In Vitro Techniques; Muscle, Smooth, Vascular; Myocardium; Nitroprusside; Serotonin; Thrombin; Transplantation, Heterotopic; Tunica Intima; Vasoconstriction; Vasodilation | 1997 |
Effect on cell kill of addition of multidrug resistance modifiers cyclosporin A and PSC 833 to cytotoxic agents in acute myeloid leukaemia.
Topics: Acute Disease; Adolescent; Adult; Aged; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cell Survival; Coloring Agents; Cyclosporine; Cyclosporins; Cytarabine; Daunorubicin; Drug Resistance, Neoplasm; Drug Synergism; Etoposide; Female; Humans; Idarubicin; Leukemia, Myeloid; Male; Middle Aged; Mitoxantrone; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 1997 |
Renal expression and urinary concentration of EGF and IL-6 in acutely dysfunctioning kidney transplanted patients.
Topics: Acute Disease; Adolescent; Adult; Cyclosporine; Epidermal Growth Factor; Female; Gene Expression; Graft Rejection; Humans; Immunosuppressive Agents; Interleukin-6; Kidney; Male; Middle Aged | 1997 |
Generalized pustular psoriasis responsive to PUVA and oral cyclosporin therapy.
Topics: Acute Disease; Administration, Oral; Biopsy, Needle; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Methoxsalen; Middle Aged; Psoriasis; PUVA Therapy | 1997 |
Acute pancreatitis in marrow transplant patients: prevalence at autopsy and risk factor analysis.
Topics: Abdominal Pain; Acute Disease; Adult; Amylases; Bile; Biomarkers; Bone Marrow Transplantation; Cause of Death; Cohort Studies; Cyclosporine; Drug Therapy, Combination; Female; Gallbladder; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Methotrexate; Neoplasms; Pancreatitis; Prednisone; Prevalence; Risk Factors; Transplantation Conditioning; Whole-Body Irradiation | 1997 |
Acute onset of colchicine myoneuropathy in cardiac transplant recipients: case studies of three patients.
Topics: Acute Disease; Colchicine; Creatine Kinase; Creatinine; Cyclosporine; Dose-Response Relationship, Drug; Electromyography; Female; Gout; Gout Suppressants; Heart Transplantation; Humans; Male; Middle Aged; Motor Neurons; Neuromuscular Diseases; Neuromuscular Junction; Peripheral Nervous System Diseases; Renal Insufficiency | 1997 |
High-dose intravenous pulse methylprednisolone hemisuccinate in acute Behçet retinitis.
Topics: Acute Disease; Behcet Syndrome; Cyclosporine; Glucocorticoids; Humans; Immunosuppressive Agents; Infusions, Intravenous; Male; Methylprednisolone Hemisuccinate; Middle Aged; Prednisone; Retinitis; Visual Acuity; Visual Fields | 1998 |
[Combination of cyclosporin and ketoconazole in immunosuppression schemes in patients with transplanted kidney].
Topics: Acute Disease; Antifungal Agents; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Ketoconazole; Kidney Transplantation; Retrospective Studies; Treatment Outcome | 1998 |
[Treatment with cyclosporine of severe colitis in hemorrhagic rectocolitis. Apropos of 7 cases].
Topics: Acute Disease; Adult; Colitis; Colitis, Ulcerative; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Recurrence; Retrospective Studies; Time Factors | 1997 |
Severe knee pain as the single symptom of CMV infection in acute ulcerative colitis treated with cyclosporine.
Topics: Acute Disease; Adult; Anti-Inflammatory Agents; Azathioprine; Colitis, Ulcerative; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Knee; Male; Methylprednisolone; Pain | 1998 |
[Acute nephrotoxicity resolved by cyclosporine A, induced by simultaneous administration of colchicine].
Topics: Acute Disease; Chemical and Drug Induced Liver Injury; Colchicine; Cyclosporine; Gout Suppressants; Humans; Immunosuppressive Agents; Male; Middle Aged | 1998 |
Effect of different immunosuppressive agents on acute pancreatitis: a comparative study in an improved animal model.
Topics: Acute Disease; Animals; Azathioprine; Cyclosporine; Immunosuppressive Agents; Male; Muromonab-CD3; Necrosis; Pancreas; Pancreatitis; Prednisolone; Rats; Rats, Sprague-Dawley | 1998 |
Intravenous cyclosporin as rescue therapy in severe ulcerative colitis: time for a reappraisal?
Topics: Acute Disease; Adult; Aged; Anti-Inflammatory Agents; Colitis, Ulcerative; Cyclosporine; Female; Humans; Hydrocortisone; Immunosuppressive Agents; Infusions, Intravenous; Male; Middle Aged; Retrospective Studies; Treatment Outcome | 1998 |
Potential interaction of troglitazone and cyclosporine.
Topics: Acute Disease; Chromans; Cyclosporine; Drug Interactions; Female; Graft Rejection; Humans; Hypoglycemic Agents; Immunosuppressive Agents; Middle Aged; Osmolar Concentration; Thiazoles; Thiazolidinediones; Troglitazone | 1998 |
[Usefulness of the EEG recording in the diagnosis of cyclosporin A-induced encephalopathy].
Topics: Acute Disease; Adult; Confusion; Cyclosporine; Electroencephalography; Epilepsy; Graft Rejection; Headache; Humans; Immunosuppressive Agents; Liver Transplantation; Lung Transplantation; Male; Middle Aged; Tremor; Vision Disorders | 1998 |
Malononitrilamides reduce IgM and IgG xenoantibodies and prolong skin xenograft survival in a mouse-to rat model.
Topics: Acute Disease; Alkynes; Animals; Antibodies, Heterophile; Antibody Formation; Cyclosporine; Graft Rejection; Graft Survival; Immunosuppressive Agents; Isoxazoles; Mice; Mice, Inbred BALB C; Nitriles; Rats; Rats, Inbred Lew; Skin Transplantation; Time Factors; Transplantation, Heterologous | 1998 |
Influence of initial antigen-independent events on acute allograft rejection: inhibition by a soluble P-selectin ligand and low-dose cyclosporine in combination.
Topics: Acute Disease; Animals; Cyclosporine; Graft Rejection; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Membrane Glycoproteins; P-Selectin; Rats; Rats, Inbred Lew; Rats, Inbred Strains; Transplantation, Homologous | 1998 |
An effect of FTY720 on acute rejection in canine renal transplantation.
Topics: Acute Disease; Animals; Blood Cell Count; Cyclosporine; Dogs; Fingolimod Hydrochloride; Graft Rejection; Graft Survival; Immunosuppressive Agents; Kidney Transplantation; Lymphocyte Count; Propylene Glycols; Sphingosine; Transplantation, Homologous | 1998 |
Role of acute rejection in chronic rejection.
Topics: Acute Disease; Cadaver; Chronic Disease; Cyclosporine; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Living Donors; Regression Analysis; Retrospective Studies; Risk Factors; Tissue Donors | 1998 |
Rescue FK506 therapy for acute rejection and early chronic rejection after liver transplantation: report of 14 cases.
Topics: Acute Disease; Azathioprine; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Male; Middle Aged; Retrospective Studies; Tacrolimus | 1998 |
Lower incidence of liver graft rejection in patients on diltiazem plus cyclosporine therapy.
Topics: Acute Disease; Adolescent; Adult; Aged; Calcium Channel Blockers; Child; Cyclosporine; Diltiazem; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Liver Transplantation; Male; Middle Aged; Muromonab-CD3; Retrospective Studies | 1998 |
Does initial graft function influence the outcome after liver transplantation?
Topics: Acute Disease; Cyclosporine; Drug Resistance; Drug Therapy, Combination; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Liver Transplantation; Methylprednisolone; Muromonab-CD3; Reoperation; Retrospective Studies; Steroids; Survival Rate; Tacrolimus; Treatment Outcome | 1998 |
Incidence of acute rejection in African-American liver transplant recipients.
Topics: Acute Disease; Adult; Black or African American; Black People; California; Cyclosporine; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Incidence; Liver Transplantation; Male; Middle Aged; Retrospective Studies; Risk Factors; Survival Rate; Tacrolimus; White People | 1998 |
Late acute rejection episodes after vascularized pancreas transplantation.
Topics: Acute Disease; Azathioprine; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Pancreas Transplantation; Prednisone; Retrospective Studies; Tacrolimus; Time Factors | 1998 |
[Indication for the steroid therapy for acute rejection].
Topics: Acute Disease; Adolescent; Adult; Child; Cyclosporine; Drug Administration Schedule; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Living Donors; Male; Middle Aged | 1998 |
Adjuvant treatment with ursodeoxycholic acid may reduce the incidence of acute cardiac allograft rejection.
Topics: Acute Disease; Cholestasis; Cyclosporine; Female; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Retrospective Studies; Ursodeoxycholic Acid | 1998 |
Malononitrilamides synergistically prevent acute and treat ongoing skin allograft rejection with cyclosporine.
Topics: Acute Disease; Alkynes; Animals; Cyclosporine; Drug Synergism; Graft Rejection; Immunosuppressive Agents; Isoxazoles; Nitriles; Rats; Rats, Inbred F344; Rats, Inbred Lew; Skin Transplantation | 1998 |
Mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant patients.
Topics: Acute Disease; Adolescent; Adult; Anemia; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukopenia; Male; Middle Aged; Mycophenolic Acid; Prednisolone | 1998 |
[Mycophenolate mofetil].
Topics: Acute Disease; Adrenal Cortex Hormones; B-Lymphocytes; Cell Division; Clinical Trials as Topic; Cyclosporine; Diarrhea; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Kidney; Kidney Transplantation; Leukopenia; Mycophenolic Acid; Risk Factors; T-Lymphocytes | 1998 |
Cyclosporin A acute encephalopathy and seizure syndrome in childhood: clinical features and risk of seizure recurrence.
Topics: Acute Disease; Adolescent; Brain; Brain Diseases; Child; Child, Preschool; Cyclosporine; Dose-Response Relationship, Drug; Electroencephalography; Epilepsy; Female; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Organ Transplantation; Recurrence; Tomography, X-Ray Computed | 1998 |
Induction of species-specific host accommodation in the hamster-to-rat xenotransplantation model.
Topics: Acute Disease; Animals; Cricetinae; Cyclosporine; Disease Models, Animal; Drug Combinations; Graft Rejection; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Isoxazoles; Leflunomide; Mesocricetus; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Models, Biological; Rats; Rats, Inbred Lew; Species Specificity; Time Factors; Transplantation, Heterologous | 1998 |
Effect of acute rejection episodes on long-term renal graft survival.
Topics: Acute Disease; Azathioprine; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Prognosis; Retrospective Studies; Steroids; Time Factors | 1998 |
Low incidence of acute graft-versus-host disease and recurrent leukaemia in patients undergoing allogeneic haemopoietic stem cell transplantation from sibling donors with methotrexate and dose-monitored cyclosporin A prophylaxis.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Drug Therapy, Combination; Female; Graft vs Host Disease; Graft vs Tumor Effect; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia; Male; Methotrexate; Middle Aged; Recurrence; Tissue Donors; Transplantation, Homologous | 1998 |
Lymphotactin: a key regulator of lymphocyte trafficking during acute graft rejection.
Topics: Acute Disease; Animals; Blotting, Northern; Cells, Cultured; Chemotaxis, Leukocyte; Cyclosporine; Gene Expression; Graft Rejection; Immunosuppressive Agents; In Situ Hybridization; Kidney Transplantation; Lymphocytes; Lymphokines; Male; Phytohemagglutinins; Rats; Rats, Inbred F344; Rats, Inbred Lew; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sialoglycoproteins; Tacrolimus; Tetradecanoylphorbol Acetate; Transplantation, Homologous | 1998 |
Late acute rejection and subclinical noncompliance with cyclosporine therapy in heart transplant recipients.
Topics: Acute Disease; Cyclosporine; Female; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Interviews as Topic; Longitudinal Studies; Male; Middle Aged; Monitoring, Physiologic; Psychometrics; Risk Factors; Time Factors; Treatment Refusal | 1998 |
[A close association of prognosis with effect of interferon in HBV carriers developing acute severe exacervation].
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Carrier State; Cyclosporine; Drug Therapy, Combination; Female; Hepatic Encephalopathy; Hepatitis B; Humans; Interferons; Male; Middle Aged; Prednisolone; Prognosis | 1998 |
Low level of interleukin 10 synthesis during liver allograft rejection.
Topics: Acute Disease; Azathioprine; Cells, Cultured; Chronic Disease; Cyclosporine; Graft Rejection; Humans; Immunosuppressive Agents; Interleukin-10; Liver Transplantation; Lymphocyte Culture Test, Mixed; Lymphocytes; Methylprednisolone; Tacrolimus; Transplantation, Homologous | 1998 |
Rescue photochemotherapy for the treatment of acute cardiac rejection in the absence of cyclosporine maintenance therapy.
Topics: Acute Disease; Adult; Biopsy; Cyclosporine; Drug Therapy, Combination; Endocardium; Female; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Myocardium; Photochemotherapy; Photopheresis; Purpura, Thrombotic Thrombocytopenic | 1998 |
Acute intestinal graft-versus-host disease in a syngeneic bone marrow transplant recipient.
Topics: Acute Disease; Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Humans; Immunosuppressive Agents; Intestinal Diseases; Lymphoma, Non-Hodgkin; Male; Middle Aged; Transplantation, Isogeneic | 1998 |
Influence of SDZ-PSC833 on daunorubicin intracellular accumulation in bone marrow specimens from patients with acute myeloid leukaemia.
Topics: Acute Disease; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bone Marrow; Cyclosporine; Cyclosporins; Daunorubicin; Drug Interactions; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Tumor Cells, Cultured | 1998 |
FK506 rescue therapy for acute renal allograft rejection.
Topics: Acute Disease; Creatinine; Cyclosporine; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Muromonab-CD3; Tacrolimus | 1998 |
Hepatitis B and C virus-induced diseases and acute rejection after liver transplantation.
Topics: Acute Disease; Adolescent; Adrenal Cortex Hormones; Adult; Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Hepatitis B; Hepatitis C; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Muromonab-CD3; Postoperative Complications; Retrospective Studies; Tacrolimus; Time Factors | 1998 |
Prophylaxis of acute renal allograft rejection using FTY720 in combination with subtherapeutic doses of cyclosporine.
Topics: Acute Disease; Animals; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fingolimod Hydrochloride; Graft Rejection; Immunosuppressive Agents; Kidney Transplantation; Macaca fascicularis; Propylene Glycols; Sphingosine; Transplantation, Homologous | 1999 |
[Liver transplantation: experiences and results of a program at the University of Liege].
Topics: Actuarial Analysis; Acute Disease; Adrenal Cortex Hormones; Adult; Azathioprine; Belgium; Chronic Disease; Cyclosporine; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney Transplantation; Liver Diseases; Liver Transplantation; Myocardial Infarction; Postoperative Complications; Reoperation; Survival Rate; Tacrolimus; Time Factors; Waiting Lists | 1998 |
Beneficial effects of calcium channel blockade on acute glomerular hemodynamic changes induced by cyclosporine.
Topics: Acute Disease; Animals; Antihypertensive Agents; Calcium Channel Blockers; Cyclosporine; Dihydropyridines; Glomerular Filtration Rate; Hemodynamics; Immunosuppressive Agents; Kidney Glomerulus; Male; Rats; Rats, Wistar; Time Factors | 1999 |
Mitoxantrone, etoposide, and cytarabine plus cyclosporine for patients with relapsed or refractory acute myeloid leukemia: an Eastern Cooperative Oncology Group pilot study.
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporine; Cytarabine; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Female; Gene Expression Regulation, Neoplastic; Genes, MDR; Humans; Leukemia, Myeloid; Leukopenia; Liver; Male; Middle Aged; Mitoxantrone; Recurrence; Remission Induction; Survival Rate; Treatment Outcome | 1999 |
Sirolimus (rapamycin) potentiates cyclosporine in prevention of acute lung rejection.
Topics: Acute Disease; Animals; Cyclosporine; Drug Synergism; Drug Therapy, Combination; Graft Rejection; Immunosuppressive Agents; Lung Transplantation; Random Allocation; Rats; Rats, Inbred BN; Rats, Inbred Lew; Sirolimus | 1999 |
Suppression of acute rejection in allogeneic rat lung transplantation: a study of the efficacy and pharmacokinetics of rapamycin derivative (SDZ RAD) used alone and in combination with a microemulsion formulation of cyclosporine.
Topics: Acute Disease; Administration, Oral; Animals; Cyclosporine; Drug Therapy, Combination; Emulsions; Everolimus; Graft Rejection; Immunosuppressive Agents; Lung; Lung Transplantation; Male; Radiography; Rats; Rats, Inbred BN; Rats, Inbred Lew; Sirolimus | 1999 |
Long-term outcomes in pediatric liver recipients: comparison between cyclosporin A and tacrolimus.
Topics: Acute Disease; Adolescent; Child; Child, Preschool; Chronic Disease; Cyclosporine; Graft Rejection; Herpesviridae Infections; Herpesvirus 4, Human; Humans; Immunosuppressive Agents; Infant; Liver Function Tests; Liver Transplantation; Retrospective Studies; Tacrolimus; Treatment Outcome; Tumor Virus Infections | 1999 |
Efficacy of tacrolimus in the treatment of refractory rejection in heart and lung transplant recipients.
Topics: Acute Disease; Adult; Aged; Biopsy; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Graft Rejection; Heart-Lung Transplantation; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Muromonab-CD3; Retrospective Studies; Severity of Illness Index; Tacrolimus; Treatment Outcome | 1999 |
Increased expression of interleukin-4 during liver allograft rejection.
Topics: Acute Disease; Adult; Cholestasis; Chronic Disease; Cyclosporine; Female; Gene Expression Regulation; Graft Rejection; Humans; Immunohistochemistry; Immunosuppression Therapy; Interleukin-2; Interleukin-4; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Receptors, Interleukin-2; Retrospective Studies; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcription, Genetic; Transplantation, Homologous | 1999 |
Myofibroblast proliferation, fibrosis, and defective pancreatic repair induced by cyclosporin in rats.
Topics: Actins; Acute Disease; Animals; Cell Division; Ceruletide; Collagenases; Cyclosporine; Fibrosis; Gastrointestinal Agents; Hydroxyproline; Immunosuppressive Agents; Male; Pancreas; Pancreatitis; Rats; Rats, Wistar; Regeneration; Transforming Growth Factor beta | 1999 |
Effects of cyclosporin A treatment on clinical course and inflammatory cell apoptosis in experimental autoimmune encephalomyelitis induced in Lewis rats by inoculation with myelin basic protein.
Topics: Acute Disease; Animals; Apoptosis; Cyclosporine; Encephalomyelitis, Autoimmune, Experimental; Flow Cytometry; G1 Phase; G2 Phase; Immunization; Immunosuppressive Agents; Male; Mitosis; Myelin Basic Protein; Rats; Rats, Inbred Lew; Resting Phase, Cell Cycle; S Phase; Spinal Cord; T-Lymphocytes | 1999 |
Neoral monitoring by simplified sparse sampling area under the concentration-time curve: its relationship to acute rejection and cyclosporine nephrotoxicity early after kidney transplantation.
Topics: Acute Disease; Adult; Area Under Curve; Biological Availability; Cyclosporine; Dose-Response Relationship, Drug; Drug Monitoring; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Time Factors | 1999 |
Optimization of the immunosuppressive protocol after lung transplantation.
Topics: Acute Disease; Adult; Animals; Antilymphocyte Serum; Azathioprine; Chronic Disease; Creatinine; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Diseases; Lung Transplantation; Male; Middle Aged; Mycophenolic Acid; Prednisone; Rabbits; Retrospective Studies; Tacrolimus | 1999 |
Acute myopathy induced by colchicine in a cyclosporine treated heart transplant recipient: possible role of the multidrug resistance transporter.
Topics: Acute Disease; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chemical and Drug Induced Liver Injury; Colchicine; Cyclosporine; Drug Resistance, Multiple; Drug Therapy, Combination; Gastrointestinal Diseases; Gout Suppressants; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney Diseases; Male; Middle Aged; Muscular Diseases; Syndrome | 1999 |
Conversion from cyclosporine to FK 506 as rescue therapy in renal transplantation with poorly steroid-responsive acute rejection.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Cyclosporine; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Retrospective Studies; Tacrolimus | 1999 |
Usefulness of the switch to tacrolimus in liver transplantation.
Topics: Acute Disease; Adult; Chronic Disease; Cyclosporine; Graft Rejection; Humans; Immunosuppressive Agents; Liver Transplantation; Retrospective Studies; Tacrolimus | 1999 |
Plasma cell-rich acute renal allograft rejection.
Topics: Acute Disease; Adolescent; Adult; Cadaver; Cyclosporine; Female; Graft Rejection; Humans; Immunohistochemistry; Immunosuppressive Agents; In Situ Hybridization; Kidney Transplantation; Male; Middle Aged; Plasma Cells; Tacrolimus; Time Factors; Treatment Outcome | 1999 |
Antisense oligodeoxynucleotides prevent acute cardiac allograft rejection via a novel, nontoxic, highly efficient transfection method.
Topics: Acute Disease; Animals; Antibodies, Monoclonal; Cyclosporine; Genetic Therapy; Graft Rejection; Graft Survival; Heart Transplantation; Intercellular Adhesion Molecule-1; Lymphocyte Function-Associated Antigen-1; Male; Oligodeoxyribonucleotides, Antisense; Rats; Rats, Inbred ACI; Rats, Inbred BN; Rats, Sprague-Dawley; Therapeutic Equivalency; Transfection; Transplantation, Homologous | 1999 |
Correlation between disparity for the minor histocompatibility antigen HA-1 and the development of acute graft-versus-host disease after allogeneic marrow transplantation.
Topics: Acute Disease; Adolescent; Adult; Aged; Alleles; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility; Histocompatibility Testing; HLA-A2 Antigen; Humans; Immunosuppressive Agents; Incidence; Infant; Male; Methotrexate; Middle Aged; Minor Histocompatibility Antigens; Nuclear Family; Oligopeptides; Parity; Retrospective Studies; Risk; Severity of Illness Index; Transplantation Conditioning; Whole-Body Irradiation | 1999 |
High-dose peripheral blood stem cell transplant for multitransfused severe aplastic anaemia patients without antithymocyte globulin in the conditioning regimen.
Topics: Acute Disease; Adolescent; Adult; Anemia, Aplastic; Antilymphocyte Serum; Blood Transfusion; Cyclophosphamide; Cyclosporine; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Methotrexate | 1999 |
Flow-cytometric measurement of cellular changes in urine: a simple and rapid method for perioperatively monitoring patients after kidney transplantation.
Topics: Acute Disease; Cyclosporine; Female; Flow Cytometry; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Kidney Tubular Necrosis, Acute; Male; Predictive Value of Tests; Sensitivity and Specificity; Urine | 1999 |
The relative influence of antigen-dependent and independent factors for development and progression of chronic rejection.
Topics: Acute Disease; Animals; Aorta; Chronic Disease; Cyclosporine; Disease Progression; Graft Rejection; Heart Transplantation; Isoantigens; Rats; Transplantation, Homologous | 1999 |
Interpretation of surveillance kidney allograft biopsies according to the Banff criteria.
Topics: Acute Disease; Adult; Biopsy; Cadaver; Creatinine; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Living Donors; Male; Pregnancy; Proteinuria; Tissue Donors | 1999 |
Impact of acute rejection therapy on infections and malignancies in renal transplant recipients.
Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Communicable Diseases; Cyclosporine; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Muromonab-CD3; Neoplasms; Postoperative Complications; Retrospective Studies; Risk; Risk Factors; Survival Analysis; Time Factors | 1999 |
Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejection.
Topics: Acute Disease; Animals; Chronic Disease; Cyclosporine; Graft Rejection; Graft Survival; Heart Transplantation; Lymphocyte Activation; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Receptors, CCR1; Receptors, Chemokine; RNA, Messenger; Transplantation, Homologous | 2000 |
Clinical benefit of neoral dose monitoring with cyclosporine 2-hr post-dose levels compared with trough levels in stable heart transplant patients.
Topics: Acute Disease; Aged; Cyclosporine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Incidence; Longitudinal Studies; Male; Middle Aged; Postoperative Complications; Stroke Volume; Treatment Outcome | 1999 |
The combined effect of total body irradiation (TBI) and cyclosporin A (CyA) on the risk of relapse in patients with acute myeloid leukaemia undergoing allogeneic bone marrow transplantation.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Cyclosporine; Disease-Free Survival; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Recurrence; Risk Factors; Transplantation, Homologous; Whole-Body Irradiation | 2000 |
Exhaled nitric oxide correlates with experimental lung transplant rejection.
Topics: Acute Disease; Analysis of Variance; Animals; Cyclosporine; Disease Models, Animal; Free Radical Scavengers; Genetic Therapy; Graft Rejection; Immunosuppressive Agents; Lung; Lung Transplantation; Male; Nitric Oxide; Organ Preservation Solutions; Rats; Rats, Inbred BN; Rats, Inbred F344; Respiration; Transfection; Transforming Growth Factor beta; Transplantation, Homologous | 2000 |
Perfusatory recovery of the grafted lung during convalescence from acute rejection.
Topics: Acute Disease; Animals; Aorta, Thoracic; Azathioprine; Blood Flow Velocity; Cyclosporine; Dogs; Graft Rejection; Immunosuppressive Agents; Laser-Doppler Flowmetry; Lung; Lung Transplantation; Pulmonary Artery; Pulmonary Circulation; Transplantation, Homologous; Ultrasonography | 2000 |
Severe acute graft-versus-host disease occurring after syngeneic BMT for AML in a patient not given prior cyclosporin A therapy.
Topics: Acute Disease; Adolescent; Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Histocompatibility Testing; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Transplantation Conditioning | 2000 |
FK506-induced intractable leukoencephalopathy following allogeneic bone marrow transplantation.
Topics: Acute Disease; Adolescent; Child, Preschool; Cyclosporine; Dementia, Vascular; Electroencephalography; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Magnetic Resonance Imaging; Male; Seizures; Tacrolimus | 2000 |
Study of acute chagasic mice under immunosuppressive therapy by cyclosporin A : modulation and confocal analysis of inflammatory reaction.
Topics: Acute Disease; Animals; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Movement; Chagas Disease; Cyclosporine; Female; Immunohistochemistry; Immunosuppressive Agents; Kinetics; Leukocyte Count; Lymphocyte Count; Macrophages; Mice; Microscopy, Confocal; Monocytes; Myocarditis; Myocardium; Organ Size; Parasitemia; Spleen; Thymus Gland; Time Factors; Trypanosomiasis | 2000 |
Neoral dose monitoring with cyclosporine 2-hour postdose levels in heart transplant patients receiving anti-thymocyte globulin induction.
Topics: Acute Disease; Antilymphocyte Serum; Cardiomyopathies; Cyclosporine; Drug Administration Schedule; Drug Monitoring; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged | 2000 |
Use of anti-hypertensive medications and post-transplant renal allograft function in children.
Topics: Acute Disease; Antihypertensive Agents; Cadaver; Child; Cyclosporine; Glomerular Filtration Rate; Graft Rejection; Humans; Hypertension, Renal; Immunosuppressive Agents; Kidney Transplantation; Living Donors | 2000 |
Excellent long-term graft survival in low risk, primary renal allografts treated with prednisolone-avoidance immunosuppression.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Antilymphocyte Serum; Azathioprine; Cohort Studies; Contraindications; Creatinine; Cyclosporine; Follow-Up Studies; Glucocorticoids; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Life Tables; Linear Models; Longitudinal Studies; Middle Aged; Muromonab-CD3; Prednisolone; Survival Rate; T-Lymphocytes; Transplantation, Homologous | 2000 |
Acute graft-versus-host disease in thalassaemic marrow transplantation with low-dose antithymocyte globulin.
Topics: Acute Disease; Adolescent; Anti-Inflammatory Agents; Antilymphocyte Serum; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Immunosuppressive Agents; Incidence; Male; Prednisolone; Severity of Illness Index; Thalassemia; Transplantation Conditioning; Treatment Outcome | 1999 |
Acute cyclosporine A-induced nephrotoxicity: a rabbit model.
Topics: Acute Disease; Animals; Cyclosporine; Glycerol; Kidney; Kidney Diseases; Male; Rabbits; Renal Circulation; Surface-Active Agents | 2000 |
Lack of acute cyclosporine nephrotoxicity in late heart-transplant recipients.
Topics: Acute Disease; Atrial Natriuretic Factor; Biomarkers; Creatinine; Cyclosporine; Glomerular Filtration Rate; Graft Rejection; Heart Failure; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney Diseases; Male; Middle Aged; Prognosis | 2000 |
Successful combined therapy of cyclophosphamide and cyclosporine for acute exacerbated interstitial pneumonia associated with dermatomyositis.
Topics: Acute Disease; Adult; Cyclophosphamide; Cyclosporine; Dermatomyositis; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Injections, Intravenous; Lung Diseases, Interstitial; Prednisolone | 2000 |
Altered distribution and density of myocardial beta-adrenoceptors during acute rejection in rats.
Topics: Acute Disease; Adrenergic beta-Antagonists; Animals; Cyclosporine; Graft Rejection; Heart Transplantation; Immunosuppressive Agents; Male; Myocardium; Propanolamines; Rats; Rats, Inbred F344; Receptors, Adrenergic, beta; Reference Values; Time Factors; Tissue Distribution; Transplantation, Heterotopic; Transplantation, Homologous; Transplantation, Isogeneic | 2000 |
The relationship between acute rejection and chronic rejection is highly dependent on specific MHC matching: a multi-strain rat heterotopic heart transplant study.
Topics: Acute Disease; Animals; Chronic Disease; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; Graft Rejection; Heart Transplantation; Histocompatibility Testing; Major Histocompatibility Complex; Postoperative Complications; Rats; Rats, Inbred BN; Rats, Inbred Lew; Rats, Inbred WF; Transplantation, Homologous; Viral Plaque Assay | 2000 |
Cardiac hypertrophy is not a required compensatory response to short-term pressure overload.
Topics: Acute Disease; Adaptation, Physiological; Animals; Aorta, Thoracic; Calcineurin Inhibitors; Cardiomegaly; Cyclosporine; Echocardiography; Enzyme Inhibitors; Hemodynamics; Hypertension; Ligation; Male; Mice; Mice, Inbred C57BL | 2000 |
Heightened CD40 ligand gene expression in peripheral CD4+ T cells from patients with kidney allograft rejection.
Topics: Acute Disease; Adult; Base Sequence; Case-Control Studies; CD4-Positive T-Lymphocytes; CD40 Antigens; CD40 Ligand; Chronic Disease; Cyclosporine; DNA Primers; Gene Expression; Graft Rejection; Humans; Immunosuppressive Agents; In Vitro Techniques; Kidney Transplantation; Ligands; Membrane Glycoproteins; Middle Aged; Tacrolimus | 2000 |
Pediatric utilization of rapamycin for severe cardiac allograft rejection.
Topics: Acute Disease; Adult; Animals; Antilymphocyte Serum; Child; Cyclosporine; Female; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Methotrexate; Methylprednisolone; Mycophenolic Acid; Platelet Count; Prednisone; Rabbits; Safety; Sirolimus; T-Lymphocytes; Tacrolimus | 2000 |
Association between a positive flow cytometry crossmatch and the development of chronic rejection in primary renal transplantation.
Topics: Acute Disease; Adult; Analysis of Variance; Chronic Disease; Cyclosporine; Female; Graft Rejection; Graft Survival; Histocompatibility Testing; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Retrospective Studies; Sex Factors; Time Factors | 2000 |
Endothelin, angiotensin II and adenosine in acute cyclosporine A nephrotoxicity.
Topics: Acute Disease; Adenosine; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cyclosporine; Endothelins; Glomerular Filtration Rate; Immunosuppressive Agents; Kidney; Kidney Diseases; Male; Perindopril; Rabbits; Renal Circulation; Theophylline; Vascular Resistance; Water | 2000 |
Prevention of acute rejection with antithymocyte globulin, avoiding corticosteroids, and delaying cyclosporin after renal transplantation.
Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Antilymphocyte Serum; Biopsy; Cyclosporine; Cytomegalovirus Infections; Drug Administration Schedule; Drug Therapy, Combination; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Kidney; Kidney Transplantation; Middle Aged; Mycophenolic Acid; Pilot Projects; Postoperative Complications | 2000 |
Hydrophobic extracts of a Chinese herb (CMX-13) exhibit potent immunosuppressive properties and prevent acute rejection in a highly histoincompatible model of rat lung transplantation.
Topics: Acute Disease; Animals; Cell Division; Cyclosporine; Drugs, Chinese Herbal; Gene Expression; Graft Rejection; Histocompatibility; Immunosuppressive Agents; Interferon-gamma; Interleukin-2; Lung Transplantation; Lymphocyte Activation; Male; Rats; Rats, Inbred BN; Rats, Inbred Lew; Reverse Transcriptase Polymerase Chain Reaction; RNA; Spleen; Statistics as Topic; Transplantation, Homologous | 2000 |
Numerous adrenal chromaffin cell preparations fail to produce analgesic effects in the formalin test or in tests of acute pain even with nicotine stimulation.
Topics: Acute Disease; Adrenal Glands; Animals; Behavior, Animal; Cattle; Cell Transplantation; Chromaffin Cells; Cyclosporine; Formaldehyde; Immunosuppressive Agents; Male; Nicotine; Nicotinic Agonists; Pain Measurement; Rats; Rats, Sprague-Dawley; Stimulation, Chemical; Transplantation, Heterologous | 2000 |
Completely reversed acute rejection is not a significant risk factor for the development of chronic rejection in renal allograft recipients.
Topics: Acute Disease; Adrenal Cortex Hormones; Aged; Azathioprine; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Muromonab-CD3; Recurrence; Retrospective Studies; Risk Factors; Transplantation, Homologous | 2000 |
Defective interleukin-1 receptor antagonist production is associated with resistance of acute liver graft rejection to steroid therapy.
Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Cyclosporine; Drug Resistance; Enzyme-Linked Immunosorbent Assay; Female; Graft Rejection; Humans; Immunohistochemistry; Immunosuppressive Agents; Interleukin 1 Receptor Antagonist Protein; Interleukin-1; Liver Transplantation; Male; Middle Aged; Polymorphism, Genetic; Reference Values; Sialoglycoproteins; Time Factors | 2000 |
Pretransplantation tumor necrosis factor-alpha production predicts acute rejection after liver transplantation.
Topics: Acute Disease; Biomarkers; Cyclosporine; Dexamethasone; Enzyme-Linked Immunosorbent Assay; Female; Glucocorticoids; Graft Rejection; Humans; Immunosuppressive Agents; Interleukin-10; Leukocytes, Mononuclear; Liver Failure; Liver Transplantation; Male; Middle Aged; Preoperative Care; Prognosis; Tacrolimus; Tumor Necrosis Factor-alpha | 2000 |
Chronic graft-versus-host disease of the liver: presentation as an acute hepatitis.
Topics: Acute Disease; Adult; Chronic Disease; Cyclosporine; Diagnosis, Differential; Drug Therapy, Combination; Female; Glucocorticoids; Graft vs Host Disease; Hepatitis, Viral, Human; Humans; Immunosuppressive Agents; Liver; Liver Transplantation; Male; Prednisone; Treatment Outcome | 2000 |
Inhibition of neutral endopeptidase potentiates the effects of atrial natriuretic peptide on acute cyclosporin-induced nephrotoxicity.
Topics: Acute Disease; Animals; Atrial Natriuretic Factor; Cyclosporine; Drug Synergism; Glomerular Filtration Rate; Immunosuppressive Agents; Injections, Intravenous; Inulin; Kidney; Male; Neprilysin; Protease Inhibitors; Rats; Rats, Wistar; Sodium Chloride; Thiorphan; Tritium | 2000 |
Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acute graft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicities.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Drug Resistance; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hemolytic-Uremic Syndrome; Humans; Immunosuppressive Agents; Kidney Diseases; Male; Middle Aged; Peripheral Nervous System Diseases; Retrospective Studies; Tacrolimus; Transplantation, Homologous; Treatment Outcome | 2000 |
Sub-clinical acute rejection detected using protocol biopsies in patients with delayed graft function.
Topics: Acute Disease; Adult; Biopsy, Needle; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Function Tests; Kidney Transplantation; Male; Middle Aged; Prednisolone; Tacrolimus | 2000 |
Orlistat decreases the plasma level of cyclosporine and may be responsible for the development of acute rejection episodes.
Topics: Acute Disease; Cyclosporine; Enzyme Inhibitors; Graft Rejection; Humans; Lactones; Lipase; Orlistat | 2000 |
Acute rejection in renal transplant patients using cyclosporine versus microemulsion-form cyclosporine: incidence and severity.
Topics: Acute Disease; Cadaver; Cyclosporine; Emulsions; Female; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Living Donors; Male; Proportional Hazards Models; Retrospective Studies; Tissue Donors | 2000 |
Acute rejection and the therapeutic choice of drug.
Topics: Acute Disease; Adult; Cyclosporine; Disease Progression; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Guanidines; Histocompatibility Testing; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Muromonab-CD3; Retrospective Studies; Tacrolimus; Time Factors; Treatment Outcome | 2000 |
Drug fever caused by mycophenolate mofetil in a renal transplant recipient--a case report.
Topics: Acute Disease; Adult; Cyclosporine; Drug Therapy, Combination; Fever; Graft Rejection; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Kidney Transplantation; Male; Mycophenolic Acid; Tacrolimus | 2000 |
More effective immunosuppression with the use of FK506 after liver transplantation.
Topics: Acute Disease; Adolescent; Adult; Child; Child, Preschool; Chronic Disease; Cyclosporine; Graft Rejection; Humans; Hypertension; Immunosuppressive Agents; Incidence; Infant; Liver Transplantation; Middle Aged; Retrospective Studies; Tacrolimus | 2000 |
Clinical course and predictive factors for cyclosporin-induced autologous graft-versus-host disease after autologous haematopoietic stem cell transplantation.
Topics: Acute Disease; Adolescent; Adult; Age Factors; Aged; Breast Neoplasms; Chi-Square Distribution; Child; Child, Preschool; Cyclosporine; Disease-Free Survival; Female; Graft vs Leukemia Effect; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; HLA-B Antigens; HLA-DR6 Antigen; Hodgkin Disease; Humans; Immunosuppressive Agents; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multiple Myeloma; Myelodysplastic Syndromes; Prospective Studies; Transplantation, Autologous | 2000 |
Successful use of cyclosporin A for the treatment of acute interstitial pneumonitis associated with rheumatoid arthritis.
Topics: Acute Disease; Adrenal Cortex Hormones; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Middle Aged; Treatment Outcome | 2000 |
Increased level of HSP27 but not of HSP72 in human heart allografts in relation to acute rejection.
Topics: Acute Disease; Cyclosporine; Graft Rejection; Heart Transplantation; Heat-Shock Proteins; HSP27 Heat-Shock Proteins; HSP72 Heat-Shock Proteins; Humans; Immunosuppressive Agents; Microscopy, Fluorescence; Molecular Chaperones; Myocardium; Neoplasm Proteins; Transplantation, Homologous | 2000 |
Tumor necrosis factor-alpha gene polymorphism and death due to acute cellular rejection in a subgroup of heart transplant recipients.
Topics: Acute Disease; Adjuvants, Immunologic; Alleles; Antilymphocyte Serum; Azathioprine; Cyclosporine; Genetic Carrier Screening; Genotype; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Polymorphism, Genetic; Prednisolone; Tumor Necrosis Factor-alpha | 2001 |
[Therapy of chronic inflammatory intestinal disease].
Topics: Acute Disease; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Budesonide; Chronic Disease; Colectomy; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Drug Combinations; Gastrointestinal Agents; Glucosamine; Humans; Immunosuppressive Agents; Infliximab; Sulfasalazine | 2000 |
Cyclosporin increases cellular idarubicin and idarubicinol concentrations in relapsed or refractory AML mainly due to reduced systemic clearance.
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Daunorubicin; Female; Humans; Idarubicin; Immunosuppressive Agents; Leukemia, Myeloid; Male; Middle Aged; Pilot Projects; Prospective Studies; Recurrence | 2001 |
Cyclosporin A withdrawal in live related renal transplantation: long-term results.
Topics: Acute Disease; Adult; Chronic Disease; Cyclosporine; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Living Donors; Male; Risk Factors; Time Factors | 2001 |
FK 506 rescue therapy for intractable liver allograft rejection.
Topics: Acute Disease; Adult; Bilirubin; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Retrospective Studies; Tacrolimus; Transplantation, Homologous; Treatment Outcome | 1994 |
Chronic rejection in pediatric renal transplantation: where are we?
Topics: Acute Disease; Animals; Calcineurin Inhibitors; Child; Chronic Disease; Creatinine; Cyclosporine; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Nephritis, Interstitial; Primates; Risk Factors; T-Lymphocytes, Cytotoxic | 2000 |
Intracellular P-gp contributes to functional drug efflux and resistance in acute myeloid leukaemia.
Topics: Acute Disease; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Cell Death; Cell Survival; Cyclosporine; Daunorubicin; Dose-Response Relationship, Drug; Drug Interactions; Drug Resistance, Multiple; Flow Cytometry; HL-60 Cells; Humans; K562 Cells; Leukemia, Myeloid; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; RNA, Messenger; Vault Ribonucleoprotein Particles; Verapamil | 2001 |
Combination therapy with tacrolimus and anti-thymocyte globulin for the treatment of steroid-resistant acute graft-versus-host disease developing during cyclosporine prophylaxis.
Topics: Acute Disease; Adult; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Isoantibodies; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphoma; Male; Methotrexate; Middle Aged; Multiple Myeloma; Myelodysplastic Syndromes; Tacrolimus; Transplantation, Homologous | 2001 |
[Acute pancreatitis after kidney transplantation].
Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Azathioprine; Cadaver; Cyclosporine; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Multiple Organ Failure; Mycophenolic Acid; Pancreatitis; Peritonitis; Retrospective Studies; Risk Factors | 2001 |
Failure to down-regulate intragraft cytokine mRNA expression shortly after clinical heart transplantation is associated with high incidence of acute rejection.
Topics: Acute Disease; Biopsy; Chemokine CCL2; Cyclosporine; Cytokines; Endocardium; Fibroblast Growth Factor 2; Gene Expression Regulation; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Incidence; Ischemia; Myocardium; RNA, Messenger; Vascular Diseases | 2001 |
Mycophenolate Mofetil in the treatment of acute and chronic GVHD in hematopoietic stem cell transplant patients: four years of experience.
Topics: Acute Disease; Adult; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Leukemia; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Nuclear Family; Recurrence; Retrospective Studies; Survival Rate; Whole-Body Irradiation | 2001 |
OKT3 versus methylprednisolone for primary treatment of rejection: a retrospective evaluation.
Topics: Acute Disease; Adrenal Cortex Hormones; Creatinine; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Methylprednisolone; Muromonab-CD3; Retrospective Studies | 2001 |
Prophylactic use of deoxyspergualin improves long-term graft survival in living related renal transplant recipients transfused with donor-specific blood.
Topics: Acute Disease; Azathioprine; Blood Transfusion; Chi-Square Distribution; Cyclosporine; Drug Therapy, Combination; Family; Follow-Up Studies; Graft Rejection; Graft Survival; Guanidines; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Incidence; Kidney Transplantation; Living Donors; Retrospective Studies; Survivors; Time Factors | 2001 |
Evaluation of various immunosuppressive regimes in second renal transplants.
Topics: Acute Disease; Antilymphocyte Serum; Azathioprine; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Muromonab-CD3; Mycophenolic Acid; Prednisolone; Reoperation; Retrospective Studies; Treatment Outcome | 2001 |
Acute cardiac ongoing rejection: comparison between different strategies.
Topics: Acute Disease; Adolescent; Adult; Aged; Antilymphocyte Serum; Azathioprine; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Female; Graft Rejection; Heart Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Muromonab-CD3; Postoperative Complications; Prednisone; Recurrence; Retrospective Studies | 2001 |
Long-term results of donor-specific blood transfusion with cyclosporine in living related kidney transplantation.
Topics: Acute Disease; Adolescent; Adult; Blood Transfusion; Child; Cyclosporine; Female; Graft Rejection; Graft Survival; Humans; Immunization; Immunosuppressive Agents; Kidney Transplantation; Living Donors; Male; Middle Aged; Retrospective Studies; Tacrolimus | 2001 |
Expression of multidrug resistance P-glycoprotein in kidney allografts from cyclosporine A-treated patients.
Topics: Acute Disease; Adult; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cells, Cultured; Chronic Disease; Cyclosporine; Graft Rejection; Humans; Immunosuppressive Agents; Kidney; Kidney Diseases; Kidney Transplantation; Kidney Tubular Necrosis, Acute; Middle Aged; Monocytes; Reference Values; Tissue Donors; Transplantation, Homologous; Tumor Necrosis Factor-alpha | 2001 |
Case 1: persistent acute rejection after kidney transplantation.
Topics: Acute Disease; Adult; Cyclosporine; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male | 2001 |
Nocardia asteroides lung abscess in acute ulcerative colitis treated with cyclosporine.
Topics: Acute Disease; Aged; Colitis, Ulcerative; Cyclosporine; Humans; Immunosuppressive Agents; Lung Abscess; Male; Nocardia asteroides; Nocardia Infections; Opportunistic Infections; Radiography | 2001 |
MC1288, a vitamin D analog, prevents acute graft-versus-host disease in rat bone marrow transplantation.
Topics: Acute Disease; Animals; Biomarkers; Bone Marrow Transplantation; Calcitriol; Cyclosporine; Graft vs Host Disease; Immunosuppressive Agents; Inflammation; Liver; Models, Animal; Rats; Rats, Inbred Lew; Skin; Spleen | 2001 |
Multidrug-resistance phenotype and clinical responses to gemtuzumab ozogamicin.
Topics: Acute Disease; Aminoglycosides; Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bone Marrow; Carbocyanines; Clinical Trials, Phase II as Topic; Cyclosporine; Drug Resistance, Multiple; Drug Synergism; Fluorescent Dyes; Gemtuzumab; Humans; Immunotoxins; Leukemia, Myeloid; Leukocytes, Mononuclear; Phenotype; Regression Analysis; Remission Induction; Treatment Outcome; Tumor Cells, Cultured | 2001 |
Results of a small series of renal graft biopsies in a Lebanese population.
Topics: Acute Disease; Biopsy; Cyclosporine; Glomerulonephritis; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Kidney Tubular Necrosis, Acute; Lebanon; Recurrence; Retrospective Studies; Transplantation, Homologous | 2001 |
Chronic renal allograft dysfunction: immunologic and nonimmunologic risk factors.
Topics: Acute Disease; Adolescent; Adult; Child; Creatinine; Cyclosporine; Female; Graft Rejection; Humans; Hypertension; Immunosuppressive Agents; Infections; Iran; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Regression Analysis; Risk Factors; Transplantation, Homologous | 2001 |
Sirolimus improves the two-year outcome of renal allografts in African-American patients.
Topics: Acute Disease; Adult; Black or African American; Black People; Cohort Studies; Cyclosporine; Drug Therapy, Combination; Female; Glucocorticoids; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Male; Middle Aged; Prednisone; Sirolimus; Time Factors; Treatment Outcome; White People | 2001 |
Accumulation and activation-induced release of preformed Fas (CD95) ligand during the pathogenesis of experimental graft-versus-host disease.
Topics: Acute Disease; Animals; Cyclosporine; fas Receptor; Graft vs Host Disease; Immunosuppressive Agents; Intestine, Small; Liver; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Organ Specificity; Spleen; T-Lymphocytes; T-Lymphocytes, Cytotoxic | 2001 |
[Apoptosis and proliferative activity of bone marrow cells in patients with aplastic syndromes as evidenced by trephine biopsy].
Topics: Acute Disease; Anemia, Refractory; Apoptosis; Biopsy; Bone Marrow Cells; Cyclosporine; Data Interpretation, Statistical; Humans; Immunohistochemistry; Immunosuppressive Agents; Leukemia; Models, Theoretical | 2001 |
Daclizumab (humanized anti-IL2Ralpha mAb) prophylaxis for prevention of acute rejection in renal transplant recipients with delayed graft function.
Topics: Acute Disease; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Biopsy; Cyclosporine; Daclizumab; Dose-Response Relationship, Drug; Graft Rejection; Graft Survival; Humans; Immunoglobulin G; Immunosuppressive Agents; Kidney; Kidney Diseases; Kidney Transplantation; Multicenter Studies as Topic; Postoperative Care; Randomized Controlled Trials as Topic; Retrospective Studies; Survival Analysis; Time Factors | 2001 |
Cyclosporin for severe ulcerative colitis does not increase the rate of perioperative complications.
Topics: Acute Disease; Adult; Anti-Inflammatory Agents; Colectomy; Colitis, Ulcerative; Cyclosporine; Female; Humans; Ileostomy; Immunosuppressive Agents; Infusions, Intravenous; Intraoperative Complications; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Steroids | 2001 |
Successful treatment with steroids of upper gastrointestinal acute graft vs. host disease after hematopoietic stem cell transplantation.
Topics: Acute Disease; Adult; Cyclosporine; Endoscopy, Gastrointestinal; Gastrointestinal Diseases; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Male; Prednisolone | 2001 |
Polyoma viral infection in renal transplantation: the role of immunosuppressive therapy.
Topics: Acute Disease; Adult; Cyclosporine; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Nephritis, Interstitial; Polyomavirus Infections; Risk Factors; Tacrolimus; Tumor Virus Infections | 2001 |
Targeting keratinocyte apoptosis in the treatment of atopic dermatitis and allergic contact dermatitis.
Topics: Acute Disease; Apoptosis; Cells, Cultured; Cyclosporine; Dermatitis, Allergic Contact; Dermatitis, Atopic; Dexamethasone; fas Receptor; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Interleukin-12; Keratinocytes; Sirolimus; T-Lymphocytes; Tacrolimus; Th1 Cells; Theophylline | 2001 |
Effects of cyclosporine in steroid-refractory severe acute ulcerative colitis.
Topics: Acute Disease; Adult; Colitis, Ulcerative; Cyclosporine; Female; Humans; Immunosuppressive Agents; Infusions, Intravenous; Steroids | 2002 |
Nonmyeloablative conditioning followed by transplantation of genetically modified HLA-matched peripheral blood progenitor cells for hematologic malignancies in patients with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Acute Disease; Adult; Anti-Bacterial Agents; Antiretroviral Therapy, Highly Active; Cyclophosphamide; Cyclosporine; Feasibility Studies; Ganciclovir; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Infection Control; Leukemia, Myeloid; Prednisone; Premedication; Recurrence; Remission Induction; Transplantation Conditioning; Treatment Outcome; Vidarabine; Viral Load | 2002 |
One-year routine renal transplant biopsies in children.
Topics: Acute Disease; Adolescent; Adult; Aging; Biopsy; Child; Child, Preschool; Cryopreservation; Cyclosporine; Female; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Kidney; Kidney Diseases; Kidney Transplantation; Male; Postoperative Period; Renal Circulation; Time Factors; Vascular Diseases | 2001 |
Tacrolimus rescue therapy for children with acute renal transplant rejection.
Topics: Acute Disease; Adolescent; Child; Child, Preschool; Cyclosporine; Drug Resistance; Glucocorticoids; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Methylprednisolone; Retreatment; Retrospective Studies; Salvage Therapy; Tacrolimus; Treatment Outcome | 2001 |
Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.
Topics: Acute Disease; Adolescent; Adult; Busulfan; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Cytarabine; Disease-Free Survival; Etoposide; Female; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Immunosuppressive Agents; Infant; Leukemia; Life Tables; Male; Methylprednisolone; Middle Aged; Premedication; Retrospective Studies; Risk; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Whole-Body Irradiation | 2002 |
Synergism of RAD and cyclosporin A in prevention of acute rat corneal allograft rejection.
Topics: Acute Disease; Animals; B-Lymphocytes; Cyclosporine; Drug Synergism; Drug Therapy, Combination; Everolimus; Graft Rejection; Graft Survival; Immunosuppressive Agents; Keratoplasty, Penetrating; Rats; Rats, Inbred F344; Rats, Inbred Lew; Sirolimus; T-Lymphocytes; Transplantation, Homologous | 2002 |
Hematopoietic cell transplantation beyond first remission.
Topics: Acute Disease; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Comorbidity; Cyclosporine; Cytarabine; Daunorubicin; Disease-Free Survival; Follow-Up Studies; Graft Survival; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid; Middle Aged; Mitoxantrone; Nuclear Family; Prospective Studies; Randomized Controlled Trials as Topic; Remission Induction; Salvage Therapy; Survival Rate; Tissue Donors; Transplantation, Homologous; Treatment Outcome; Vidarabine | 2002 |
Fulminant colitis: the case for operative treatment.
Topics: Acute Disease; Colitis, Ulcerative; Cyclosporine; Humans; Hydrocortisone; Proctocolectomy, Restorative; Severity of Illness Index | 2002 |
The value of switching from cyclosporine to tacrolimus in the treatment of refractory acute rejection and obliterative bronchiolitis after lung transplantation.
Topics: Acute Disease; Adult; Bronchiolitis Obliterans; Cyclosporine; Female; Graft Rejection; Humans; Immunosuppressive Agents; Lung Transplantation; Male; Tacrolimus | 2002 |
Diurnal cyclosporine dosing optimizes exposure and reduces the risk of acute rejection after kidney transplantation.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Area Under Curve; Cyclosporine; Drug Administration Schedule; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Pilot Projects; Prospective Studies | 2001 |
Low-dose oral prednisone in the treatment of acute cardiac allograft rejection.
Topics: Acute Disease; Azathioprine; Biopsy; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Prednisone; Retrospective Studies | 2002 |
[Combined antithymocyte globulin. cyclosporin. methylprednisolone and granulocyte colony-stimulating factor are effective in a patient with hepatitis-associated severe aplastic anemia].
Topics: Acute Disease; Adult; Anemia, Aplastic; Antilymphocyte Serum; Cyclosporine; Drug Therapy, Combination; Granulocyte Colony-Stimulating Factor; Hepatitis; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Remission Induction; Severity of Illness Index | 2002 |
Expression of nonmuscle myosin heavy chain B (SMemb) in rat allogeneic kidney transplantation.
Topics: Acute Disease; Animals; Cyclosporine; Graft Rejection; Immunohistochemistry; Immunosuppressive Agents; Kidney Glomerulus; Kidney Transplantation; Male; Myosin Heavy Chains; Nonmuscle Myosin Type IIB; Rats; Rats, Inbred Lew; Rats, Wistar; Transplantation, Homologous | 2002 |
A novel CD154 monoclonal antibody in acute and chronic rat vascularized cardiac allograft rejection.
Topics: Acute Disease; Animals; Antibodies, Monoclonal; CD4-Positive T-Lymphocytes; CD40 Ligand; Chronic Disease; Cricetinae; Cyclosporine; Cytokines; Gene Expression; Graft Rejection; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Immunotherapy; Male; Rats; Rats, Inbred Lew; Rats, Inbred WF; Ribonucleases; Transplantation, Homologous | 2002 |
Cyclosporine modulation in poor-risk acute myeloid leukemia.
Topics: Acute Disease; Clinical Protocols; Cyclosporine; Drug Resistance; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Remission Induction; Risk Assessment; Statistics as Topic; Treatment Outcome | 2002 |
Antilymphocyte globulin with a small dose of cyclosporine A and prednisone as the induction of immunosuppression in renal allograft recipients.
Topics: Acute Disease; Acute Kidney Injury; Adult; Antilymphocyte Serum; Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Humans; Incidence; Infections; Ischemia; Kidney; Kidney Transplantation; Male; Middle Aged; Muromonab-CD3; Phlebitis; Postoperative Complications; Prednisone; Survival Rate; Thrombocytopenia; Transplantation, Homologous | 1992 |
Strong donor mononuclear cell reactivity for herpes simplex virus antigen in immune donor/recipient pairs is associated with acute graft-versus-host disease.
Topics: Acute Disease; Adult; Antigens, Viral; Bone Marrow Transplantation; Cyclosporine; Female; Graft vs Host Disease; Humans; Leukocytes, Mononuclear; Lymphocyte Depletion; Male; Methotrexate; Simplexvirus | 1992 |
Hemolytic uremic syndrome in a patient with systemic sclerosis treated with cyclosporin A.
Topics: Acute Disease; Cyclosporine; Female; Fibrosis; Hemolytic-Uremic Syndrome; Humans; Kidney; Middle Aged; Scleroderma, Systemic | 1992 |
Clinical, laboratory, and histopathologic indicators of the development of progressive acute graft-versus-host disease.
Topics: Acute Disease; Adolescent; Adult; Bilirubin; Biopsy; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Feces; Graft vs Host Disease; Humans; Middle Aged; Skin; Whole-Body Irradiation | 1992 |
Endothelin receptor antagonism is protective in in vivo acute cyclosporine toxicity.
Topics: Acute Disease; Animals; Cyclosporine; Endothelin Receptor Antagonists; Injections; Injections, Intra-Arterial; Injections, Intravenous; Kidney; Kidney Diseases; Male; Rats; Rats, Wistar; Renal Artery | 1992 |
Increased levels of tissue plasminogen activator (t-PA) and tissue plasminogen activator inhibitor (PAI) correlate with tumor necrosis factor alpha (TNF alpha)-release in patients suffering from microangiopathy following allogeneic bone marrow transplanta
Topics: Acute Disease; Adult; beta-Thromboglobulin; Bone Marrow Transplantation; Cyclosporine; Factor VIII; Fibrin Fibrinogen Degradation Products; Graft vs Host Disease; Humans; Microcirculation; Middle Aged; Plasminogen Activator Inhibitor 1; Platelet Factor 4; Prospective Studies; Severity of Illness Index; Tissue Plasminogen Activator; Transplantation, Autologous; Transplantation, Homologous; Tumor Necrosis Factor-alpha; Vascular Diseases; von Willebrand Factor | 1992 |
Acute rejection of lung allografts with various immunosuppressive protocols.
Topics: Acute Disease; Adolescent; Adult; Antilymphocyte Serum; Azathioprine; Biopsy, Needle; Child; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Heart-Lung Transplantation; Humans; Immunosuppressive Agents; Lung; Lung Transplantation; Middle Aged; Postoperative Complications; Prednisone; Survival Rate | 1992 |
Improvement in outcome for children receiving allogeneic bone marrow transplantation in first remission of acute myeloid leukemia: a report from the Groupe d'Etude des Greffes de Moelle Osseuse.
Topics: Acute Disease; Adolescent; Analysis of Variance; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Female; Graft vs Host Disease; Humans; Infant; Leukemia, Myeloid; Male; Methotrexate; Regression Analysis; Retrospective Studies; Transplantation, Homologous; Treatment Outcome | 1992 |
Effective prevention of acute GVHD following allogeneic BMT with low leukaemic relapse using methotrexate and therapeutically monitored levels of cyclosporin A.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Leukemia; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Recurrence | 1992 |
Flow cytometric measurements in 104 anti-T-lymphocyte globulin treatments.
Topics: Acute Disease; Adult; Antilymphocyte Serum; Cadaver; CD3 Complex; Cyclosporine; Dose-Response Relationship, Drug; Female; Flow Cytometry; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Reoperation; Risk Factors; T-Lymphocyte Subsets | 1992 |
Morphology of rejection in experimental pancreas transplantation and its modification by cyclosporin A administration.
Topics: Acute Disease; Animals; Cyclosporine; Graft Rejection; Lymphocytes; Male; Pancreas; Pancreas Transplantation; Rats; Rats, Inbred Strains; Transplantation, Homologous; Transplantation, Isogeneic | 1992 |
Clinical and experimental studies of acute pancreatitis after renal transplantation.
Topics: Acute Disease; Adult; Animals; Child; Cyclosporine; Female; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Pancreatitis; Rats; Rats, Inbred Strains; Survival Analysis | 1992 |
Severe acute form of adult dermatomyositis treated with cyclosporine.
Topics: Acute Disease; Cyclosporine; Dermatomyositis; Drug Resistance; Female; Humans; Middle Aged; Prednisolone; Severity of Illness Index | 1992 |
Effects of prostaglandin E2 (PGE2) and drugs affecting PGE2 degradation on acute rejection of rat cardiac allografts.
Topics: Acute Disease; Animals; Benzophenones; Cyclosporine; Dinoprostone; Graft Rejection; Graft Survival; Heart Transplantation; Male; Propiophenones; Rats; Rats, Inbred Strains; Rats, Inbred WKY | 1992 |
Acute lichen planus treated by Sandimmun (ciclosporin)
Topics: Acute Disease; Adult; Cyclosporine; Etretinate; Humans; Lichen Planus; Male | 1992 |
FK 506 for rescue treatment of acute and chronic rejection in liver allograft recipients.
Topics: Acute Disease; Chronic Disease; Cyclosporine; Follow-Up Studies; Graft Rejection; Humans; Liver Transplantation; Middle Aged; Tacrolimus; Treatment Outcome | 1991 |
FK 506 used as rescue therapy for human liver allograft recipients.
Topics: Acute Disease; Chronic Disease; Cyclosporine; Follow-Up Studies; Graft Rejection; Humans; Liver Transplantation; Steroids; Transplantation, Homologous; Treatment Outcome | 1991 |
[Infantile dermatomyositis. Clinical aspects and prospective treatments].
Topics: Acute Disease; Adolescent; Adrenal Cortex Hormones; Biopsy; Child; Child, Preschool; Chronic Disease; Cyclophosphamide; Cyclosporine; Dermatomyositis; Drug Therapy, Combination; Female; Humans; Male | 1991 |
Histological features of acute pancreatic allograft rejection after pancreaticoduodenal transplantation in the rat.
Topics: Acute Disease; Animals; Cyclosporine; Graft Rejection; Graft Survival; Islets of Langerhans; Pancreas; Pancreas Transplantation; Pancreatic Ducts; Rats; Rats, Inbred BN; Rats, Inbred Lew; Transplantation, Homologous | 1991 |
Complete remission and possible immune tolerance after multidrug combination chemotherapy for cyclosporine-related lymphoma in a renal transplant recipient with acute pancreatitis.
Topics: Acute Disease; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Female; Humans; Immune Tolerance; Kidney Transplantation; Lymphoma; Pancreatitis | 1991 |
Acute cyclosporin A induced nephrotoxicity in renal allografts.
Topics: Acute Disease; Adult; Creatinine; Cyclosporine; Female; Humans; Kidney; Kidney Transplantation; Male; Middle Aged; Renal Circulation | 1991 |